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It is now widely accepted that even with universal access and greater use of existing core 
malaria control measures, elimination of the disease will prove unattainable, especially in areas 
holoendemic for malaria. There is therefore a major public health imperative to identify new 
effective interventions to consolidate the major but fragile gains achieved over recent years. 
House improvement contributed to malaria elimination in developed countries but its potential 
as a vector control method remains generally underexploited in Africa. In2Care’s electrostatic 
charged netting is a core component of the novel In2Care® EaveTubes vector control method, 
which is an example prototype belonging to a new house-based intervention class defined by 
the Vector Control Advisory Group (VCAG) as “lethal house lure”. It is described as 
“Modifications made to a house to decrease exposure of inhabitants to vector”. Although a 
range of laboratory and semi field studies provided some evidence on its potential to reduce 
malaria transmission, very little is known about its mode of functioning (“modus operandi”) if 
deployed in mass at village level for vector control. 
To fill this gap in knowledge, the present PhD project was designed as part of a cluster 
randomized controlled trial (CRT) evaluating the epidemiological impact of this new 
intervention in areas highly affected by pyrethroid resistance in central Côte d’Ivoire. A series 
of resistance genotyping, laboratory and experimental hut studies were performed: (i) to 
investigate initially the dynamics of insecticide resistance and associated genetic mechanisms 
in Anopheles mosquitoes from the trial area and explore its entomological impact on 
pyrethroid-only LLINs, (ii) to select and evaluate a long-lasting insecticide for use in In2Care® 
EaveTubes and investigate whether the community-wide deployment of EaveTubes treated 
with the chosen insecticide would exert any selection pressure on mosquitoes and (iii) explore 
whether existing vector control technologies including new generation LLIN or IRS insecticide 
formulations could be adapted to serve as alternative options for delivering insecticides in 
EaveTubes.  
Resistance to insecticides from major classes was prevalent prior to the trial and was mediated 
primarily by target-site mutations and detoxification enzymes including cytochrome P450s and 
carboxylesterase. Pyrethroid resistance levels were extremely high and was shown to 
compromise the performance of pyrethroid-only LLIN in experimental huts. Although a wide 
range of insecticide classes could be deployed in EaveTubes for effective control of pyrethroid 




~50% reduction in overnight mosquito survival in hut studies. However, the community-level 
use of beta-cyfluthrin treated EaveTubes resulted in a significant increase in the intensity of 
pyrethroid resistance over two years and, this was underpinned by a temporal increase in 
expression of metabolic genes coupled with the rise of cuticular genes over the course of the 
CRT. Alternative ways of delivering insecticides in EaveTubes by using netting from new 
generation LLIN or dipping the tube in insecticide solutions was shown to provide similar 
levels of control as with electrostatic netting despite low persistence.  
These studies demonstrate the significant malaria control potential of EaveTubes in areas with 
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1. Introduction and literature review 
1.1. Malaria control in Africa: progress and challenges 
Malaria is a life-threatening disease caused by protozoan parasites of the genus Plasmodium. 
Human malaria is mostly mediated by four malaria parasites species including Plasmodium 
vivax, P. malaria, P. ovale and P. falciparum, which is the most prevalent on the African 
continent. In addition to these parasites known to exclusively affect humans, a fifth malaria 
parasite, Plasmodium knowlesi, which was originally described as malaria parasite of monkeys 
[1] was also shown to occasionally infect humans. Malaria is transmitted by female Anopheles 
mosquitoes with about 70 species of these having demonstrable malaria transmission potential 
[2]. The most important mosquito vector populations driving malaria transmission in Africa 
are Anopheles gambiae, Anopheles coluzzii, Anopheles arabiensis and Anopheles funestus [3]. 
The disease disproportionately affects children and pregnant women, with the highest burden 
occurring in sub-Saharan Africa [4]. 
Although the first global malaria eradication attempt launched in the 1950s was successful in 
a range of settings, no major success occurred  in equatorial Africa. After a long period of 
neglect, partly due to the economic and financial crisis in the 70s and 80s, the Roll Back 
Malaria initiative was established in 1998 as part of a global plan to reduce malaria burden. 
This initiative culminated in the Abuja declaration in 2000 with recognition of country-level 
leadership as a major requisite for the reduction and eventual elimination of malaria in Africa. 
This renewed political commitment with increased international and domestic financing has 
resulted in the scale up of effective malaria control interventions. The wide scale 
implementation of these control measures has contributed to an unprecedented decline in 
malaria burden over recent years [5]. Indeed, between 2000 and 2015 worldwide malaria 
mortality rates declined by 47%, corresponding to an estimated 4.3 million malaria deaths 
averted, and by 54% in the World Health Organization Africa region. 
To build on the headway achieved over the past 15 years and sustain progress, the World Health 
Organization (WHO) has developed the Global Technical Strategy for Malaria 2016-2030 [6]. 
However, recent estimates suggest that progress has stalled for the first time in over a decade 
between 2015 and 2017, with evidence of increased cases of malaria in some areas [7]. To meet 
the milestones set forth in the WHO strategic document, there is a need to address a range of 




frontline antimalarial medicines in the Greater Mekong sub-region [8], reports of increasingly 
high levels of vector resistance [9–11] and transmission occurring at times and places not 
targeted by existing tools are significant challenges [12–14]. Additionally, financial resources 
currently allocated to malaria control are far less than what is required for malaria control and 
elimination [15]. Achieving the 2030 goal is therefore contingent on development of innovative 
control tools and sustained investment in malaria. 
 
1.2. Malaria vector control  
Vector control is an important facet of the global malaria prevention and control efforts, 
preventing malaria transmission by reducing mosquito daily survival, human-vector contact 
and vector abundance [16]. Prior to World War II, the focus of vector control measures was 
mainly on environmental management, biological control, house improvement and larviciding 
[17,18]. However, the discovery of the insecticidal property of DDT in 1939 triggered a shift 
in control strategies toward insecticide based interventions [19]. Current vector control practice 
still relies on the use of insecticides deployed on mosquito nets and on mosquito resting 
surfaces inside houses. Interestingly, the recent reduction in malaria burden, which is attributed 
mostly to the wide scale roll-out of insecticide based interventions, either in the form of long 
lasting insecticidal nets (LLINs) or indoor residual spraying (IRS), provides tangible evidence 
that vector control is central to the elimination goal.  
 
1.2.1 Insecticide treated nets 
Mosquito nets are the most widely used form of vector control method and an important vehicle 
of insecticide due to their robustness and scalability even in hard-to-reach settings. Although 
all mosquito nets currently in use are treated with insecticides, mosquito nets were originally 
non-insecticidal [20]. Intact, untreated mosquito nets provide some level of protection as a 
physical barrier against blood-seeking mosquitoes [21]. However, protection from untreated 
nets is reduced when the nets acquires holes during routine household use. In the early 2000s, 
insecticide treated nets (ITNs) were introduced to preserve net efficacy even when nets become 
moderately damaged. The efficacy of ITNs was demonstrated in a meta-regression analysis, 
showing up to 41% reduction in malaria incidence among net users compared to non-users 
[22]. While ITNs have proven effective in controlling malaria, there were operational 




treatment to maintain efficacy [23]. Re-treatment of mosquito nets is cumbersome for the 
community. Inevitably, user-fatigue resulting from recurrent net treatment led to low rates of 
re-treatment. With the advent of innovative net manufacturing technologies, the short 
serviceable life of ITNs was addressed through the development of long lasting insecticidal 
nets (LLINs) [24]. Insecticide in LLINs is either coated or incorporated in the net fibres. To 
receive a recommendation from the World Health Organization (WHO), LLINs are expected 
to demonstrate resistance to washing (up to 20 washes) and retain efficacy under routine 
household use for three years [25]. Evidence from field studies suggest that LLINs can retain 
efficacy for three years or more under field use [24]. All currently available LLINs are treated 
with pyrethroids, which provides personal protection to net-user through excito-repellency; the 
protective efficacy is extended to non-users when nets are used on a large scale due to mosquito 
population reduction creating a community mass-effect. 
The efficacy of vector control interventions including LLIN was originally evaluated through 
the World Health Organization Pesticide Evaluation Scheme (WHOPES). However, this 
process was revised in 2017 in order to: (i) speed up the evaluation process, (ii) support wide-
scale distribution of frontline vector control tools, (ii) improve control of neglected tropical 
disease and (iii) address some of the challenges facing vector control programs including 
insecticide resistance in malaria vector mosquitoes. Twenty-two different brands of LLINs 
have so far been PQ listed (https://www.who.int/pq-vector-control/prequalified-lists/en/) 
(Annex 1).  
With increased financial support from the Global Fund to Fight AIDS, Tuberculosis and 
Malaria (Global Fund) and the President’s Malaria Initiative (PMI), coupled with renewed 
political will, the number of people owning and using an insecticide treated nets have increased 
substantially over the past years. For instance, ITN use rose from a low of < 2% in 2000 to 
50% in 2018 [4]. This increase in net use has resulted in a substantial reduction in malaria 
burden, with protection from ITNs accounting for most of the reduction in disease burden (68% 
of 663 million clinical malaria averted) between 2000 and 2015 [5].  
  
1.2.2 Indoor residual spraying 
Targeting indoor resting mosquitoes with residual insecticide is the second most important 
form of vector control. Spraying house walls with insecticide interrupts malaria transmission 
by killing female mosquitoes that enter houses and rest on walls. Indoor residual spraying (IRS) 




was successful in different parts of the world and contributed to the elimination of malaria in 
parts of Europe, North America, Latin America, Japan and Central Asia. The elimination 
campaign was also deployed in a number of African countries including Namibia, 
Mozambique, Botswana, South Africa, and Swaziland [26]. Despite the successful 
implementation of DDT-based IRS, spray campaigns with DDT have been discontinued in 
many endemic countries because of the potential hazardous effect [27] of the insecticide. 
Nevertheless, DDT was reintroduced in some countries and deployed in restricted areas with 
high malaria transmission intensity following the “Stockholm Convention on Persistent 
Organic Pollutants” in 2007 [28]. Spraying with pyrethroids, on the other hand, is considered 
safer and was shown to reduce malaria prevalence when applied on house walls [29,30]. There 
are currently eight insecticides and one insecticide mixture prequalified by WHO as IRS 
insecticides (Annex 2). These chemicals belong to four classes of public health adulticides 
including pyrethroids, carbamates, organophosphates and neonicotinoids. With resistance to 
pyrethroids increasing in strength and prevalence [31], many spray programmes have switched 
to non-pyrethroids to improve control and reduce selection pressure on mosquito vectors. Even 
though WHO advocates for a shift in insecticide policy toward non-pyrethroid chemicals [32], 
IRS operations using insecticides from alternative classes of chemistry including carbamate 
and organophosphate are now under threat from the rapid spread of resistance to these actives 
in malaria vectors [10,33,34]. Moreover, these insecticides are short-lived especially on mud 
walls which are the type of wall commonly found in rural areas. The short residual life of 
alternative compounds leading to multiple sprays round in year-round malaria transmission 
areas together with logistic challenges associated with recurrent campaigns is resulting in fewer 
people being protected by IRS. For example, recent estimates from the WHO world malaria 
report show that global IRS protection have declined from 5% in 2010 to less than 3% in 2018 
[4]. This low IRS coverage rate could be further reduced if a proposed cut of 44% for PMI-
funding on IRS campaign takes effect [35].  
 
In addition to the low IRS coverage rate, the effectiveness of this vector control strategy could 
be undermined by changes in mosquito resting behavior inside houses. Although spray 
operations mainly target house walls and occasionally ceilings, this is based on historical 
evidence showing resting behavior of mosquitoes on these surfaces. However, data from recent 
investigations showed that a signification proportion of mosquitoes, up to 50% in metal-roofed 




that IRS does not cover all resting surfaces are a concern for vector control, additional studies 
are needed to determine whether observed change in mosquito resting behavior result in 
reduced IRS effectiveness.  
House modification following house spraying is another factor that decrease IRS impact [37]. 
A few studies conducted in South Africa [38] and India [39] report between 50-80% decline in 
IRS coverage rate within two to three months post-spray. The sudden decrease in IRS protected 
properties was due to the insecticide being removed by house owners through wall 
washing/brushing, wall plastering and painting. This change in house design often goes 
undetected as there is currently no follow up monitoring of sprayed houses. However, given 
the proven effectiveness of IRS in vector control and its already low coverage rate, guidelines 
on IRS monitoring are required to capture the actual IRS coverage rate and inform decision 
making by national malaria control programmes. 
 
1.3. The challenge of insecticide resistance 
1.3.1. Emergence of insecticide resistance in Africa 
Insecticide resistance is an inherited genetic trait which provides individual mosquitoes the 
ability to survive exposure to a toxic dose of insecticide that would be lethal to most individuals 
of the same species [40]. As effort to increase ownership and use of insecticide based vector 
control tools have intensified, so has the spread of resistance in African malaria vectors [10]. 
Between 2010 and 2018, resistance to at least one insecticide class has been reported in malaria 
vector species in 73 countries with ongoing malaria transmission [7]. The resistance situation 
in sub-Saharan Africa is concerning as this part of the world carries the highest burden of 
malaria. Resistance to pyrethroids, the main insecticide class used on bed nets, has increased 
in prevalence and intensity over recent years [31,41]. The first case of resistance to this 
insecticide was reported in Africa in An. gambiae s.l. from Côte d’Ivoire [42] and has now been 
found in all major African malaria vectors in West [43–49], Central [50–54], East [55–58] and 
Southern Africa [59]. Surprisingly, no pyrethroid resistance has been reported in Anopheles 
mosquitoes from Namibia [60] and Botswana [61] in south-western Africa despite presence of 
resistance in neighbouring countries. The increase in the prevalence of pyrethroid resistance is 
a major concern for vector control efforts as all currently available LLINs rely on pyrethroids. 




during the first malaria elimination programme and was considered the main factor that 
contributed to the failure of the eradication campaign [19,62]. DDT resistance has spread across 
Africa with a distribution pattern similar to that of pyrethroids. Malaria mosquitoes have also 
developed resistance to insecticides from other classes of insecticide. Resistance to carbamates, 
for example the commonly used insecticide bendiocarb, is widespread, with prevalence of 
resistance being highest in countries located in West and Southern Africa (irmapper.com, 
accessed September 2020). Unlike the above-mentioned insecticide classes, resistance to 
organophosphates is less common. Perhaps as a result of the increasing use of the 
organophosphate insecticide pirimiphos methyl in IRS campaigns and in agriculture, cases of 
resistance to this insecticide has been reported in An. gambiae and An. arabiensis in West 
[63]and East Africa [64], but no resistance has so far been detected in An. funestus.  
Multiple insecticide resistance phenotypes have been reported in various African countries 
including Côte d’Ivoire [44], Mali [65]and Kenya [66]. Malaria vector control may prove 
challenging in these countries given the limited insecticide options currently available. 
1.3.2. Insecticide resistance mechanisms 
To survive exposure to otherwise lethal doses of insecticide, mosquitoes have developed a 
range of defensive mechanisms. Mosquitoes develop resistance to insecticides mainly through 
modification of the target site of the insecticide (target site resistance) and through increased 
breakdown or sequestration of the insecticide (metabolic resistance). In addition to these two 
major types of insecticide resistance mechanisms, less well-studied resistance mechanisms 
have been reported. These include: (i) reduced penetration or absorption of the insecticide 
through modification of mosquito’s cuticle (cuticular resistance), (ii) sequestration of 
chemosensory proteins and (iii) behavioural avoidance of insecticide-treated surfaces. 
Although these mechanisms of resistance differ in the way the insecticide is prevented from 









1.3.2.1. Major types of insecticide resistance mechanisms 
1.3.2.1.1. Target-site resistance 
Target site resistance is one of the major and well-characterized mechanisms of resistance. It 
entails changes in insecticide-binding target site and this alteration results in a reduction of the 
amount of insecticide reaching the site. For example, point mutations in the para voltage-gated 
sodium channel (VGSC) ─ the target site for pyrethroids and the organochlorine DDT [67–69] 
─ alter the binding affinity of these insecticides. This type of resistance is also referred to as 
knockdown resistance (kdr), since it enables mosquitoes to withstand longer exposure to 
insecticides without being knocked down. Knock down resistance stems from the substitution 
of the amino acid leucine (Leu) to either phenylalanine (Phe) or serine (Ser) at codon 1014. 
Due to their original disparate geographical distribution, the Peu-Phe substitution is referred to 
as kdr West because it was originally found mostly in West Africa whereas the Leu-Ser was 
limited to East Africa and termed as kdr East. However, there is now evidence of an overlap in 
the distribution of these mutations, with both occurring across most of the African continent –
[70–73][68–71]. The N1575Y (substitution of asparagine to tyrosine), originally identified in 
Burkina Faso, is another VGSC mutation [69] which, in combination with 1014F, enhances 
strength of resistance to pyrethroids and DDT [74]. Although the frequency of the N1575Y is 
relatively low, the mutation is spreading rapidly and has been reported in several West African 
countries (Benin [69,75], Burkina Faso [69], Côte d’Ivoire [76], Ghana [69]) and  two countries 
in central Africa (Democratic republic of Congo [54] and Cameroon [77]). Despite their 
widespread distribution, kdr mutations alone have not been associated with any control failure 
in Anopheles mosquitoes. Similar to knock down resistance, a point mutation in the gene 
coding for the neuro-transmitter acetyl-cholinesterase (Ace-1), which is the target site for 
carbamate and organophosphate insecticides, leads to a mutant form of the enzyme (Ace-1R) 
that does not bind with these insecticides. This resistance mechanism results from the 
substitution of the amino acid glycine to serine at codon 119. Resistance to carbamate and 
organophosphate was initially reported in Culex pipiens but is now widespread in Anopheles 
mosquitoes. A fitness cost associated with the G119S mutation in the absence of insecticides 
has been documented in Culex and Anopheles mosquitoes [78,79]. However, the deleterious 
effect linked with the G119S mutation was shown to be offset by duplications which pair 





1.3.2.1.2. Metabolic resistance 
Metabolic resistance is the other major type of resistance mechanism with demonstrable 
epidemiological significance [83]. This form of insecticide resistance arises from enhanced 
detoxification/sequestration of insecticides. The role of a range of metabolic enzymes including 
carboxylesterases (COEs), Glutathione S-Transferases (GSTs) and cytochrome P450 mono-
oxygenases (P450s) in insecticide resistance have been demonstrated in various species of 
mosquitoes. The latter type of metabolic enzymes, the cytochrome P450s, is involved in the 
majority of metabolism based detoxification of insecticides, mainly pyrethroids and 
carbamates. The most important P450 enzymes, known to detoxify most insecticides used in 
public health, belong mainly to the Cyp6 subfamily [61,82–84]. Some of these enzymes have 
been linked to pyrethroid resistance in a number of Anopheles species, including Cyp6P3, 
Cyp6P4, Cyp6M2, Cyp6Z1, Cyp6Z2, Cyp4J5 and CYP9K1 in Anopheles gambiae s.l. [53,87–
93], and Cyp6P9a,b, Cyp6P4a,b, Cyp6Z1, Cyp6AA1 and Cyp6M7 in Anopheles funestus 
[85,86,94–96][83,84,92–94]. CYP6M2 and CYP6P3 have been validated as pyrethroid 
metabolizers, and the latter has also been shown to detoxify carbamates [63,97], providing 
evidence of the ability of these genes to metabolize insecticides from unrelated classes. This is 
a serious concern for malaria control since insecticide resistance management strategies 
involving rotation or combination of these insecticides may be compromised. Interestingly, the 
juvenile hormone analogue pyriproxyfen (PPF) can be metabolized by a broad range of P450 
genes including Cyp6P2, Cyp6Z2, Cyp6M2 and Cyp9J5 [98]. PPF is combined with permethrin 
on Olyset DUO net to sterilize insecticide resistant mosquitoes for improved control, thus 
metabolic resistance potentially threatens the future efficacy of this new class of net. 
While an increasing number of countries are reporting data on nation-wide distribution of target 
site resistance mechanisms kdr and Ace-1R, detection and tracking of metabolic resistance 
genes has lagged. This is mostly due to the lack of DNA marker associated with metabolic 
resistance in African malaria vector mosquitoes [99]. However, some markers have recently 
been identified that could support the surveillance of the occurrence and spread of metabolic-







1.3.2.2. Additional insecticide resistance mechanisms 
The role of target site mutation and overexpression of detoxification enzymes in conferring 
resistance in malaria vector populations is well established. However, the emergence of 
resistant mosquitoes displaying strong and multiple-resistance phenotype suggest the 
occurrence of additional broad-spectrum resistance mechanisms.  
1.3.2.2.1. Cuticular and Sequestration of chemosensory proteins 
Cuticular resistance is changes in the mosquito cuticle ─ the outermost part of the mosquito 
body ─ which delays or prevents the uptake of external compounds, including insecticides, 
either through changes in cuticle thickness or composition [101]. The cuticle thickening 
phenotype is conferred by the over-expression of cytochrome P450 genes (mainly Cyp4G16 
and Cyp4G17) [102] and a number of cuticle proteins (CPs) [103]. This mechanism of 
resistance has been documented in major African Anopheles populations including An. 
gambiae [103], An. funestus [104] and An. arabiensis [89]. While cuticle thickening results in 
slow insecticide uptake, alteration in cuticle composition leads to a complete inhibition of 
insecticide penetration. Altered cuticle composition is associated with hardening of the 
mosquito cuticle through the over-expression of two oxidases (a laccase and a tyrosinase) and 
the translocation of cuticular component toward the cuticle, which is driven by over-transcribed 
ABC transporters [101]. Since the mechanism underlying decreased insecticide penetration is 
not insecticide-specific, its spread in malaria vectors might pose a serious threat to insecticide-
based vector control measures because of its potential to render a large spectrum of unrelated 
insecticides ineffective. 
Sequestration of chemosensory proteins has been described only recently as an insecticide 
resistance mechanism in multiple insecticide resistant strains of An. gambiae mosquitoes from 
Burkina Faso and Côte d’Ivoire [105]. It results from an over-expression of a member of the 
chemosensory proteins (CPs) ─ sensory appendage protein SAP2─ which is enriched in the 
mosquito leg and was shown to specifically target pyrethroids. Although this additional 
mechanism of resistance is a concern for malaria vector control, SAP2 silencing was shown to 
substantially restore susceptibility to pyrethroids [105]. This could pave the way for the 
identification of SAP2 neutralizing compounds which could be incorporated in bed nets to 





1.3.2.2.2. Behavioural resistance 
Changes in mosquito behaviour that results in the avoidance of insecticide treated surfaces is 
referred to as behavioural resistance [13,106]. Indoor-evading vectors are difficult to control 
as they mediate transmission at places (outdoor) [107–109] and times (when people are indoor 
but not under bed nets) [110,111] not targeted by current core interventions. Behavioural 
resistance differs from a shift in species composition, which typically occurs after a successful 
elimination of the dominant vector species in a given area [112]. Although there is good 
evidence that changes in mosquito behaviour are a direct consequence of the extensive use of 
indoor-targeted vector control measures, the mechanisms underpinning this form of resistance 
remain sparse [113].  
1.3.3. Impact of insecticide resistance on current frontline control tools 
Although the decreased susceptibility of Anopheles mosquitoes to major adulticides used in 
public health has been demonstrated, the impact of resistance on malaria transmission remains 
inconclusive. Data from observational studies indicate that pyrethroid-based vector control 
interventions are still protective even in areas with pyrethroid resistance. For instance, the use 
of pyrethroid ITNs in various malaria endemic countries was associated with a substantial 
reduction in malaria incidence in children despite moderate to high pyrethroid resistance in the 
local Anopheles malaria vectors [114–117]. A further example is the impact of deltamethrin 
based IRS in a pyrethroid resistance setting on Bioko Island. Malaria indicator surveys 
conducted during the deltamethrin spray campaign showed a significant decline in malaria 
prevalence in children [118]. Some of the factors potentially contributing to the continued 
efficacy in areas of insecticide resistance include: (i) impaired development of malaria parasite 
in mosquitoes surviving exposure to insecticides [119], (ii) increased susceptibility to 
insecticides of older, potentially infectious mosquitoes [120,121] and (iii) reduced longevity of 
mosquitoes following exposure to insecticide treated surfaces [122]. Although these studies 
provide evidence that pyrethroid ITNs and IRS retain efficacy in areas with pyrethroid 
resistance, these investigations are observational and were not designed to rigorously evaluate 
the potential impact of pyrethroid resistance. A WHO-coordinated study involving five 
countries (Benin, Sudan, Kenya, Cameroon and India) was designed to investigate whether the 
efficacy of pyrethroid LLINs was being compromised in areas of pyrethroid resistance [123]. 
Although findings from Benin showed no association between pyrethroid resistance and 




resistance intensity between study arms may have masked the impact of resistance. Ultimately, 
randomized controlled trials to assess the public health impact of resistance cannot be 
conducted given that random allocation of resistance in the field to account for confounding 
factors is impossible.  
Despite the challenge in demonstrating the epidemiological impact of insecticide resistance, 
several lines of evidence provide insight into the negative effect that insecticide resistance may 
be having on malaria control. Experimental hut studies conducted in Benin showed 
significantly reduced entomological efficacy (personal protection and mosquito mortality) of 
pyrethroid ITN in a high pyrethroid resistance area (Ladji) in the south of the country compared 
to the north (Malanville) where Anopheles mosquitoes were susceptible to pyrethroids [125]. 
These findings were confirmed in subsequent household studies  reporting no added protective 
benefit of pyrethroid ITN relative to untreated net in areas with high pyrethroid resistance 
[126]. Moreover, a systematic review and meta-analysis of experimental hut studies evaluating 
the performance of pyrethroid ITN demonstrated a significant impact of pyrethroid resistance 
on entomological indicators [127]. Mathematical modelling using experimental hut data 
predicted up to 40% fewer malaria cases averted by ITN deployed in areas with resistance 
compared to settings with fully susceptible vector populations [128]. Further evidence that 
resistance may be compromising the efficacy of control tools is provided in a recent 
randomized controlled trial in an area with pyrethroid resistance in Muleba, Tanzania [129]. 
Data from the trial showed a significant reduction in malaria prevalence in children sleeping 
under Olyset Plus LLIN compared to those using standard pyrethroid net. Olyset Plus is a 
synergist net which incorporates a mixture of deltamethrin and piperonyl butoxide (PBO) on 
all net panels. PBO is a synergist that neutralizes the action of metabolic enzymes and partially 
restore the efficacy of pyrethroid insecticides. The reduced efficacy of standard pyrethroid nets 
compared to the PBO LLINs in the community trial suggests that pyrethroid resistance may 
have an epidemiological impact. The most cited example of the impact of resistance comes 
from a study in an area bordering Mozambique and South Africa (KwaZulu Natal) where the 
emergence of metabolic resistance in An. funestus led to an increase in malaria cases [130]. 
However, it should be noted that development of drug resistance in malaria parasites could 
have also contributed to the observed control failure. A similar finding was reported from 
Dielmo village in Senegal where insecticide resistance was considered the likely cause of 
reduced LLIN efficacy and a rebound in malaria-specific morbidity [131]. Improvement in 




increased malaria cases, has been documented and provide indirect evidence that insecticide 
resistance is adversely impacting pyrethroid based control measures. For example, reduction 
in malaria transmission as a result of a switch from pyrethroids to carbamate or 
organophosphate insecticides has been reported in several countries such as Bioko Island [132] 
and Uganda [133].  
Although there is as yet no unequivocal evidence that insecticide resistance is undermining the 
efficacy of pyrethroid LLINs, it is now generally accepted that if resistance continue to spread, 
the gains made so far will be lost. Indeed, modelling simulations predict that the loss of 
pyrethroid efficacy in a context of universal coverage will translate into an increase in malaria 
burden [134]. The threat of insecticide resistance prompted the release of the Global Plan for 
Insecticide Resistance Management (GPIRM) in malaria vectors [134]. The GPIRM is a five-
pillar strategy developed by the World Health Organization in 2012 with the aim of slowing 
the spread of resistance and preserving the efficacy of current control methods. However, 
insecticide resistance has increased in prevalence and intensity since the introduction of this 
resistance mitigating plan, with the lack of alternative tools required to implement the range of 
strategies laid out in GPIRM being the likely contributing factor. The low uptake of the plan is 
also driven by the lack of clear-cut evidence of the epidemiological impact of resistance, the 
limited availability and high cost of insecticides with new mode of action and a shortage of 
human, infrastructural and financial resources [135].  
1.3.4. Insecticide resistance management 
Insecticide resistance management is one of the five pillars in the GPIRM, which aims to delay 
the occurrence of insecticide resistance, preserve the efficacy of current insecticides and thus 
reduce the need to switch to cost-prohibitive alternative products. Insecticide resistance 
strategies should ideally be deployed when resistance-linked mutations are very rare and barely 
detectable in the insect population. Unfortunately, resistance to the most commonly used 
insecticides is widespread with evidence of some resistance alleles reaching fixation. However, 
the implementation of currently proposed resistance management activities may still reduce 
resistance gene frequency, particularly for emerging resistance mechanisms and those that 
come with a cost for the mosquitoes. WHO recommended insecticide resistance management 
strategies are based on current core vector control interventions (LLINs and IRS) and include: 
(i) rotation of insecticides, (ii) combination of interventions, (iii) mosaic and (iv) mixtures. 




(rotation and mosaics) or killing of resistant mosquitoes using new classes of insecticides 
(combined interventions and mixtures) [136]. 
1.3.4.1. Rotation and mosaics 
These strategies work through suppression of the insecticide selection pressure and are mostly 
effective when the resistance mechanism is associated with a fitness cost. Individual 
mosquitoes carrying costly resistance mechanisms thrive only in the presence of insecticide. 
Consequently, the removal of the selection pressure provides a survival advantage to 
susceptible mosquitoes and reduces the proportion of resistant vectors. This is most effective 
when resistance-associated fitness cost is high.  
Rotation entails the deployment over time of two or more insecticides with different mode of 
action. The rationale behind this technique is to reduce mosquito exposure to a particular 
insecticide. Under the scenario of low resistance frequency and high fitness cost, rotation of 
different insecticides results in a decline of resistance to the first insecticide while the second 
chemical is being introduced, thus preserving susceptibility. The most cited example of a 
successful implementation of rotational strategy is the case of the West African Onchocerciasis 
Control Program (OCP) [137]. Also known as river blindness, Onchocerciasis is caused by a 
parasitic worm Onchocerca volvulus and is transmitted by blackflies. In addition to the use of 
Mectizan to clear the parasite reservoir in human host, the programme targeted the blackfly 
larvae through weekly application of the organophosphate temephos in breeding habitats. 
Following emergence of resistance to the larvicide, the programme subsequently initiated a 
rotational strategy involving the use of six insecticides from three chemical classes (a 
pyrethroid, a carbamate and three organophosphate) and a biological insecticide (Bacillus 
thuringiensis) to successfully mitigate the resistance problem. Implementation of a similar 
resistance management approach is not currently feasible in malaria vector control. First, unlike 
the blackfly which breeds only in a particular type of water (river water with 2m/s current), 
rotational use of insecticides is not feasible in malaria control programmes targeting immature 
stages of mosquitoes as these vectors breed in various types of breeding habitats that can be 
temporary. Second, there is currently very limited insecticide options available for malaria 
control. However, with funding from UNITAID, the NgenIRS partnership led by the 
Innovative Vector Control Consortium (IVCC) has been set up to accelerate the introduction 
of third generation IRS insecticides and support insecticide resistance management through 




delay the rise of insecticide resistance (http://www.ngenirs.org). Rotational use of insecticides 
from unrelated classes is in use in Bioko [118] Island and Southern Africa [138] and is now 
part of the PMI (President’s Malaria Initiative) plans for countries across sub-Saharan African.  
Mosaics can be used to avoid the build-up of resistant mosquito populations. The aim of this 
approach is to reduce the potential of the mosquitoes being exposed to a single compound over 
their lifetime, which otherwise would impose selection pressure and lead to resistance. 
Deployment of unrelated chemicals in neighbouring areas offers the opportunity for the 
mosquitoes to be exposed to both insecticides through migration between areas and be killed, 
provided that genes conferring resistance to both insecticides are rare or absent in the mosquito 
population. Mosaics can be used in IRS campaigns either at broad scale in neighbouring 
communities or at fine small scale within village with different types of insecticides deployed. 
1.3.4.1. Combined interventions and mixtures 
The aim of these approaches is to kill or reduce the population of resistant mosquitoes by 
simultaneously exposing them to two or more unrelated insecticides. The insecticides are 
deployed in the same place and at the same time such that mosquitoes surviving exposure to 
one insecticide due to resistance would be killed by the other insecticide provided multiple 
resistance is absent or rare in the vector population. Unlike rotation and mosaics, this resistance 
management concept does not rely on fitness cost and is designed to overpower resistance 
rather than preserving susceptibility. Evidence from modelling work indicate that the use of 
mixture and combined interventions are more effective at delaying the emergence of insecticide 
resistance than rotation and mosaics [136].  
Ideally, the two interventions should contain insecticides with a different mode of action to 
reduce selection pressure and kill resistant mosquitoes. Hut studies demonstrated improved 
control with pyrethroid LLIN combined with non-pyrethroid IRS compared to LLIN alone in 
pyrethroid resistance settings where the local malaria vectors were susceptible to the IRS 
insecticide [140,141]. However, given that resistance to classes of insecticides being 
considered for IRS in spreading, such an approach may not be effective in area with multiple 
resistance. For instance, combining pyrethroid LLIN with pirimiphos methyl IRS failed to 
improve control in an area of Côte d’Ivoire where Anopheles mosquito populations were 
resistant to the insecticides in both interventions [142]. This underscores the need for new 




Mixing insecticide into a single product reduce the chance of resistance developing as 
mosquitoes not killed by the first active ingredient will be killed by the partner insecticide 
provided the target vector population is not resistant to both insecticides. Mixtures are more 
effective than the previously described resistance management approaches, as mosquito 
exposure to the unrelated insecticides is guaranteed [143]. For mixtures to be effective, the two 
co-formulated insecticides should possess similar decay rate and be used at their full 
application rate. LLIN and IRS mixtures are currently available for vector control and were 
shown to improve control of resistant mosquito populations [144,145].  
 
1.4. Addressing the insecticide resistance challenge: improved versions of current 
mainstay control strategies 
In response to the increasing threat of pyrethroid resistance, considerable efforts are being 
made to preserve the efficacy of current control tools. New generation nets incorporating 
different compounds deployed in a mosaic or mixture style have been introduced to improve 
control of pyrethroid resistant mosquitoes. Mixture nets are treated either with two unrelated 
insecticides (alpha-cypermethrin-chlorfenapyr mixture net: Interceptor G2 net) [146,147] or an 
insecticide mixed with an insect growth regulator (permethrin-pyriproxyfen mixture nets: 
Olyset DUO LN) [148] or the synergist PBO (piperonyl butoxide-treated insecticidal net: PBO 
LN such as Olyset Plus [149]).. PBO inhibits the action of metabolic enzyme of the P450 family 
and enhance the toxicity of pyrethroid insecticide in the net. In some synergist LLINs, the two 
compounds (the PBO and the pyrethroid insecticide) are spatially separated with different 
compounds applied on the top and the side panel of the net (PermaNet 3.0 [150]). The disease 
control potential of mixture and synergist nets relative to pyrethroid-only nets have been 
confirmed in randomized controlled trials in areas of high pyrethroid resistance [129,139,151]. 
Drawing on the evidence that most mosquito host seeking activity occurs on a bed net roof, a 
mosquito net with an insecticidal barrier net placed above the top panel of the net has recently 
been designed to target insecticide resistant malaria vectors with alternative resistance breaking 
insecticides [152]. The location of the barrier net means that insecticides not currently 
recommended for net treatment due to safety concern could be used for effective vector control. 
This new type of net holds significant vector control potential and was shown to kill a greater 




a pyrethroid resistant area in Burkina Faso [152]. This simple innovative modification to net 
design is predicted to reduce malaria incidence to level similar to that with new generation 
LLINs and may be favoured over these nets as small quantity of insecticide is required for net 
treatment. However, community field trials demonstrating impact on malaria metrics are 
required before this new net is considered for use in public health.  
The significant contribution of IRS to reducing the malaria burden over the past years makes 
it an important tool within the global malaria elimination effort. In light of the value of IRS, 
new classes of insecticides such as pyrroles and neonicotinoids are being tested as indoor 
residual sprays to address current constraints on IRS including vector resistance and the short 
residual life of currently available chemistries [145]. 
While development efforts to improve the efficacy of current core interventions (i.e. LLINs 
and IRS) should be sustained, additional control strategies are obviously needed to supplement 
these tools and drive transmission to level required for malaria elimination, especially in areas 
with high insecticide resistance and transmission intensity [153]. 
 
1.5. House improvement as a malaria control strategy  
Traditional malaria control methods target exclusively mosquito behaviour that occurs inside 
houses: mosquito nets are designed to prevent insects from feeding on humans sleeping beneath 
them whilst IRS kills female mosquitoes once they have successfully fed on unprotected 
humans. However, a careful scrutiny of the life cycle of the adult mosquito indicates that there 
is a range of vulnerable stages that can be targeted to further reduce malaria transmission [154–
160]. A key phase is the behaviour of host-seeking female mosquitoes around residential 
houses. There is a strong body of evidence that major African malaria vectors primarily enter 
houses via the “eave space” which is the gap between the edge of walls and the roof of houses 
[16–1631]. This has been confirmed in a recent behavioural study by means of video tracking 
techniques [164]. The observation that mosquitoes enter houses via eave gaps has been 
exploited to reduce indoor mosquito density and malaria transmission by physically blocking 
the eave space [165] or screening this space using an insecticide treated curtain [166] or eave 
baffles [167]. Protection can be enhanced by screening windows, doors and filling up cracks 
in house walls which make the house mosquito-proof. There is also empirical evidence that 




More recently, a systematic review on housing and malaria provides evidence that residents of 
houses with features that restrict mosquito entry had lower odds of malaria infection and lower 
incidence of clinical malaria [169]. In some settings, protection derived from better housing is 
on par with that from insecticide treated nets [170].  
House modification as a protective measure against disease-spreading insects is not a new 
practice. The vector control potential of mosquito-proofed houses was first demonstrated in the 
pioneering work of Angelo Celli [171] over a century ago. Although there is evidence that 
incremental improvement to housing has contributed to malaria reduction and elimination in 
developed countries [172–174], its full disease reduction potential remain largely 
underexploited in the developing world. However, with the rapid economic growth in Africa 
and the need for additional houses to meet its expanding population, there is an opportunity to 
deploy improved housing as a complementary measure to existing control tools. As now being 
supported by the Roll Back Malaria and the United Nations Development programmes, a cross-
sector collaboration, especially with the housing sector to promote incorporation of protective 
designs into housing in areas at risk of malaria is key to the successful implementation of this 
strategy [175]. The reason for the increasing momentum for better housing as a sustainable 
malaria control approach is threefold. First, improved dwellings have few or no openings and 
are thus less prone to invasion by disease-carrying vectors. Second, although there are 
increasing reports of outdoor biting, the bulk of malaria transmission still occurs indoors [176], 
making house-tailored interventions an important measure within the global malaria 
elimination strategy. Third, there is empirical evidence that development of the malaria parasite 
and survival of females mosquitoes is compromised when temperature exceeds an optimal 
threshold [177,178]. This occurs mostly in modern iron-roofed houses which have higher 
maximum indoor temperature compared to cooler thatched-roofed residences [179]. Together, 
these factors make better housing a promising control approach which could be integrated into 
existing method for improved malaria transmission control.  
1.6. The EaveTubes strategy 
The observation that host-seeking African malaria vectors predominantly enter human 
dwellings through eaves ‒ an important source of host attractant cues ‒ motivated the initial 
development of the EaveTubes technology [180]. EaveTubes are pieces of PVC pipe that can 




airflow and to attract mosquitoes. When mosquitoes are drawn in the tubes by the human 
odours emanating through the openings, they contact a piece of netting laden with powdered 
insecticides. The netting is treated with an electrostatic coating that uses polarity to bind 
insecticides onto the netting. This innovative delivery system, originally used for various 
purposes including control of cotton pests [181], enables the transfer of a high dose of 
insecticide capable of killing highly pyrethroid resistant Anopheles mosquitoes, even when 
pyrethroids are used [182]. In addition to the improved insecticide bioavailability and the 
resistance breaking potential of the electrostatic netting, insecticides that are prohibitively 
costly for use in IRS could be used in EaveTubes because only small quantities of active 
ingredient per house are required. Moreover, since insecticide treated tubes are placed at eave 
level, there is potentially a lower risk of exposure to house occupants. As a result, products 
considered unsuitable for use on nets could be acceptable for use in EaveTubes. EaveTubes are 
combined with “mosquito proofing” of houses, which involves screening of windows and 
blocking of gaps in houses.  By attracting and killing blood-seeking mosquitoes, the EaveTubes 
are comparable to a “lure and kill” bait. This may have led to the recent classification of this 
type of control method as a “lethal house lure” approach by the WHO Vector Control Advisory 
(VCAG).(https://apps.who.int/iris/bitstream/handle/10665/274451/WHO-CDS-VCAG-
2018.03-eng.pdf) 
Although house improvement does not require insecticide treatment, the addition of an 
insecticidal component in the EaveTubes approach could have community benefit by killing 
mosquitoes and reducing local populations. A modelling study using data from small-scale 
investigations of this control method has predicted a 70% reduction in malaria transmission 
potential, even when only one-third of houses in a community receive EaveTubes [183]. The 
insecticide component of the strategy could address the concern of mosquito being deflected 
from EaveTubes protected houses to neighbouring unprotected houses. Indeed, results from a 
recent study suggest that deployment of EaveTubes in houses does not result in an increased 
risk of mosquito bites among people living in adjacent unprotected houses [184]. This is a 
positive outcome since coverage is unlikely to be 100% either due to houses that are not 
amenable to the EaveTubes installation or poor community adherence. However, findings from 
this study should be interpreted with caution given that deflection was investigated under 
controlled conditions in experimental houses and potential for a different outcome with real 
houses cannot be ruled out. As with any potential complementary tools, EaveTubes will be 




suggest that the benefit of integrating EaveTubes into traditional control measures depend on 
how the technology is implemented with respect to LLIN and IRS. According to the model 
simulation, the benefit of combining EaveTubes with LLIN or IRS is additive [183].  
The potential of the EaveTubes approach to reduce malaria transmission has been explored in 
a number of initial studies conducted in experimental huts within large enclosures. The first 
series of experiments were designed to optimize the technology by examining various aspects 
of EaveTubes that impact mosquito entry including diameter of the tubes, optimal height above 
ground and angle of the tube [185]. Further experiments were performed and served as a proof 
of concept, demonstrating that EaveTubes plus screening reduce mosquito house entry and kill 
host-seeking female mosquitoes as they make contact with the insecticide treated tubes. There 
is also evidence that female mosquitoes that manage to enter houses e.g. through open doors, 
could be killed by the insecticide treated insert when trying to exit houses via the eaves either 
to carry on searching for blood meals or to find an oviposition site [184]. The most interesting 
part of this set of initial studies was conducted in a complex ecosystem simulating a Tanzanian 
village environment inside a large, screened field cage to assess potential of the technology on 
a self-sustaining colonies of An. arabiensis mosquitoes. Findings from these semi-field studies 
demonstrated the greater impact of EaveTubes on mosquito population suppression and indoor 
biting relative to LLIN alone [185].  
The promising results from these preliminary studies on EaveTubes have led to a cluster 
randomized controlled trial (CRT) designed to investigate whether the technology reduces 
malaria transmission, compared to current best practice of LLINs [186]. 
 
1.7. Rationale of the study 
LLINs and IRS have been instrumental in reducing the global malaria burden and have 
contributed to the elimination of the disease in a number of countries. While these tools will 
continue to play a major role in malaria control, their continued effectiveness may be 
undermined by insecticide resistance in vectors, as evidenced by the recent rise in malaria cases 
in some endemic African countries [4]. To sustain the considerable advances in malaria control, 
there is a need to expand the current “vector control tool-box”. Most malaria transmission 




disease reduction potential. The EaveTubes is a type of house improvement that could be 
integrated with current control tools for a more effective control of malaria [6]. This vector 
control strategy reduces mosquito vectorial capacity by limiting human-vector contact (house 
modification) and reducing vector longevity through deployment of insecticide in EaveTubes. 
As described above, a series of studies have provided evidence for the potential of this control 
measure to reduce malaria transmission, but a number of important questions remain related to 
the functioning of the technology. Research studies making up this PhD thesis were conducted 
in the context of the CRT investigating whether EaveTubes plus screening (SET) deployed in 
combination with LLIN provide additional protection against malaria transmission compared 
to current standard of care in a high pyrethroid resistance area in central Côte d’Ivoire [186].  
 
The electrostatic netting, which is the insecticide delivery system and an essential component 
of the EaveTubes strategy, has resistance breaking potential [182]. However, evidence of this 
has, to date, been mostly obtained using laboratory colonies. Field studies investigating this 
claim need to be conducted in areas where insecticide resistance has been characterized in 
detail (i.e. prevalence, intensity and associated underlying mechanisms). The potential impact 
of resistance on the entomological efficacy of pyrethroid-only LLIN in these areas also need 
to be tested to understand what is possible in the absence of EaveTubes. 
 
Current insecticide resistance management strategies work by removing the insecticide 
selection pressure or by bypassing  resistance through the use of insecticides with a novel mode 
of action [134]. The EaveTubes intervention overpowers resistance through increased 
bioavailability of insecticide on the surface of the electrostatic netting. Although existing 
insecticides were found to be more effective when applied on the electrostatic netting, whether 
the community deployment of these insecticides would select for resistance needs testing. This 
would require monitoring of changes in the prevalence, intensity and genetic mechanisms of 
insecticide resistance over time following wide-scale use of this new control measure in a high 
pyrethroid resistance setting. 
 
The electrostatic netting within the EaveTubes was shown to hold powder formulation of 
insecticide for effective control of resistant mosquitoes. However, only chemicals from a 
handful of classes including pyrethroids have been previously tested against Anopheles 




use against insecticide resistant Anopheles mosquitoes warrants investigation. In addition, 
given that the nature of the electrostatic netting differs from that of common substrates such as 
house walls and bed nets, the residual activity of a range of insecticides belonging to various 
classes need to be explored.  
 
Although only a small amount of powder formulated insecticide (1g) is deployed on 
electrostatic netting for high-level control of resistant malaria vectors [182], deployment of the 
insert has logistical costs including heavy machinery and regular washing of the netting (insert) 
before re-treatment. This could be a major obstacle to the implementation of the strategy, 
especially in resource-poor settings. There is therefore a need to investigate alternatives means 
of delivering insecticide in EaveTubes that could provide a more scalable and practical 
insecticide delivery system for use in the “lethal house lure” approach for malaria control.  
 
 
1.8. Study objectives 
My thesis aims to improve our understanding of how EaveTubes control malaria transmission 




1: Characterise insecticide resistance and its impact on pyrethroid-only LLIN in central 
Côte d’Ivoire 
a) To investigate the prevalence, intensity and genetic mechanisms of insecticide resistance in 
Anopheles gambiae in a selection of study clusters 
b) To evaluate in experimental huts the efficacy of standard pyrethroid-only LNs in a highly 
pyrethroid-resistant site adjacent to the CRT area  
2: Optimise and evaluate EaveTubes 
a) To screen multiple insecticides and select the one with highest residual activity for 
application on eave tubes inserts 




c) Investigate whether the “resistance breaking” powder formulation selects for resistance in 
wild Anopheles gambiae mosquito population 
3. Explore alternatives to powders, including the use of next generation LLIN material 
and IRS formulations 
a) To evaluate the efficacy of synergist LLINs against pyrethroid resistant An. gambiae in 
experimental huts prior to testing in EaveTubes  
b) To assess as a proof of concept whether netting pieces of new generation LLINs and 
dipping of tube plus netting in insecticide formulation could be used as long lasting 
alternatives to powder formulations 
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Fine scale spatial investigation of multiple insecticide resistance and underlying target-
site and metabolic mechanisms in Anopheles gambiae in central Côte d’Ivoire 
Abstract 
Routine monitoring of occurrence, levels and mechanisms of insecticide resistance informs 
effective management strategies, and should be used to assess the effect of new tools on 
resistance. As part of a cluster randomised control trial evaluating a novel insecticide-based 
intervention in central Côte d’Ivoire, we assessed resistance and its underlying mechanisms in 
Anopheles gambiae populations from a subset of trial villages. Resistance to multiple 
insecticides in An. gambiae s.s. and An. coluzzii was detected across villages, with dose-




deltamethrin (>1500-fold), and mortality following exposure to pyrethroid-treated bednets was 
low (<30% mortality in cone bioassays). The 1014F kdr mutation was almost fixed (>90%) in 
all villages but the 1575Y kdr-amplifying mutation was relatively rare (<15%). The carbamate 
and organophosphate resistance-associated Ace-1 G119S mutation was also detected at 
moderate frequencies (22-43%). Transcriptome analysis identified overexpression of P450 
enzymes known to metabolise pyrethroids (CYP9K1, CYP6P3, and CYP6M2), and also a 
carboxylesterase (COEAE1F) as major candidates. CYP6P3 expression was high but variable 
(up to 33-fold) and correlated positively with deltamethrin resistance intensity across villages 
(r2=0.78, P = 0.02). Tools and strategies to mitigate the extreme and multiple resistance 









Insecticide-based control methods continue to play a crucial role in reducing vector-borne 
diseases. Insecticides are deployed against malaria mosquitoes most commonly via long lasting 
insecticidal nets (LLINs) and indoor residual spraying (IRS). The significant increase in 
coverage with LLINs over the past 20 years has been associated with a marked reduction in 
malaria burden [1]. However, recent estimates suggest that progress has stalled, with 
insecticide resistance likely one of the major contributing factors. Whilst selection from other 
sources, especially agriculture [2], may be important in some areas, there is evidence that the 
wide scale use of IRS and particularly LLINs is contributing to selection for pyrethroid 




further over the coming years, given that pyrethroids remain an important component of all 
currently available bednets, including newer dual-action LLINs [4–6]. 
 
Until recently, only four classes of insecticides (pyrethroids, organochlorines, carbamates and 
organophosphates) were licenced for use to control adult mosquito vectors. The pyrrole 
insecticide, chlorfenapyr, and the neonicotinoid, clothianidin, have recently been added to this 
list and are deployed either alone or in combination with pyrethroids [7–9]. Except for these 
new insecticide classes, resistance to all currently available insecticides has been documented 
in Anopheles mosquito species across much of sub-Saharan Africa [10–14]. The best known 
mechanisms conferring resistance to insecticides are target site modification and increased 
detoxification. Substitutions in the para voltage-gated sodium channel (VSGC) ─ the target site 
for pyrethroids and DDT [15–17] (L1014F and L1014S) ─ are widespread in An. gambiae and 
confer knock down resistance (kdr), with a third variant (N1575Y)[17] capable of amplifying 
resistance where present[18]. A further mutation (G119S) in acetylcholinesterase (Ace-1) 
causes resistance to organophosphate and carbamate insecticides, which target this enzyme 
[19–21]. The G119S mutation is associated with a fitness cost in the absence of insecticides 
[22] but Ace-1 gene duplication, coupling resistant and susceptible alleles, or multiple resistant 
alleles on the same chromosome, has emerged in Anopheles gambiae mosquitoes to offset 
deleterious effects [23].  
Metabolic resistance arises from enhanced detoxification of insecticides. Three classes of 
metabolic enzymes, carboxylesterases (COEs), glutathione-S-transferases (GSTs) and 
cytochrome P450s have been linked with resistance in various species of mosquitoes, with the 
latter most frequently implicated in metabolism of pyrethroids and carbamates [10,24–26]. 
Overexpression of several P450s has been associated with insecticide resistance, but relatively 
few have been validated as metabolizers in vitro, and thus only these can be regarded 
definitively as candidates capable of causing resistance. Notably, CYP6M2, CYP6P3 and 
CYP9K1 have all been validated not only as pyrethroid-metabolizers but also of unrelated 
insecticides (DDT, bendiocarb and pyriproxyfen, respectively) demonstrating how the 
substrate flexibility of some P450s can cause cross-resistance by metabolizing insecticides 





Here we report on a study aimed at evaluating the current status of insecticide resistance in 
malaria vectors in central Côte d’Ivoire. Previous research has shown that Anopheles malaria 
vectors in Côte d’Ivoire have developed resistance to all of the four traditional classes of 
approved adulticides [21,29,30]. Resistance mechanisms detected in Côte d’Ivoire to date 
include kdr and Ace-1 (mutation and duplication) [29] and, in An. coluzzii from the southern 
part of the country, overexpression of P450 genes, especially Cyp6M2 and Cyp6P3 [10]. 
However, information on resistance intensity and a comprehensive assessment of the genetic 
mechanisms driving resistance in An. gambiae is lacking (and especially for central Côte 
d’Ivoire). The present study was thus conducted prior to the onset of a cluster randomized 
controlled trial (CRT) of the In2Care EaveTubes [31], to characterize insecticide resistance 
across a subset of villages and provide a baseline against which future changes may be 
measured through the course of the CRT. 
Results 
Insecticide resistance and LLIN efficacy 
Mortality rates of An. gambiae s.l. exposed to WHO diagnostic doses of deltamethrin, 
cyfluthrin, and bendiocarb were generally quite low with most villages below 50% (Fig. 2.1), 
and lower still for DDT (<15%). Mortality results for the two pyrethroids were strongly 
correlated across villages (Spearman’s ρ = 0.98, n = 8, P < 0.001), and each was also positively 
correlated with bendiocarb mortalities, though neither significantly (maximum ρ = 0.64, 
minimum P = 0.09). There was significant variation among villages in bioassay mortalities for 
each insecticide, though there was no difference between groups of villages comprising the 
study arms for any insecticide (Table 2.1). For pirimiphos methyl, there was only one survivor 
out of over 800 females tested. However, the 1% dose used is four times the standard 
recommended diagnostic concentration, and results are best interpreted as evidence that higher 
intensity resistance is absent, rather than the population being fully susceptible.  
The intensity of resistance to deltamethrin measured using adapted CDC bottle assays was 
extremely high in all villages (RR50 range 1441 to 2405) (Table 2.2 and Table 2.S1A&B). 
There was no difference between villages (overlapping 95% confidence intervals of LD 50 




Exposure to a pyrethroid-only LLIN (PermaNet 2.0) killed 100% of the susceptible An. 
gambiae Kisumu strain but fewer than 30% from any study village (Fig. 2.2). Though the 
correlation between net-induced mortality and resistance intensity to deltamethrin was not 
significant (ρ = 0.41, n = 8, P = 0.32), the generally poor performance of the pyrethroid-only 
LLIN tested is consistent with the very high pyrethroid resistance in the villages. Mortality 
rates of mosquitoes exposed to LLIN material differed significantly between villages (Table 
2.3).  
Species identification and target-site resistance 
 Overall, 975 randomly selected An. gambiae s.l., which comprised of unexposed and 
pyrethroid bioassay survivors, were identified to species by PCR. A subset of these mosquitoes 
were screened for common resistance-linked kdr mutations in the voltage-gated sodium 
channel. The predominant malaria vector species in seven of the villages was An. gambiae (84-
98%) with a single village (Kouakro) in which An. coluzzii and An. gambiae were found in 
comparable proportions (50%) (Table 2.4).  
The 1014S mutation was not detected in any of the 367 mosquito samples screened. The 1014F 
mutation was found at very high frequency (>0.9) whereas the 1575Y allele was present at low 
frequency (<0.15) in mosquito populations across villages. Allele frequencies of the 1014F 
mutation did not differ among villages (χ27 = 12.2, P = 0.59) (Table 2.5). Likewise, allele 
frequencies of the 1575Y mutation were very similar across villages (χ27 = 1.1, P = 0.99) (Table 
2.5). The frequency of 1575Y also did not differ between unexposed mosquitoes and bioassay 
survivors (χ21 = 0.05, P = 0.82). In each village, neither locus showed significant deviation 
from Hardy-Weinberg equilibrium (Table 2.5).  
There was significant variation in allelic frequency of the G119S polymorphism across villages 
(22% to 43%; χ27 = 22.75, P = 0.002), which essentially reflected variation in heterozygote vs 
susceptible homozygotes because resistant homozygotes were extremely rare (Fig. 2.3). 
Analysis of the qPCR dye balance ratio in heterozygotes, which can indicate variation in the 
relative number of duplicated serine alleles, showed no significant variation among villages in 
serine/glycine ratios (F1,7 = 0.94, P = 0.47), suggesting a similar copy number profile of serine 
alleles. There was no evidence that the frequency of G119S differed between An. coluzzii and 




Genome-wide transcription analysis 
Whole genome microarray experiments were conducted to identify candidate genes potentially 
involved in insecticide resistance in the dominant species An. gambiae collected from two of 
the study villages (N’Guessan Pokoukro and Sessenouan), in comparison with two susceptible 
strains, using a strict criterion for significance based on replicated fold change and multiple-
testing corrected P-value thresholds.  
Out of a total of 14,914 probes screened, 616 corresponding to 525 genes were significant 
according to the above filtering criteria (Fig. 2.4, Table 2.S2A). Of the 267 genes (with 340 
transcripts) over-expressed in all comparisons, we focused on those with known or putative 
links to detoxification or resistance more broadly, which comprised of 18 genes, including 11 
cytochrome P450s, 3 glutathione S-transferases (GSTs), 2 carboxylesterases, an alcohol 
dehydrogenase, and peroxidase, a redox gene and transporters and cuticular genes (Table 
2.S2A). The three detoxification genes within the top 20 most over-expressed genes were 
cytochrome P450s (Table 2.S2B) of which Cyp6P3 and Cyp9K1 exhibited >10-fold change 
and Cyp6M2 with ≥8 fold-change, but more variability across comparisons, relative to 
susceptible lab strains (Table 2.S2B). Other highly over-expressed genes (within top 20) lack 
current description or have no putative link to insecticide resistance, based on current 
knowledge, such as the most highly expressed gene (h+ transporting atp synthase subunit: fold 
change >60). It is interesting to note that one of the two overexpressed esterases is the target 
site gene Ace-1 with average overexpression of almost 3-fold, consistent with the expected 
presence of duplicated resistance alleles.  
 
 
Quantitative RT-PCR expression of candidate genes in selected villages 
Candidate genes chosen for further analysis using qRT-PCR included the most over-expressed 
detoxification genes (Cyp6P3, Cyp9K1, and Cyp6M2), the most overexpressed esterase 
COEA1F, and the redox partner gene cytochrome P450 reductase. A further P450, Cyp6Z3, 
was chosen because it was significant in 3 out of four comparisons and we wished to examine 
whether the stringency of our filtering might be excluding potential valid detoxification 
candidates. The validation also included two under-expressed genes; one meeting the 




underexpressed in one population (Cyp9J5), providing additional variation for qPCR vs 
microarray validation.  
There was good agreement between qPCR and microarray estimates of gene expression (r2 = 
0.73, P = 0.001) (Fig. 2.S1). Fold change was generally higher in microarray results except for 
Cyp6P3 and Cyp9K1, which showed higher expression in qPCR analysis. 
The expression levels of the eight chosen candidate genes were assessed for variation across 
the eight villages. There was significant variation in the level of expression of all genes among 
villages (Kruskal Wallis tests, maximum P < 0.01) (Fig. 2.5 & Table 2.S4A). The highest 
general level of expression was for Cyp6P3; with a particular peak in the N’Guessan Pokoukro 
village (33-fold change) but much lower levels in some other villages. Interestingly, there was 
a significant correlation between fold change in Cyp6P3 and the intensity of resistance to 
deltamethrin (r2 = 0.78, P = 0.023) (Fig. 2.S2). Expression level of all screened genes did not 
differ between unexposed mosquitoes and those that survived exposures to deltamethrin and 
cyfluthrin (Fig. 2.S3 & Table 2.S4B).  
Discussion 
Insecticide resistance in African malaria vectors is one of the major challenges facing malaria 
control programmes. A better understanding of the prevalence, intensity and mechanisms of 
resistance could inform the development of resistance management strategies. Results from the 
present study, the first of its kind on An. gambiae s.s. from Côte d’Ivoire, demonstrate 
phenotypic variation at a small spatial scale likely underpinned by variation in resistance 
mechanisms, notably P450 expression level and variation in Ace-1 genotypic frequencies. 
 
Phenotypic resistance 
High prevalence of resistance was evident for all insecticides tested, with the exception of 
pirimiphos methyl which was tested at a higher than diagnostic dose. These results are 
consistent with findings from previous studies conducted in the same area [21,32]. Multiple 
insecticide resistance has been previously documented in An. coluzzii from the southern part of 
the country (Tiassale) [10,21]. This observation is of significant concern for vector control, as 




The intensity of deltamethrin resistance detected in the present study is among the highest 
reported to date in Anopheles mosquitoes. While quantitative measure of resistance enables 
detection of potential changes in resistance level in mosquito populations [33], intensity level 
associated with operational control failure has yet to be defined. Nevertheless, the poor 
performance of LLINs in WHO cone assays against the local Anopheles mosquitoes is 
consistent with the high resistance intensity recorded and is suggestive of a potential loss of 
community protection from pyrethroid-only LLINs in this area. 
Resistance mechanisms 
The molecular basis of the multiple insecticide resistance phenotype was investigated using 
microarray experiments performed on An. gambiae from two villages (one from each study 
arm). Analysis focused on overexpression of potential resistance-linked gene, but it should be 
noted that many genes of unknown function or no putative link to insecticide resistance were 
also significantly over-expressed in field mosquitoes compared to susceptible lab colonies. If 
this observation is reproducible, it could merit further investigation. Of the most highly 
overexpressed genes, Cyp6P3 and Cy6PM2 have been implicated repeatedly in pyrethroid 
resistance and also in resistance to carbamates in An. gambiae and/or An. coluzzii [10,34] and 
are known to metabolize pyrethroids [35]. Overexpression of Cyp9K1 has been linked to 
pyrethroid resistance in An. gambiae s.l. from Cameroon [12], Benin [36] and Bioko Island 
[28], and has also recently been validated as a pyrethroid and pyriproxyfen metabolizer [28]. 
This is the first report of significant over-expression of Cyp9K1 in Côte d’Ivoire, and the fold 
change in expression in mosquitoes from our study area is much higher than expression 
reported in previous studies [28,36]. The over-transcription of this set of P450s, coupled with 
the near fixation of Vgsc 1014F and the presence of the 1575Y mutations in the local malaria 
vectors, likely underpins the extreme resistance to pyrethroids and DDT in this part of Côte 
d’Ivoire. The carboxylesterase COEAE1F and the cytochrome P450 reductase (CPR) were 
among the significantly over-expressed detoxification candidates. Carboxylesterases can play 
a role in pyrethroid metabolism, for example when paired secondarily with P450s such as 
CYP6Z2 [37] (to which the candidate CYP6Z3 is extremely similar) and CPR is a redox partner 
for P450s and might also link with resistance [38]. These over-transcribed genes could have 
contributed to the high pyrethroid resistance observed. Although pyrethroid resistance in this 
population of mosquitoes is associated with both target site insensitivity and metabolic 




account for the most extreme pyrethroid resistance intensity detected [11]. DDT resistance is 
often mediated by over-expression of Glutathione S transferases (GST) and kdr-based 
mechanisms. The absence of over-expressed GST indicates that the high DDT resistance might 
have been primarily due to 1014F and in some cases also 1575Y kdr mutations, perhaps 
coupled with overexpression of some genes less commonly associated with DDT resistance 
such as Cyp6M2 [39]. The resistance intensifying mutation 1575Y was detected at relatively 
low frequency (<15%) and found only in mosquitoes with the phenylalanine allele, confirming 
that this mutation only occurs on a 1014 haplotype background [17]. Originally identified in 
Burkina Faso, the 1575Y mutation is spreading across the continent and has been reported in 
West and Central Africa [13,40]. Understanding the key determinants behind the rapid increase 
in the prevalence of the 1575Y kdr allele could help slow or even stop the spread of this 
mutation. Further investigation is also needed to determine if the survival advantage associated 
with the co-occurrence of the 1575Y and 1014F [34] mutations could negatively impact control 
efforts. The allelic frequency of this emerging gene should be closely monitored in areas where 
novel tools incorporating pyrethroids are deployed.  
Carbamate resistance is primarily mediated by acetylcholinesterase insensitivity (G119S) and 
elevated expression of certain P450s [10]. The high survival to bendiocarb is consistent with 
the high frequency of Ace-1 heterozygotes, which as shown by elevated Ace-1 expression are 
likely present in higher copy numbers which raises carbamate resistance [10]. Cyp6P3 was also 
over-expressed and has been shown to generate a moderately bendiocarb-resistant phenotype 
via transgenic expression and to metabolize bendiocarb, albeit with low catalytic efficiency. 
Indeed, susceptibility to bendiocarb in An. gambiae mosquitoes from Bioko has been reported 
despite over-expression of Cyp6P3 [28], and it may be that this is a mechanism of lesser 
importance. The role of Cyp6M2, which generates a much stronger resistance phenotype than 
Cyp6P3 via transgenic expression but does not metabolise bendiocarb remains unclear, but it 
is certainly plausible that both combine with Ace-1 copy number variation of resistant alleles 
to generate resistance phenotypes as observed in An. coluzzii from southern Côte d’Ivoire [10].  
Overall the resistance mechanisms detected in the study area are similar to those of An. coluzzii 
from southern Côte d’Ivoire [10]. These vector populations are from the same country and 
potentially exposed to the same insecticide selection pressure; mainly from the use of 
pyrethroid treated nets and insecticides for crop protection [2]. However, the elevated 




not reported in the Tiassale mosquitoes. It could be that the frequency of this gene was low and 
undetectable at the time the Tiassale mosquito was characterised (in 2014) and might have 
increased only recently. 
Fine scale variation 
The villages were all within 50 km radius away from the town of Bouaké and varied between 
a few km and a few tens of km apart. Yet, there was significant variation in both phenotypic 
data for all insecticides to which resistance was detected and in expression of all genes studied 
across villages. Monitoring of insecticide resistance in malaria vectors is often performed at 
large geographical scale. However, as seen in the present and previous studies [41,42], 
variation in insecticide resistance can occur at small spatial scales. This result indicates the 
need to account for potential micro geographic variation during resistance surveys, rather than 
assuming broad-scale homogeneity for which single sites can act as reliable sentinels. Although 
wide-ranging phenotypic testing programmes incorporating fine-scale testing are unlikely to 
be realistic for most programmes, variation detected by molecular marker-based surveillance 
could aid in identifying sites of interest which could be prioritised for phenotypic testing. 
Interestingly, Cyp6P3, which showed the highest expression and high variation among villages 
correlated positively with resistance intensity suggesting a useful gene expression assay to 
predict resistance intensity.  
 
Conclusion 
Results from this study are concerning given that Anopheles mosquitoes from this part of Côte 
d’Ivoire have developed strong resistance to the main insecticides currently being used for 
malaria control. Metabolic genes that were found to be over-expressed in this study have 
previously been shown to metabolize some of the compounds being incorporated in new classes 
of bed nets. For example, a range of P450s, including those identified in the present study 
(Cyp6P3, Cyp6M2 and Cyp9K1) metabolize pyriproxifen - an insect growth regulator deployed 
in nets to sterilise pyrethroid resistant mosquitoes [43]. This is consistent with the poor 
performance of Olyset Duo, a permethrin plus pyriproxyfen mixture LLIN in experimental huts 
in these areas of Côte d’Ivoire [44] and in a randomised controlled trial in Burkina Faso [45] 




LLINs could be a more promising option in this area, given the apparent importance of P450 
overexpression, though careful evaluation of efficacy and durability will be required.  
The insecticide selected for use in the lethal house lure CRT is the pyrethroid beta-cyfluthrin 
[46]. This is because a previous study showed that the EaveTubes technology delivers an 
overwhelming dose of insecticide causing high levels of mortality of even resistant mosquitoes 
[46]. The data from the current study provides baseline information to track whether this 
additional use of pyrethroids on top of LLINs in the trial area will lead to changes in phenotypic 
resistance and associated molecular mechanisms. 
 
Methods 
Study area and collection of mosquitoes 
This study was performed as part of a two-armed cluster randomized controlled trial (CRT) 
evaluating the impact of an intervention defined by the WHO Vector Control Advisory Group 
as a “Lethal House Lure”, which combines household screening (S) with a novel insecticide 
delivery system called In2Care EaveTubes (ET). The trial, which ran between May 2017 and 
May 2019 in central Côte d’Ivoire in the Gbèkè district, aimed to investigate whether the use 
of screening plus EaveTubes (SET) on top of universal coverage of LLINs (PermaNet 2.0), 
provides greater protection against malaria than LLINs alone. The design of the trial is 
described in Sternberg et al [31] and involves 40 villages, half assigned to SET plus LLINs, 
and the other half allocated to LLINs alone. The study area is a pre-forest zone with a humid 
tropical climate and covers an area of 9,136 km2 with a population of over one million people. 
Rice farming is the dominant form of subsistence agriculture and the presence of rice growing 
valleys across the region provides extensive breeding sites for Anopheles mosquitoes. Malaria 
transmission is year-round with a peak during the rainy season (from May to October) [47,48].  
Eight study villages (four in each treatment arm) were selected for insecticide resistance 
monitoring, based on the availability of mosquito breeding sites for sampling (Fig. 2.6). A 
description of each sampling site is provided in Table 2.6. Mosquitoes were collected from 
each village using the dipping method from September 2016 to November 2016. Whenever 
possible, mosquito larvae were collected from at least two breeding sites spread out over the 
village, and collections from the same village were subsequently pooled. Larvae were 




and reared to adulthood under ambient temperature. Emerging adult mosquitoes were kept in 
netted cages and maintained on 10% honey solution. All adult female mosquitoes were 
morphologically identified as An. gambiae s.l. using taxonomic keys. 
 
Insecticide susceptibility assays 
To assess the prevalence of resistance in Anopheles mosquitoes from the CRT area (central 
Côte d’Ivoire), WHO susceptibility tests were performed between September and November 
2016 using adult An. gambiae s.l. mosquitoes emerged from larvae collected in eight selected 
CRT villages. The pyrethroid insecticide, beta-cyfluthrin is the active deployed in the 
EaveTubes [46] whereas deltamethrin is the insecticide in the LLIN (PermaNet 2.0). Bioassays 
were conducted using papers treated with diagnostic concentration of these two insecticides: 
0.05% deltamethrin and 0.15% cyfluthrin. Additionally, susceptibility tests using paper 
impregnated with 4% DDT, 0.1% bendiocarb and 1% pirimiphos methyl were performed to 
assess the level of resistance to all four classes of WHO approved neurotoxic insecticides. The 
mosquitoes tested were 2-3 day-old adult female mosquitoes, emerged from larvae collected 
from study villages and reared in the insectary at IPR. Approximately 100 mosquitoes, in batch 
of 25, were exposed for 1h to insecticide-treated papers, and mortality was recorded 24h later. 
The same number of mosquitoes were exposed to untreated papers and served as control. 
Mosquitoes that survived exposure to either of the pyrethroids were monitored for an additional 
24h, after which the survivors were preserved in RNA later for subsequent molecular testing. 
 
Resistance intensity assays 
To determine the intensity of resistance to pyrethroids in the local Anopheles mosquitoes, 
adapted CDC bottle assays were performed. Since both interventions (LLIN and EaveTubes) 
are treated with the same type of pyrethroids (pyrethroid type II), the intensity of pyrethroid 
resistance was determined using pyrethroid from one of these interventions. Bottles were 
coated with a range of deltamethrin concentrations (7.81µg/mL to 1000µg/mL), producing a 
range of mortality rates between 0% and 100% in mosquitoes from the study villages. Each 
bioassay included a control bottle treated with only acetone. The susceptible An. gambiae 




0.5µg/mL. Two to three days old adult female mosquitoes were exposed for 1h at each 
concentration in four replicates of 25.  
 
WHO cone bioassay 
To determine the impact of resistance on susceptibility to the bed nets (PermaNet 2.0) deployed 
in the study area, standard cone bioassays were performed according to WHO procedures using 
adult female mosquitoes emerged from larvae collected from the eight study villages and the 
susceptible Kisumu strain. Approximately 60 mosquitoes were exposed to netting sample for 
3 min and the mortality rate was determined 24h later. Control mosquitoes (~60) were exposed 
to an untreated net and served as control.  
 
Species identification and target site resistance mechanisms  
To type mosquitoes to species and identify target site resistance mechanisms in Anopheles 
mosquitoes from study villages, genomic DNA was extracted from a pair of legs taken from 
field mosquitoes that survived exposure to deltamethrin and cyfluthrin in WHO cylinder 
assays, and from a subset of unexposed female mosquitoes. The legs were boiled in 20µL of 
buffer solution for 90 min at 95°C. The member of the An. gambiae complex were identified 
to species using SINE-PCR [49]. 
TaqMan PCR assays were used to screen mosquito samples for mutations in the voltage gated 
sodium channel, including the 1014S, 1014F and 1575Y [17,50], and for the ace-1 G119S [51] 
resistance mutation in acetylcholinesterase. Heterozygotes for An. gambiae and An. coluzzii 
are all expected to include duplications in some combination of (1) G and S alleles are paired 
on a single chromosome - a heterogeneous duplication (2), an unduplicated G allele, and (3) a 
multicopy S allele [52]. Variation in composition of G and duplicated S alleles can be detected 
quantitatively as a difference in dye balance in heterozygotes in TaqMan qPCR [53]. 
 
Whole genome microarray  
A genome-wide transcription profiling was performed to identify genes differentially 




susceptible lab strains. All of the villages involved in the CRT were at least 2km apart; 
however, to capture the whole range of over/under expressed genes in mosquitoes from the 
study area, two villages much further away from each other were selected for microarray 
analysis. Mosquitoes used in microarray studies were confirmed as An. gambiae using SINE-
PCR. 
 
Gene expression profiles of unexposed, female An. gambiae mosquitoes from one control 
village (N’Guessan Pokoukro) and the survivors of deltamethrin exposure from one 
intervention village (Sessenouan) were compared to those of two susceptible lab strains, 
Anopheles gambiae Kisumu and Anopheles gambiae Ngousso, using an interwoven loop 
design (Fig. 2.S4). Inclusion of survivors from one village and unexposed from another, with 
the highest prevalence of pyrethroid resistance maximised chances of identifying resistance-
associated candidate genes, whilst ensuring that overexpression induced primarily by exposure 
(i.e. gene induction) was precluded. Field-collected mosquitoes included in the microarrays 
analysis were solely the most predominant species, Anopheles gambiae. Significant differential 
expression between field mosquitoes from the two villages and the two insecticide susceptible 
lab strains was identified using a filtering approach. This was based on a P < 0.05 (after 
Bonferroni correction), a fold change in expression > 2 or <-2 and directionality i.e. the same 
direction of differential expression (upregulated or down-regulated) in the 4 comparisons 
(N’guessan Pokoukro vs Kisumu, N’guessan Pokoukro vs Ngousso, Sessenouan vs Kisumu, 
Sessenouan vs Ngousso). Total RNA was extracted from batches of ten female An. gambiae 
mosquitoes using a PicoPure RNA isolation kit (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. Total RNA extracted from mosquitoes was treated using DNase 
(RNase free DNase set, Qiagen Hilden Germany). Before further use, the concentration and 
quality of the extracted RNA were evaluated using a NanoDrop spectrophotometer (Thermo 
Fisher Scientific) and a 2100 Bioanalyzer (Agilent Technologies). Four biological replicate 
extractions of total RNA for each mosquito population or colony were amplified and labelled 
using the Low Input Quick Amp Labeling Kit (Agilent Technologies). The Agilent Agam15k 
array was used for dual-color hybridizations (N’guessan Pokoukro vs Kisumu, N’guessan 
Pokoukro vs Ngoussou, Sessenouan vs Kisumu, Sessenouan vs Ngoussou) [54]. The labelled 
samples were hybridized using a Gene Expression Hybridization Kit (Agilent Technologies). 




recommendations. The design of the microarray experiment was optimized through 
comparison of the above strains across four microarray slides.  
Quantitative reverse transcriptase PCR for candidate gene expression in field mosquitoes 
The expression of a subset of genes from microarray known to play a role in insecticide 
resistance in Anopheles gambiae mosquitoes was taken forward for validation and 
measurement in field mosquitoes from the eight villages using reverse-transcription 
quantitative PCR (RT-qPCR). For each village, the expression for each gene of interest was 
measured in three cohorts of mosquitoes: non-exposed, deltamethrin and cyfluthrin survivors. 
Prior to qPCR experiments, RNA was extracted from field mosquitoes and quantified using the 
Nanodrop spectrophometer. cDNA was subsequently synthesized from 11ng of RNA using 
oligo(dT) 20 (50 μM) and SuperScript III (200U) (Invitrogen) and purified through a DNA-
binding column (Qiagen). Three pairs of primers of each target gene were designed using 
Primer-BLAST tool (NCBI: http://www.ncbi.nhi.gov/tools/primers-blat/). The primer pair 
with the highest efficiency value (~100%), determined by running standard qPCR using serial 
dilution of a single cDNA sample, was selected for subsequent qPCR (details of the primers 
are given in Table 2.S3). For each qPCR reaction, four biological replicates of each treatment 
group and two technical replicates were used. QPCR was performed using an Agilent Mx3005P 
QPCR System and the cycling condition was as follow: 95°C for 3 min, 40 cycles of 95°C for 
10 s and 60°C for 10 s. Expression of the genes was normalized using references genes 
(Ribosomal S7 and Elongation Factor).  
Statistical analysis 
Mosquito mortality rates were compared using Generalized linear models with a binary link 
function in SPSS v23. WHO assessments of mortality rates are: less than 90% indicates 
resistance; higher than 98% indicates susceptibility: between 90 and 98% requires further 
testing to confirm resistance status [55]. The intensity of resistance (Resistance Ratio, or RR50) 
was estimated using the R statistical software version 2.15.0 to compare the LD50 of the wild 
population relative to that of the susceptible lab strain. The variation in bioassay mortality rates 
of An. gambiae mosquitoes between villages was tested using Generalised Linear Model 
(GLM). The spearman test was used to test the correlation between resistance intensity to 
deltamethrin and bioassay mortality rates. The frequencies of target site resistance mutations 




square test with Yates continuity correction. Concordance with Hardy-Weinberg equilibrium 
was assessed for each resistance marker in each village using the permutation-based probability 
test in Genepop [56,57], with Bonferroni correction applied for multiple testing. 
A MAANOVA model was used to analyse microarray data using previously described custom 
R-scripts[54]. Differentially expressed genes (over/under expressed) were those with a fold 
change consistently greater than 2 or less than -2 across the four comparisons (N’guessan 
Pokoukro vs Kisumu, N’guessan Pokoukro vs Ngousso, Sessenouan vs Kisumu, Sessenouan 
vs Ngousso) and with a significant Bonferroni-corrected p value in all four comparisons. 
Outliers were identified and excluded from the qPCR dataset prior to analysis. The ΔΔCt 
method incorporating PCR efficiency was used to compare expression of each target gene 
between field mosquitoes and the lab strain [58]. Significant difference in fold change between 
field samples and the reference lab colony was estimated using a t-test (P < 0.05). Kruskal 
Wallis test was used to compare the level of expression of candidate genes across the three 
groups of field mosquitoes (unexposed group and mosquitoes surviving exposure to the two 
different pyrethroids in WHO cylinder assays).  
 
Data availability 
All data generated or analysed during this study are included in this published article (and its 
Supplementary Information files) 
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Fig. 2.1 Twenty-four-hour percentage mortality of An. gambiae from each village exposed 
in diagnostic bioassays to A) 0.05% deltamethrin, B) 0.15% cyfluthrin, C) 0.1% 
bendiocarb, D) 4% DDT and E) 1% pirimiphos methyl. Error bars represent 95% Cis 















        
   Village (arm)   
  Wald χ2 df P 
deltamethrin 35.245 6 0.000004 
cyfluthrin 25.53 6 0.0003 
bendiocarb 14.52 6 0.024 
DDT 18.03 6 0.006 




Table 2.2: Intensity of resistance to deltamethrin in An. gambiae from different villages in the 
study area prior to the study. 
 *Susceptible reference strain;  
 LD: lethal doses expressed in μg/mL;  




Table 2.3: Generalised linear model testing the effects of village on net induced mortality  
 
  Village (arm)   
  Wald χ2 df  P 










Strain Slope (SE) LD 50 (95% CI) LD 95 (95% CI) RR50  
Kisumu* 1.3 (0.18) 0.015 (0.009-0.022) 0.261 (0.136-0.767) 
  
 -  
     
Akanzakro 1.7 (0.2) 27.2 (20.3-35.2) 250.1 (166.7-451.-0) 1873  
 
Kologonouan 1.5 (0.1) 21.9 (15.8-28.5) 289.3 (190.0-534.4) 1504  
 
Konzo 1.6 (0.1) 23.5 (19.1-28.3) 237.4 (173.7-358.2) 1617  
 
Kouakro 1.7 (0.17) 22.4 (17.3-28.0) 213.5 (145.0-376.6) 1542  
 
N’Guessan Pokoukro 2.1 (0.2) 33.7 (25.7-43.2) 207.0 (139.6-377.6) 2314  
 
Saoundi 1.7 (0.1) 35.0 (28.9-41.9) 322.4 (237.8-477.3) 2405  
 
Seoule  1.7 (0.1) 21.0 (17.2-25.0) 183.0 (139.1-261.3) 1441  
 




Table 2.4: Species composition in the study villages 





Akanzakro 117 0 2 
Kologonouan 86 0 0 
Konzo 99 2 0 
Kouakro 53 53 0 
N’Guessan Pokoukro 160 12 1 
Saoundi 116 2 0 
Seoule 99 1 1 
Sessenouan 158 12 1 
N: number of Anopheles gambiae mosquitoes identified to species by SINE-PCR 
 
 
Table 2.5: Frequencies of 1014F and 1575Y kdr alleles in Anopheles gambiae from study villages. 
N: number of samples, L: leucine, F: phenylalanine, N: asparagine, Y: tyrosine. P values are from χ2-squared tests 
 
Study villages N tested L1014F      N1575Y     
P value    LL LF FF F (1014F) P value   NN NY YY F (1575Y) 
Akanzakro 47 0 0 47 1 0.59  36 11 0 0.12 0.32 
Kologonouan 46 0 1 45 0.99   38 6 2 0.11  
Konzo 48 0 4 44 0.96   35 13 0 0.14  
Kouakro 45 0 9 36 0.90   36 9 0 0.10  
N'Guessan Pokoukro 47 0 5 42 0.95   37 10 0 0.11  
Saoundi 41 1 4 36 0.93   34 6 1 0.11  
Seoule  40 1 1 38 0.96   31 8 1 0.13  





Fig. 2.2 Percentage mortality of susceptible Kisumu and resistant Anopheles gambiae 
exposed to LLIN material in WHO cone bioassays. Error bars indicate 95% Cis. 
 
Fig. 2.3 Genotypic frequencies of the Ace-1 G119S mutation in Anopheles gambiae 






Fig. 2.4 Differentially expressed probes in Anopheles gambiae s.s. from two villages 
compared to two susceptible lab colonies. Average log2-transformed fold-differences are 
plotted against average negative log probabilities. Probes from genes chosen for qPCR 






Fig. 2.5 Box-whisker plots show mean fold difference in expression of candidate genes (relative to susceptible colony samples) across 
villages. The boxes represent the 25% and 75% quartiles and the whiskers indicate 5% - 95% quartile ranges. The horizontal line within each box 





Fig. 2.6 Map showing study villages involved in insecticide resistance monitoring (rm) 
 
 
Table 2.6: Location of study villages and description of mosquito breeding habitats. 
SET: Screening plus EaveTubes, LLIN: long-lasting insecticidal net. 
 
 
     
Study village Geographic coordinates Arm Type of breeding habitats 
  Longitude Latitude     
N'Guessan Pokoukro (NP) 7°56’N   5°20’W Control (LLIN) Water puddle 
Kologonouan (Kolo) 7°66’N  5°17’W Control (LLIN) Water puddle 
Konzo (Kon) 7°46’N   5°07’W Control (LLIN) Vegetable farm + rice field 
Seoule Ahounzè (Seou) 7°76’N 5°42’W Control (LLIN) Rice field 
Sessenouan (Sesse) 7°69’N  5°17’W SET and LLIN Vegetable farm + rice field 
Kouakro (Koua) 7°83’N   5°08’W SET and LLIN Rice field + water puddle 
Saoundi (Saou) 7°78’N   5°26’W SET and LLIN Rice field 





Fig. 2.S1: Side-by-side fold change in gene expression measured by microarrays and qRT-PCR for selected candidate genes. The overall 










Fig. 2.S3: Boxplots show mean fold change in expression of candidate genes across 
treatments. The boxes represent the 25% and 75% quartiles and the whiskers indicate 5% - 95% 
quartile ranges. The horizontal line within each box represents the mean fold difference in gene 




Fig. 2.S4: Interwoven microarray loop design comparing field mosquito samples from two CRT 
villages (one control cluster: np=N’guessan Pokoukro and one intervention cluster: se=Sessenouan) 
and two lab colonies (kis= An. gambiae Kisumu and ng= An. gambiae N’goussou). Each circle 
represents mRNA extracted from a pool of 10 female An. gambiae s.s. Individuals microarrays are 
represented by arrows (32 in total). The direction of the arrows indicates dye labelling. 
Table 2.S1: Twenty-four-hour mortality of A) Anopheles gambiae Kisumu and B) Anopheles gambiae 
from each study village after exposure to a range of deltamethrin concentration in adapted CDC 
bottle assay. 
Table 2.S2: Microarray results (.xlsx). Table 2.S2A: Microarray results for all probes. Table 2.S2B: 




Table 2.S3: Details of primers used in qRT-PCR analysis (.xlsx) 
Table 2.S4: Statistical results on comparison of fold change in gene expression among chosen CRT 
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huts against pyrethroid resistant Anopheles gambiae M’bé, Côte d’Ivoire: potential for impact on 






Evaluation of standard pyrethroid based LNs (MiraNet and MagNet) in experimental huts 





There is evidence from experimental hut and household studies that the entomological efficacy of 
long lasting pyrethroid treated nets (LLINs) is compromised in areas of pyrethroid resistance. The 
rapid increase in resistance intensity in African malaria vectors could further undermine the 
performance of these nets. The pyrethroid resistance intensity in Anopheles gambiae s.l. M’bé 
from central Côte d’Ivoire is reported to be high (> 1700 fold). Whether this translates into an 
increase in entomological indicators of malaria transmission needs investigation. 
Method 
The efficacy of two long lasting insecticidal nets (LN) MiraNet and MagNet, both alpha-
cypermethrin based was evaluated in experimental huts against pyrethroid resistant Anopheles 
gambiae in M’bé, central Côte d’Ivoire. All nets were deliberately holed to simulate wear-and-tear 
and were tested unwashed and after 20 standardized washes. 
Results 
The entry rates of An. gambiae s.l. into huts with insecticide treated nets were 62-84% lower than 
entry into huts with untreated nets (p < 0.001). Exit rates of An. gambiae s.l. with unwashed 
MiraNet and MagNet LNs were significantly greater than with untreated nets (50-60% vs 26%) 
and this effect after washing 20 times nets did not decrease. Blood-feeding with both nets was 
significantly inhibited relative to the untreated reference net (31-55%) (p < 0.001). Washing 
MiraNet LN 20 times had no significant impact on protection against An. gambiae s.l. bites but it 
did cause a significant fall by 40% in protection with MagNet LN (p < 0.001). All insecticide 
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treated nets induced higher mortality of An. gambiae s.l. than the untreated net (p < 0.05). The 
impact though significant was limited (14-30%). The personal protection against An. gambiae s.l. 
bites derived from all treatments was high (75-90%). The overall insecticidal effect was 
compromised by pyrethroid resistance and was not detectable in some treatments.  
Conclusion 
In this area of high pyrethroid resistance intensity (over 1700 fold), both MiraNet and MagNet 
LNs still conferred appreciable personal protection against mosquito bites despite inducing only 
slightly greater mortality of pyrethroid resistant Anopheles mosquitoes than untreated nets. The 
impact is comparable to moderately intense Benin resistance area (207 fold) and Burkina Faso 
(over 1000 fold). This preserved level of protection plus the small but sensitive killing of 
mosquitoes may continue to impact vectorial capacity despite high intensity of resistance. 
Nevertheless, there is an obvious need for strategies and nets with novel mode of action to enhance 




















Insecticide treated mosquito nets and indoor residual spraying of insecticide remain the 
cornerstones of public health strategies for preventing malaria. These core vector control methods 
have contributed to the decline in malaria burden, accounting for over three-quarters of the 663 
million clinical cases of malaria averted over the past 15 years in Sub-Saharan Africa [1]. Long 
Lasting Insecticidal Nets (LLINs) made the major contribution due to the increased ownership and 
use of these nets in malaria endemic areas. The estimated proportion of households in areas at risk 
with at least one LLIN has increased from only 2% in 2000 to 79% in 2015 [2]. Control measures 
based on house spraying, on the other hand, have declined in coverage. The high cost of alternative 
non-pyrethroid chemicals might explain the recent decline in IRS coverage from 5 to just 3% [2]. 
While a range of insecticides is available for use in IRS, although effectively limited by cost, there 
is a few classes of insecticides (pyrethroids and pyrrole) and recently an insect growth inhibitor 
(pyriproxyfen) approved for net treatment [3–5]. Resistance to pyrethroids is now widespread in 
major malaria vectors [6], thus threatening the continued effectiveness of pyrethroid-based 
interventions. While a resistance mitigating plan has been developed [7], options are presently 
limited but momentum for the development of new classes of chemistry is growing and new 
products may become available in the near future [8].  
 
Although there is extensive evidence from experimental hut and household studies showing 
reduced entomological efficacy of insecticide treated nets against insecticide resistant vectors 
[9,10], there is as yet no definitive evidence of a correlation between insecticide resistance and 
malaria metrics. A recent study across five countries (Benin, Soudan, Kenya, Cameroon and India) 
has attempted to address the question of whether insecticide resistance can undermine the 
protective efficacy of insecticide treated nets [11] and results from one of the study sites (Benin) 
showed that LLINs continue to provide some protection against malaria even with highly 
pyrethroid resistant Anopheles mosquitoes [12]. However, determination of resistance levels (high 
versus low) in the study was based on WHO susceptibility assay mortality and such resistance 
prevalence assays may give an incomplete picture of resistance [13]. It is therefore plausible that, 
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the absence of resistance impact on bed net efficacy seen in southern Benin could be due to the 
fact that the resistance intensity profiles did not differ between both study arms.  
 
The impact of resistance is difficult to demonstrate because resistance cannot be randomized [7]. 
Although there is no empirical data linking experimental hut data to malaria transmission 
indicators, mathematical models do predict an impact on transmission [14]. Hut data furthermore 
provides the opportunity to assess the impact of insecticide resistance on the potential for LLINs 
to provide individual (blood feeding inhibition) and community level protection (killing effect).  
 
Measuring resistance intensity in Anopheles mosquitoes across experimental hut stations could 
help link the strength of resistance with the efficacy of interventions being evaluated. So far 
resistance intensity using adapted CDC bottle assays has been determined in local Anopheles 
mosquitoes from only two Western African countries (Benin and Burkina Faso). In Benin areas 
with moderate intensity of resistance to alpha-cypermethrin (207 fold), Interceptor 1 LN, an alpha-
cypermethrin based LN washed 20 times continued to inhibit blood feeding by 47% in 
experimental huts [15] while in Burkina Faso with higher resistance intensity to deltamethrin (over 
1000 fold) it reduced feeding by 15% [16]. Mortality rates of An. gambiae in the two scenarios 
were low (around 20%) but greater than that with untreated nets. This suggests that LLINs would 
continue to provide some level of protection even when resistance is as high as that reported in 
Burkina Faso. Whether such limited level of control and protection is maintained across settings 
with similar or higher resistance intensity needs investigation.  
 
The intensity of pyrethroid resistance in An. gambiae s.l. from the M’bé field station in central 
Côte d’Ivoire is among the highest ever reported (>1700 fold) [17]. The present experimental hut 
study was designed to investigate whether the extremely high level of resistance observed in the 
local Anopheles mosquito population from M’bé translates into an increase in entomological 
indicators of malaria transmission such as mosquito survival and blood feeding rates. The 
performance of two LNs (MiraNet and MagNet), both alpha-cypermethrin based was therefore 









The M’bé field site is located in central Côte d’Ivoire, 40km south of Bouaké. The station is 
surrounded by a large rice growing valley producing year round An. gambiae s.l., mainly M form. 
The resistance profile of the M’bé mosquito population appears multifactorial involving target site 
insensitivity and increased expression of metabolic enzymes. A recent study conducted in 2016 at 
the M’bé field site showed over 1700 fold resistance to deltamethrin in the local Anopheles 
mosquitoes [17]. This level of resistance intensity is among the highest ever reported in African 
malaria vectors.  
 
Susceptibility tests 
Bioassays were conducted using papers treated with diagnostic concentration of 0.05% alpha-
cypermethrin (insecticide on the LNs). Two to three-day old adult female mosquitoes, emerged 
from larvae collected at M’bé field station and reared in the insectary at the Institut Pierre Richet 
were used for the susceptibility tests. Approximately 100 mosquitoes in batch of 25 were exposed 
for 1h to insecticide-treated papers and mortality was recorded 24h later. 
 
Experimental huts 
A field trial was carried out at M’bé in experimental huts constructed to WHOPES-approved West 
African design [18]. The hut trial took 5 weeks (from October to November 2014), corresponding 
to 25 night collections per hut. The huts were made of bricks, plastered with cement, with a 
corrugated iron roof. The ceilings were lined with plastic sheeting and the walls were supplied 
with four 1-cm window slits which serve as mosquito entry points. The huts were built on a 
concrete pillar surrounded by water-filled moats to prevent entry of predators. Exiting mosquitoes 
were captured in verandah trap.  
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LLINs and washing procedure  
MiraNet LN is a Long Lasting net manufactured by A to Z Textile Mills, Tanzania. Alpha-
cypermethrin is incorporated into 135-denier, monofilament, high-density polyethylene (HDPE) 
fibres, with the target dose of 4.5g/kg alpha-cypermethrin. MiraNet LN was a prototype under 
evaluation by WHO for recommendation at the time of the trial. 
MagNet LN is a warp knitted fabric netting material containing 5.8 g/kg alpha-cypermethrin 
incorporated in monofilament HDPE, 150-denier manufactured by V.K.A. Polymers. MagNet LN 
received full WHOPES recommendation in 2011[19].  
LNs were washed individually in accordance with standardized WHO Phase II washing protocols 
[20]. Nets were washed in 10 litres of tap water containing 2g/litre of soap (“savon de Marseille”). 
Each net was agitated for 3 min, left to soak for 4 min and further agitated for 3 min totalling 10 
min for one washing cycle. Agitation was done by stirring the net with a wooden pole at 20 
rotations per minute. Nets were rinsed using clean water and dried horizontally in the shade and 
subsequently stored at ambient temperature (27°C± 2°C). The regeneration interval between 
washes was 2 days for MiraNet LN and 1 day for MagNet LN [18]. 
 
Experimental hut study design 
The following five treatment arms were tested in experimental huts: (i) unwashed MiraNet LN, 
(ii) MiraNet LN washed 20 times, (iii) unwashed MagNet LN, (iv) MagNet LN washed 20 times 
(v) untreated 100 denier polyester net. 
Treatments were randomly assigned to five experimental huts and rotated on a weekly basis 
according to a randomized Latin square design to account for potential bias resulting from 
differential hut attractiveness. Prior to the trial, the nets were artificially holed with 16cm2 holes 
(2 on each side and 1 on each end) to simulate the physical condition of damaged net in the field. 
At the end of a five-night rotation, the huts were thoroughly cleaned and aired for one day to 
prevent cross-contamination of huts from the different treatment arms. Five adult men took part in 
the hut trial as volunteer sleepers after informed consent. Human volunteers slept in the huts from 
20.00 to 05.00 and were rotated between huts on successive nights to minimize any bias resulting 
from difference in individual attractiveness to host-seeking mosquitoes. Each morning, dead and 
live mosquitoes were collected from inside the room, under bed nets and traps using mouth-suction 
97 
 
aspirators and torches. Mosquito collections were done on 25 nights over 5 weeks. Upon 
transportation to the laboratory, mosquitoes were identified to species using taxonomic keys and 
gonotrophic status was scored as unfed, blood fed, semi-gravid or gravid. Live female mosquitoes 
were held in plastic cups covered with netting and provided with 10% honey solution; mortality 
was recorded after 24h. 
The efficacy of MiraNet and MagNet LNs was evaluated using the following entomological 
parameters as per WHO guidelines [21]: (i) deterrency: the percent reduction in the number of 
mosquitoes in treatment hut relative to control hut with untreated net; (ii) exit rate (iii) blood 
feeding inhibition rate: the percentage reduction in blood feeding in hut with treated net compared 
to hut with untreated net; (iv) percentage mortality of adult females; (v) overall insecticidal effect 
(as described in N’Guessan et al [9]) = 100 (Kt-Ku)/Tu where Kt is the number killed in the treated 
hut, Ku is the number dying in the untreated control hut, and Tu is the total number collected from 
the control hut [9,22,23]; (vi): personal protection: percentage reduction in mosquito biting in hut 
with treated net compared to hut with untreated net = [1-(number bloodfed in treatment/number 
bloodfed in control) x100]. 
 
Chemical assays 
The alpha-cypermethrin content of the LNs (washed and unwashed) from the five treatment arms 
was assessed before, after washing and after field trial based on WHO guidelines [20]. A piece of 
netting measuring 30cm x 30cm was cut from each of the five locations of each net. Extraction of 
alpha-cypermethrin was performed using the CIPAC method [24]. Alpha-cypermethrin was 
extracted by refluxing with xylene for 30 minutes in presence of dioctyl phthalate as internal 
standard and citric acid. Concentration of the insecticide was subsequently quantified by Gas 
Chromatography with Flame Ionization Detection (GC-FID). 
 
Cone bioassays on nets 
Bio-efficacy of LNs (washed and unwashed) was assessed using WHO cone bioassays at two 
different time points: before and after field trial. Five insectary-reared An. gambiae Kisumu 
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females aged 2-5 days were tested in four replicate cone assays on five sections of each net as per 
WHO guidelines at 25± 2°C and 75± 10% humidity. Knocked down mosquitoes were scored 60 
min post-exposure and mortality recorded after 24 h observation period. 
Ethical permission 
Ethical approval for the study was granted by the Ministry of Health in Côte d’Ivoire and the 
Ethical committee of the London School of Hygiene and Tropical Medicine. Written informed 
consent was obtained from all trial participants. Study volunteers were monitored for potential 
intervention-related side effects and were provided with antimalarial drug (ACTs) when tested 
positive for malaria. In the event that volunteers fell sick from any disease, including malaria, they 
were replaced until they recover and take over. 
 
Statistical analysis 
Data were analysed using the R statistical software version 2.15.0. Proportional outcomes from 
the bioassays (mortality) and the hut trial (exophily, blood feeding and mortality) were analysed 
using generalised linear mixed models (GLMMs) with a binomial distribution and a logit link 
function was fitted to the data using the “lme4” package [25]. For the hut data, net type and hut 
were included as fixed effects and sleepers, day of mosquito collection were treated as random 
effects. Interactions between bednet type and washes were also included in the models. Numeric 
outcomes (number entering each hut, feeding and dying) were analysed using generalised linear 
models with a Poisson distribution. Pairwise comparisons were performed using the “multcomp” 




Prior to the experimental hut trial, WHO susceptibility assays on female An. gambiae s.l. 
mosquitoes from M’bé to 0.05% alpha-cypermethrin-treated papers resulted in 32% mortality (n 
tested = 104), indicating a high frequency of resistance to pyrethroids in the study area. 
Experimental hut trial 
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Overall, 3614 An. gambiae s.l. females were caught in huts over the 5-week trial at M’bé (Table 
3.1). The entry rates of An. gambiae s.l. into huts with insecticide treated nets were 62-84% lower 
than entry into huts with untreated nets (p < 0.001) (Table 3.1).  
Exit rates of An. gambiae s.l. with unwashed MiraNet and MagNet LNs were significantly greater 
than untreated net (50-60% vs 26%) and washing 20 times these nets did not decrease the effect 
(Table 3.1).  
Blood-feeding was inhibited in every hut relative to control but the levels of inhibition though 
significant were moderate (31-55%) (p < 0.001). Washing MiraNet LN 20 times had no significant 
impact on protection against An. gambiae s.l. bites, but washing MagNet LN 20 times resulted in 
a 40% decrease in protection, with evidence for significant interaction between net type and wash 
treatment (p = 0.005) (Table 3.1, Fig. 3.1 A). 
The mortality before and after washing the LNs mirrored that of the blood-feeding. All insecticide 
treated nets induced higher mortality of An. gambiae s.l. than the untreated net (p < 0.05). The 
mortality rates across all treatment types were limited (range 14%-30%) (Fig. 3.1 B). There was 
evidence for significant loss of activity with MagNet LN after 20 washes but not with MiraNet LN 
(significant interaction between net type and wash treatment; p < 0.05).  
The level of personal protection against An. gambiae s.l. bites that derived from all treatments was 
high (75-90%). The overall insecticidal effect on mosquitoes was compromised by pyrethroid 
resistance at this site and was marginal (< 4%) across all treatments (Table 3.1).  
 
Cone bioassays  
Before and after field trial, knock down and mortality rates of susceptible An. gambiae s.l. were 
nearly 100% (> 99%) with all treated nets (data not shown).  
 
Chemical assays 
The mean alpha-cypermethrin content in nets before and after field testing is shown in Table 3.2. 
Chemical analysis showed that initial concentrations of alpha-cypermethrin in both LNs were close 
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to the target dose of 4.5 g/kg±25% for MiraNet LN and 5.8g/kg±25% for MagNet LN, with a 
within-net variation of less than 10%. After 20 washes, the alpha-cypermethrin content was 4.13 
with MiraNet LN and 5.35 with MagNet LN, corresponding to an overall retention rate of about 
85% for both LNs. The drop in insecticide content did not differ between MiraNet LN (14%) and 
MagNet LN (15%) (Table 3.2). While the loss in alpha-cypermethrin content after washing did 
not impact the efficacy of MiraNet LN (Fig. 3.1A & B), the same magnitude of decline in chemical 
content resulted in a significant decrease in the effect size (blood feeding inhibition and mortality) 
with MagNet LN. After 5 weeks of use in experimental huts, there was a marginal decrease (< 
10%) in alpha-cypermethrin content.  
Discussion 
The present study was designed to investigate in experimental huts the performance of two 
pyrethroid LNs (MiraNet and MagNet) against An. gambiae s.l. in an area of high resistance 
intensity to deltamethrin (over 1700-fold resistance) in Bouaké, Côte d’Ivoire. We observed 
appreciable levels of protection against mosquito bites (blood feeding inhibition) in the order of 
31-55% despite high resistance intensity. These are within the protection range seen in Burkina 
Faso (15-25%) [27] with comparable resistance strength and in areas of lower intensity in Benin 
(47-57%) [15].  
 
MiraNet and MagNet LNs in our present trial induced marginal mortality of An. gambiae s.l. (14-
30%) albeit greater than the untreated nets. The trend is consistent with the hut trials from Burkina 
Faso and Benin and there is no evidence to suggest that increasing intensity of resistance worsens 
control of An. gambiae mosquitoes. However, one potential limitation of the study is that the 
intensity study by Glunt et al. was conducted at the same site as the current trial but at different 
time period: E.g. the intensity data was collected in October 2016 whereas the hut trial fell two 
years behind, i. e. October to November 2014. Considering that insecticide resistance is dynamic, 
one cannot rule out the fact that intensity might have been different at the time of the hut trial. It 
is plausible that with an intensity of 1700 fold in that year 2014, the corresponding effect size 
might have been different. Nevertheless, in the same paper by Glunt et al. PermaNet 2.0 LN, 
another pyrethroid-only LN, evaluated at the same site and period as the 1700-fold resistance 
intensity bioassays showed an impact against An. gambiae s.l. similar to that in the current trial 
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(60% blood feeding inhibition vs 31-55%; 20% mortality vs 14-30%). 
 
Before washing, mosquito mortality and blood feeding inhibition rates were significantly higher 
with MagNet LN compared to MiraNet LN. The difference in efficacy could be due to the 
difference in concentration of alpha-cypermethrin in both LNs (6.43 g/kg AI for MagNet LN 
versus 4.5 g/kg AI for MiraNet LN). While washing both nets 20 times decreased blood feeding 
inhibition and mortality rates, the reduction in effect size was significant only for MagNet LN, 
indicating that MiraNet LN was more wash resistant than MagNet LN.  
 
Although the overall insecticidal effect of pyrethroid-treated nets is lost in the presence of 
resistance, a substantial protection can still be afforded to net users as evidenced in this study. 
Vectorial capacity as expressed by MacDonald [28] is sensitive to the reduction in vector host 
contact and more so to the mortality of the malaria vector. The significant level of protection that 
holed nets continue to offer plus the small but sensitive killing of pyrethroid resistant Anopheles  
population in the present study and in neighboring Benin and Burkina Faso would suggest that 
LLINs could still reduce malaria transmission despite resistance. This supports the WHO 
continuous advocacy of universal coverage with pyrethroid LNs, despite increasing level of 
insecticide resistance. Recent observational cohort studies conducted in Benin and Malawi 
demonstrated a reduction in incidence of malaria infection in LLINs users compared to bed net 
non-users in settings with moderate to high pyrethroid resistance [12,29]. However, this level of 
protection could be lost not only when resistance strength increases further [27] but also with 
declining bed net physical integrity [30].  
 
To preserve the efficacy of LLINs, a range of new generation LNs have been developed. The 
design of these nets is generally based on the combination of unrelated insecticides (alpha-
cypermethrin-chlorfenapyr mixture net: Interceptor G2 net) [16,31] or mixture of one insecticide 
with either a synergist (piperonyl butoxide-treated insecticidal net: PBO LN) [32,33] or an insect 
juvenile hormone mimic (permethrin-pyriproxyfen mixture net: PPF LN) [34]. Combination of 
insecticides with contrasting mode of action is one of the WHO recommended tactics for 
insecticide resistance management [7]. In a recent experimental hut trial in M’bé, Interceptor G2 
LN killed very high proportion of An. gambiae s.l. (82-87%) that entered huts [35]. This effect 
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size (high mortality) with the G2 LN demonstrates the impact of resistance on pyrethroid LNs and 
indicates what pyrethroids would have achieved in the absence of resistance. It also stresses the 
need for alternative tools or strategies to overcome insecticide resistance. 
  
The design of new brand of bed net treated with pyrethroids only seems to be driven by the 
availability of commercially sustainable market further supported by the WHO policy for universal 
coverage with LLINs. However, with clear-cut evidence from a number of observational studies 
that elimination of malaria will require additional measures beyond current best practice of 
pyrethroid-only LNs, control efforts should be devoted to the development of new and effective 
insecticides and strategies to counter resistance and sustain progress toward elimination.  
 
Conclusion 
Despite high resistance intensity (over 1700 fold) found in M’bé, both MiraNet and MagNet LNs 
still confer appreciable protection against mosquito bites and induce slightly greater mortality of 
pyrethroid resistant Anopheles mosquitoes than untreated nets. The impact is comparable to 
moderately intense Benin resistance area (207 fold) and Burkina Faso (over 1000 fold). The 
significant level of protection that holed nets continue to offer plus the small but sensitive killing 
of pyrethroid resistant Anopheles population would suggest that LLINs may still reduce malaria 
transmission despite high intensity of resistance. However, the data suggests that the community 
protection arising from the overall insecticidal effect of LLINs could be compromised in this area 
of Côte d’Ivoire with high vector resistance. There is an urgent need for development of novel 
strategies or LLIN with novel mode of action to enhance vector control.  
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Table 3.1: Experimental hut trial results against pyrethroid resistant An. gambiae s.l.  




Table 3.2: Chemical analysis of alpha-cypermethrin on LNs in the experimental hut trial in M’bé  
 
Treatment Concentration of alpha-cypermethrin (g/kg) 
Before trial After washing After trial 
MiraNet LN unwashed 4.50 ̶ 4.62 
MiraNet LN 20 washes 4.79 4.13 4.10 
MagNet LN unwashed 6.43 ̶ 5.95 
MagNet LN 20 washes 6.33 5.35 4.87 
  Untreated net MiraNet LN 0w MiraNet LN 20w MagNet LN 0w MagNet LN 20w 
    
Total females caught 1594a 257b 582c 578c 603c 
% Deterrency  ‒ 83.9 63.5 63.7 62.2 
Total females exiting 419 130 336 349 343 
% Exiting (95% CI) 26.3 (24.1-28.4)a 50.6 (44.5 - 56.7)b,c 57.7 (53.7-61.7)c 60.4 (56.4-64.4)c 56.9 (52.9-60.8)c 
Total females blood fed 983 100 249 159 246 
% Blood feeding Inhibition   ‒ 36.9 30.6 55.4 33.8 
Personal protection %  ‒ 89.8 74.7 83.8 75.0 




Fig.3.1 Experimental hut trial against wild free-flying pyrethroid resistant An. gambiae s.l. M’bé with MiraNet and MagNet LNs. (A) 
Percentage blood-feeding, (B) Percentage mortality. Bars bearing the same letter label are not significantly different at the 5% level (p < 




PART THREE: Optimize and evaluate EaveTubes against pyrethroid resistant 
Anopheles gambiae mosquitoes 
 
 
Chapter 4: Screening and field performance of powder-formulated insecticides 
on eave tube inserts against pyrethroid resistant Anopheles gambiae: an 
investigation into actives prior to a randomized controlled trial in Côte d’Ivoire. 
 
Chapter 5: Spatio-temporal trend in insecticide resistance in Anopheles gambiae 
following wide-scale deployment of a “Lethal house Lure” in combination with 
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The widespread emergence of insecticide resistance in African malaria vectors remains one of 
the main challenges facing control programmes. Electrostatic coating that uses polarity to bind 
insecticide particles is a new way of delivering insecticides to mosquitoes. Although previous 
tests demonstrated the resistance breaking potential of this application method, studies 
screening and investigating the residual efficacy of broader range insecticides are necessary. 
Methods 
Eleven insecticide powder formulations belonging to six insecticide classes (pyrethroid, 
carbamate, organophosphate, neonicotinoid, entomopathogenic fungus and boric acid) were 
initially screened for residual activity over 4 weeks against pyrethroid resistant Anopheles 
gambiae sensu lato (s.l). from the M’bé valley, central Côte d’Ivoire. Tests were performed 
using the eave tube assay that simulates the behavioural interaction between mosquitoes and 
insecticide-treated inserts. With the best performing insecticide, persistence was monitored 
over 12 months and the actual contact time lethal to mosquitoes was explored, using a range of 
transient exposure time (5s, 30s, 1min up to 2 min) in the tube assays in laboratory. The 
mortality data were calibrated against overnight release recapture data from enclosure around 
experimental huts incorporating treated inserts at the M’bé site. The natural recruitment rate of 
mosquitoes to the tube without insecticide treatment was assessed using fluorescent dust 
particles. 
Results 
Although most insecticides assayed during the initial screening induced significant mortality 
(45-100%) of pyrethroid resistant An. gambiae during the first two weeks, only 10% beta-
cyfluthrin retained high residual efficacy, killing 100% of An. gambiae during the first month 
and >80% over 8 subsequent months. Transient exposure for 5 seconds of mosquitoes to 10% 
beta-cyfluthrin produced 56% mortality, with an increase to 98% when contact time was 
extended to 2min (P = 0.001). In the experimental hut enclosures, mortality of An. gambiae 




contacted the inserts treated with fluorescent dusts. This indicates that all host-seeking female 
mosquitoes that contacted beta-cyfluthrin treated inserts during host-seeking were killed. 
Conclusion 
The eave tube technology is a novel malaria control approach which combines house proofing 
and targeted control of Anopheles mosquitoes using insecticide treated inserts. Beta-cyfluthrin 
showed great promise for providing prolonged control of pyrethroid resistant An. gambiae and 
has potential to be deployed year-round in areas where malaria parasites are transmitted by 

























Wide scale use of insecticide-based interventions such as indoor residual sprays (IRS) and long 
lasting insecticide treated nets (LLINs) has contributed to a substantial reduction in the global 
malaria burden in recent years [1,2]. However, the sustainability of these approaches is now 
being threatened by the evolution of insecticide resistance [3,4], creating a need for more 
diverse vector control tools [5].  
 
The eave tube is a recent innovation that offers a novel approach for delivering insecticides to 
malaria mosquitoes [6]. The approach involves blocking the eaves of houses (if open) and 
inserting pieces of PVC pipe to act as ‘chimneys’ to channel the human odours mosquitoes use 
as cues to locate hosts for blood feeding, out of the house. When host-seeking mosquitoes enter 
a tube, they encounter an insert treated with an insecticide. The current version of the eave tube 
inserts uses electrostatic netting to hold powder formulations of insecticides. Mosquito contact 
with the netting results in very efficient transfer of powder particles such that even highly 
pyrethroid resistant mosquitoes can be killed with pyrethroid insecticides due to the 
overwhelming doses[7]. When eave tubes are combined with screening of windows and doors 
to reduce mosquito entry via other routes, the approach provides both physical protection and 
a killing effect, much like an insecticide treated net but at the level of the household.  
 
Semi-field and modelling studies indicate that screening plus eave tubes (SET) could reduce 
transmission of malaria at community level above and beyond universal coverage of LLINs [8–
10]. Based on these promising results, a cluster randomized controlled trial (CRT) is now being 
conducted in central Côte d’Ivoire [11] to evaluate epidemiological impact at village level. The 
current paper reports on a series of initial studies to screen a range of candidate insecticides for 
use in this trial, together with an evaluation of potential residual activity of a smaller number 
of promising insecticides to select a final product and inform likely retreatment frequency for 
the CRT.  
 
Materials and methods 
Mosquitoes and insecticides  
Experiments were performed with Anopheles gambiae mosquitoes collected from a rice 
growing area adjacent to the M’bé experimental hut station in central Côte d’Ivoire, 




habitat year-round. A comprehensive characterization of the local mosquito population showed 
that the M variant of the An. gambiae complex, now referred to as Anopheles coluzzii, is 
predominant in the area and exhibits high levels of resistance to pyrethroid and carbamate 
insecticides [12,13]. Recently, over 1700 fold resistance against deltamethrin was detected in 
the M’bé population of An. coluzzii compared to the Kisumu laboratory strain, using adapted 
CDC bottle assays [14]. The high resistance intensity exhibited by this vector population makes 
it a good strain for testing potential resistance breaking chemistry or novel insecticide delivery 
systems, such as the electrostatic coating technology. In the experiments described below, 
mosquitoes were collected as larvae and pupae from breeding sites around M’bé and reared to 
adult in the insectary of the Institut Pierre Richet (IPR) in Bouaké, under ambient climatic 
conditions. Five-day-old sugar-fed only female mosquitoes were used in all laboratory and 
semi-field assays. 
 
The list of insecticides initially screened for residual performance is given in Table 4.1. Overall, 
11 wettable powder formulation of insecticides including pyrethroids, carbamates, 
organophosphates, neonicotinoids, entomopathogenic fungus and boric acid were tested. The 
products were selected for testing based on, criteria such as toxicity, commercial availability as 
pest control products, however a handful of experimental formulations were also tested. All the 
insecticides evaluated were powder formulations. 
 
Application of insecticide powders on eave tube inserts 
Eave tube inserts that fit into locally produced PVC tubes have been designed with electrostatic 
netting attached to a polyethylene frame consisting of a plastic circle with six spokes and a 
central protruding node (see [9] for images of the insert design). The frame provides physical 
support to the netting and allows easy insertion inside eave tubes. This prototype was used in 
the present study to investigate the persistence of insecticide applied on eave tube insert.  
Candidate active ingredients were applied on eave tube inserts manually; 5g of each “active” 
(powder-formulated insecticide) was weighed and poured evenly onto an eave tube insert 
placed in the middle of a 20 cm long PVC tube. To prevent active from falling through the tube, 
both ends of the pipe was sealed off with a plastic lid and the tube was then shaken by hand for 
1 min. To allow for adequate distribution of the insecticide on the two sides of the insert, the 
tube was turned every 10 seconds. The tube was then put on a table for 2 minutes to allow the 




shaken for 15 seconds to remove any excess of powder. After treatment, the insert was placed 
in a third, clean tube. Four to six inserts were treated for each insecticide; approximately 4g of 
powder were collected after treatment, leaving approximately 1 g of powder on the insert. An 
excess of powder was used during treatment to ensure thorough saturation of the inserts with 
the powders. Inserts were tested 1-day post-treatment (T0), then kept for subsequent monitoring 
of residual efficacy at regular intervals. To better approximate decay rates under realistic 
conditions, the inserts were kept individually in eave tubes inserted in holes drilled at eave level 
in an experimental house on the IPR campus. The inserts were stored in these tubes throughout 
the testing period and removed only for persistence monitoring.  
 
The “eave tube” bioassay 
This bioassay method used a 20 cm long piece of PVC tube with an insecticide-treated insert 
placed in the tube such that it is flush with one end of the pipe (Fig. 4.1a). The opposite end of 
the tube is fitted with untreated netting to keep mosquitoes inside of the tube, and mosquitoes 
are introduced into the tube on this clean end using mouth aspirators. The “eave tube” bioassay 
was performed during daytime. A host cue is placed behind the treated insert and the mosquitoes 
are allowed to recruit freely to the insert over a fixed period of time. This experimental set up 
was designed to simulate the interaction between mosquitoes and eave tube inserts in the field, 
where heat and odor cues draw host-seeking female mosquitoes into the tube where they then 
make contact with the insecticide-laden insert (see [15] for similar methodology).  
 
Initial screening of powder insecticides  
The aim of this set of experiments was to identify chemicals that retained efficacy against 
pyrethroid resistant mosquitoes for at least 4 weeks post-treatment. Persistence assays were 
performed on a fortnightly basis, and insecticides with significant declines in residual activity 
over the testing period were dropped from further testing. A total of ~ 60 unfed female 
mosquitoes aged 4-5 days were exposed in batch of 15 to each insert for 3 min using the eave 
tube bioassay. A hand was used as the attractive cue behind the treated insert. To eliminate any 
potential biases from differential attractiveness of volunteers, hand from the same individual 
was used in all assays. Exposure to an untreated insert served as the control. At the end of the 
exposure period, mosquitoes were released in netted cages with access to a 10% honey solution 
on cotton pads. Mortality was scored after a 24h holding period, except for the fungus-exposed 





The only insecticide that persisted for 1 month during the initial screening was 10% beta-
cyfluthrin. New inserts were treated with 10% beta-cyfluthrin and residual activity was 
monitored at approximately monthly intervals for 12 months using the same eave tube 
bioassays, but with some refinement of the protocol. The three modifications were: (1) the host 
cue was changed from a hand to a bottle filled up with boiling water and wrapped in a worn 
sock (worn over night), to allow for more assays to be run in parallel, (2) female mosquitoes 
were deprived of sugar 6 h prior to the bioassay to maximize host-seeking behavior, and (3) the 
duration of the bioassay was extended from 3 min to 1 h. Although mosquitoes remained inside 
the tube for 1h, it is important to note that the actual contact time was still determined by the 
host-seeking response of each individual mosquito. Approximately 60 mosquitoes (four 
replicates of 15 mosquitoes per tube) were tested. At the end of the 1h behavioral assay, 
mosquitoes were transferred to observation cages, supplied with 10% sugar water solution, and 
mortality scored 24h.  
 
Supplementary experiments 
Results from residual efficacy assays show that 10% beta-cyfluthrin was the longest lasting 
chemical when applied on eave tube inserts. To further explore the vector control potential of 
this insecticide formulation, additional experiments were performed in a semi-field setting and 
in the laboratory using reduced contact times. 
 
Field performance of insecticide treated insert 
Experiments were conducted at the M’bé phase II experimental huts station between June and 
September 2017 using experimental huts constructed to the West African design [16]. The huts 
are 3.25 m long, 1.76 m wide and 2 m high. The interior walls of the huts are made of concrete 
brick, with a corrugated iron roof. A plastic cover was affixed onto the roofing as ceiling. Each 
hut was built on a concrete base with a water-filled moat, to protect against invertebrate 
predators. The huts were customized to allow evaluation of eave tube inserts; namely, six holes 
were drilled at eave level (1.7 m from the ground) on three sides of the hut (two holes on each 
side). Eave tubes were fitted into the holes and inserts freshly treated with 10% beta-cyfluthrin 
were placed in the tubes. To allow for the recapture of mosquitoes after contact with the eave 
tube inserts, the huts had to be in an enclosed structure (Fig. 4.1b). A wooden frame was erected 




roof on the enclosure, and extended beyond the edge of the enclosure as an awning, to protect 
against rain entering the enclosure. The bottom half of the frame was made out of wooden 
panels and the top half was screened with polyethylene netting. White plastic sheeting was 
installed on the floor of the enclosure to facilitate the collection of dead mosquitoes. The door 
of the enclosure was positioned on the front side of the hut and closed with a zipper to prevent 
mosquitoes escaping. 
 
Overnight release-recapture experiments were conducted in two modified experimental huts, 
situated 50 m apart. In the first experiment, six inserts treated with beta-cyfluthrin were installed 
in one experimental hut and six untreated inserts were placed in tubes in the second 
experimental house. Two adult volunteers were recruited from nearby villages to sleep in the 
huts. During the experiment, sleepers were rotated between the two huts. Before the start of the 
experiment, study participants slept in the experimental huts for a week to build up human odors 
and maximize mosquito host seeking response. At 20:00, volunteers entered the huts to sleep 
under intact, untreated net. A total of 100, 5 day-old female An. gambiae (M’bé strain) were 
released into each enclosure 15 min after volunteers retired to their respective huts. Mosquitoes 
were sugar-starved for 6 h prior to the release, but still provided with tap water to prevent 
desiccation. In the following morning, at 05:00, mosquitoes were recaptured both inside the 
experimental huts and within the enclosures using flashlights and aspirators. Live recaptured 
mosquitoes were subsequently held in netted plastic cups and supplied with 10% sugar solution. 
Survival was monitored for 24h. 
 
Measurement of mosquito host-seeking response in the enclosure 
To assess how many mosquitoes actually enter the eave tubes and came into contact with the 
inserts over the course of a night, a second experiment was conducted using fluorescent powder. 
The procedure of the experiment was similar to that described above, except that the inserts 
were treated with a non-toxic fluorescent dust instead of beta-cyfluthrin. The procedure for 
applying the fluorescent dust was similar to that used for hand-treating insert with powder 
insecticide as described in an earlier section. Again, the experimental huts were fitted with 6 
eave tube inserts and 100 sugar-starved An. gambiae M’bé mosquitoes were released in each 
enclosure each study night. To prevent cross-contamination with the fluorescent powder, 
mosquitoes were caught individually using clean hemolysis tubes. Recaptured mosquitoes were 




indicative of contact with treated inserts, using a UV light microscope (Dino Lite Premier, 
USA). A third experiment was also conducted where eave tubes were simply left open overnight 
to estimate how many mosquitoes passed through the tubes. The following morning at 05:00, 
the volunteers blocked the eave tubes using untreated inserts and mosquitoes inside and outside 
the hut were collected and counted.  
 
Short contact assays 
Unlike house walls, where a mosquito might rest for a longer period of time, the time that 
vectors spend in contact with an eave tube insert could be relatively transient [17,18]. Overnight 
survival in the enclosures with insecticide-treated inserts could indicate either that the mosquito 
did not come into contact with a treated insert or that it did not stay in contact long enough to 
pick up a lethal dose. 
 
Likewise, while the presence of coloured particles on a recaptured mosquito does indicate 
contact with the eave tube insert, the absence of fluorescent particles could indicate either no 
contact, or that the mosquito did not stay in contact long enough to be contaminated with a 
visible amount of particles.  
 
To evaluate whether beta-cyfluthrin can kill even with brief contact, individual mosquitoes 
were exposed to freshly treated inserts using the same modified eave tube bioassay. A range of 
exposure time (5s, 30s, 1min and 2 min) was tested on 6 h sugar-starved 5-day-old female An. 
gambiae M’bé. A transparent tube was used instead of a standard PVC tube, to enable direct 
observation of mosquito behaviour within the tube and to allow measurement of contact 
duration using a stopwatch. A total of 52 mosquitoes was tested individually for each time 
period. Following exposure, mosquitoes were removed from the eave tube and housed in 
150mL plastic cups and provided with sugar solution. Mortality was scored 24h post-exposure. 
 
To test whether a contact time of only 5 seconds is sufficient for fluorescent particles to transfer 
from the insert to the mosquito, 50 female An. gambiae mosquitoes were exposed individually 
to inserts treated with fluorescent powder using the same modified eave tube assay. After 5 s 
of contact, the mosquito was removed and the body examined under UV light for the presence 






Data were entered into an excel spreadsheet and transferred into the R statistical software 
version 3.4.0 for analysis. The decline in efficacy over time across insecticides was analysed 
using Bayesian generalized linear models (BGLMs) with the “arm” package. Insecticide 
treatments were included in the model as explanatory variable and mosquito mortality as the 
outcome. Interactions between insecticides and persistence testing intervals (time since 
treatment) were also included in the model. Pairwise comparisons were performed with the 
final model using the “multcomp” package in R. For the release recapture experiments, 
generalized mixed effect models (GLMMs) with a binomial distribution and a logit link 
function was fitted to the data using the “lme4” package for R. Treatment and enclosure were 
included as fixed effects and sleepers were included as a random effect. Data from the short 




Initial screening of powder insecticides 
Fig. 4.2 shows the results of the eave tube bioassay tests with the 11 initial candidate powder 
insecticides, tested at T0, 2 weeks and 1 month post-treatment against the pyrethroid resistant 
An. gambiae M’bé strain. Comparing the 11 insecticides at T0 and 2 weeks post-treatment, 
most killed a significant proportion (45 - 100%) of An. gambiae mosquitoes. However, there 
was a significant (P < 0.05) decline in activity 4 weeks after treatment, with mortality dropping 
below 25% for almost all of the insecticides (P<0.001). In contrast, beta-cyfluthrin retained full 
residual activity (>90% mortality) over the screening period of 1 month. 
 
Persistence monitoring 
Based on the initial screening, beta-cyfluthrin was selected for its persistence on inserts over 
12 months; the results are summarized in Fig. 4.3. Beta-cyfluthrin was highly effective, 
continuing to kill >80% of An. gambiae up to 9 months post-treatment. Mortality of An. 
gambiae declined steadily over time down to 67% by month 11 and 20% by month 12.  
 
Experimental hut evaluations 
The proportions of An. gambiae mosquitoes recaptured in the experimental hut enclosures are 




using inserts treated with fluorescent dust. Table 4.2 also presents the proportions of mosquitoes 
found dead (insecticide treatment) or recaptured with fluorescent dust particles.  
 
Mosquito recapture rate was consistently high in all experiments (more than 80%). It is possible 
that a few mosquitoes escaped through the door of the enclosure during release, thus accounting 
for the small difference in number between mosquitoes released and that recaptured.  
 
Mortality rates with the untreated control and fluorescent powder treated inserts was <5%. 
When inserts treated with beta-cyfluthrin were used, about half of the mosquitoes tested died 
by the morning of collection (55% immediate mortality) and this increased to 64% within 24 h 
post-exposure, but the difference was not significant (P > 0.05).  
 
Results from the experiment using the fluorescent powder showed that, on average 44% of 
mosquitoes released in the enclosure had coloured particles on their body after recapture. This 
suggests that slightly less than half of the released mosquitoes made contact with the inserts 
overnight. Given that this is broadly consistent with the mortality observed when beta-
cyfluthrin was used in the experimental huts (44% with coloured particles versus 55% 
immediate mortality with beta-cyfluthrin), this suggests that all of the mosquitoes encountering 
the insecticide-treated inserts were killed. When eave tubes were left open, > 75% of 
mosquitoes were caught inside the experimental hut. This indicates that, in the absence of the 
inserts the majority of mosquitoes will pass through the tubes overnight.  
 
Short contact assay 
Fig. 4.4 shows the 24h mortality of An. gambiae mosquitoes after 5s, 30s, 1min or 2 min 
exposure to inserts freshly treated with beta-cyfluthrin. There was a positive relationship 
between exposure duration and mortality, i.e. the longer the exposure time the higher the 
mortality rate. Percent mortality was 56% with the shortest exposure time (5s), and increased 
significantly to 88.5% when contact time was increased to 1 minute (P = 0.003). A 2-min 
contact with a freshly treated insert was sufficient to produce almost 100% mortality in a 
pyrethroid resistant An. gambiae strain, But the difference in mortality between 1 min and 2min 
exposure was not significant (P > 0.05). There was no mortality in the control group. When 
mosquitoes were exposed for just 5 s on inserts treated with fluorescent dust, 100% of 





Malaria elimination will require innovative vector control tools that are not compromised by 
insecticide resistance. The eave tube is part of a new mosquito control strategy that involves 
screening windows, closing eaves, and the targeted delivery of insecticide on eave tube inserts. 
The intervention will be trialed in Côte d’Ivoire to test whether it can impact malaria incidence. 
The study presented here was designed, in part, to identify a suitable insecticide for use in the 
trial, and to explore a diversity of insecticides that could potentially be used in the eave tubes 
for prolonged control of insecticide resistant Anopheles populations. 
 
Results from residual efficacy bioassays show that the majority of insecticides tested in the 
present study produced significant mortality (45-100%) in the local M’bé strain of An. gambiae 
mosquitoes, when freshly applied on eave tube insert. This confirms that a wide range of actives 
from diverse insecticide classes could be successfully applied on electrostatic netting for 
effective control of insecticide resistant malaria vectors and provides further evidence of the 
potemtial of the technology to bypass resistance [7].  
 
While most candidate actives were highly effective at killing mosquitoes immediately 
following treatment, only one (10% beta-cyfluthrin) retained efficacy beyond 1 month. 
Previous studies with some of the same insecticides have reported longer residual activity than 
what was observed in the present study but this could be due to the difference in the nature of 
the substrate (electrostatic netting versus walls). The rapid loss in efficacy observed with some 
actives could also be due to a number of factors that are known to degrade insecticides used 
during indoor residual spraying campaign, including temperature, humidity and UV-light [19]. 
The underlying mechanisms for the rapid decay that was observed with some actives should be 
evaluated in further studies. However, different formulations could help mitigate some of these 
factors. For example, the use of UV protection additive could prevent insecticide breakdown 
due to photolysis and prolong the effective lifespan of chemicals. Although candidate actives 
were exposed to environmental conditions similar to those in local villages, persistence could 
still differ for a number of reasons when the insecticides are deployed in the field. For example, 
exposure to smoke from cooking in real houses could impact the long-term insecticidal efficacy 
of chemicals deployed in the eave tube. This issue has also been reported with insecticide-




This emphasizes the need for continued monitoring of persistence and timely re-treatment of 
inserts once efficacy starts to decline. 
 
Although the focus of this study was on readily available formulations of insecticides, there is 
clearly an opportunity for reformulating or repurposing a number of active ingredients for use 
in eave tubes. This could be useful, for example, in resistance mitigation and management 
where one of the recommended strategy is the use of unrelated insecticidal compounds in 
rotations or mosaics to delay the spread of insecticide resistant genes [21,22]. Additionally, a 
diversity of active ingredients suited for deployment in eave tubes could be useful for 
addressing constraints on IRS. The relatively high cost of non-pyrethroid insecticide 
formulations coupled with a proposed reduction in IRS funding will result in much fewer houses 
being sprayed across sub-Saharan Africa [23] but only a small amount of insecticide is needed 
to protect a house with eave tubes. Moreover, most insecticides are short-lived when applied 
on mud wall, which is common in most rural endemic areas across sub-Saharan Africa. This 
may be less of a problem with the eave tube technology given that insecticides are deployed on 
substrate with standard characteristics.  
 
In the experimental huts, beta-cyfluthrin produced 55% mortality of pyrethroid resistant An. 
gambiae mosquitoes. Although the mortality observed in the experimental huts is consistent 
with findings from previous studies [8,9], mortality was much higher in laboratory bioassay. 
This could be either due to a percentage of mosquitoes not entering the tubes over the course 
of the night or that contact with the treated inserts was too transient for the mosquito to pick up 
a lethal dose of insecticide. When inserts were treated with fluorescent powder and placed in 
the experimental huts, the proportion of mosquitoes that contacted the fluorescent dust (44%) 
was generally consistent withthe mortality (55%) induced by beta-cyfluthrin treated inserts. 
This suggests that not all female mosquitoes came into contact with the treated inserts but those 
females that contacted the tube died, and this would have happened within the first 2 minutes 
of exposure. In other words, overnight mortality is likely determined by the probability a 
mosquito will come into contact with the treated insert rather than the probability the probability 
the mosquito will die given it has contacted a treated insert (if the inserts are freshly treated 
with insecticides). Interestingly, the proportion of mosquitoes entering through open tubes 
(>75%) was higher than the contact rates estimate with beta-cyfluthrin and fluorescent powder. 




emanating from volunteer-occupied hut, which might be attenuated when tubes are screened 
with the inserts.  
 
Overall, on the basis of its performance and residual activity, as well as commercial availability 
and existing regulatory approval in Côte d’Ivoire, beta-cyfluthrin was selected for the eave tube 
CRT. While having a pyrethroid insecticide in the eave tube might not seem an ideal option in 
an area of pyrethroid resistance, the resistance breaking properties of the electrostatic netting 
still enables use of a pyrethroid. Nonetheless, it will be important to monitor the potential for 
further selection for pyrethroid resistance. Moreover, screening for other active ingredients 
should be considered a priority in order to increase the scope for developing more sustainable 
resistance management strategies [24].  
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Table 4.1: List of insecticides initially screened for residual performance against 
pyrethroid resistant An. gambiae M’bé strain. 
Commercial names are provided for insecticides that are available on the market; NA indicates the 





Commercial name (supplier) Active ingredients (Dose) Chemical classes 




   
NA  Azametiphos (10%) Organophosphate 
   
NA Beauveria bassiana (10%) Fungus 
   
Ficam D (Bayer, Germany) Bendiocarb (1.25%) Carbamate 
   
BISTAR 10 WP (FMC, India) Bifenthrin (10%) Pyrethroid 
   
BorActin (Rockwell labs Ltd, USA) Orthoboric acid (99%) Boric acid 
   
Tempo Ultra (Bayer, Germany) Beta-cyfluthrin (10%) Pyrethroid 
   
Spritex (Denka International BV, Barneveld, The Netherlands Deltamethrin (0.25%) Pyrethroid 
   
Drione (Bayer, Germany) Pyrethrin (1%) ; Piperonyl  
Butoxide (10%)  
Pyrethroid; synergist 
   
 NA Permethrin (25%) Pyrethroid 
   




                     Table 4.2: Release-recapture (%) and response of pyrethroid resistant An. gambiae s.l. within enclosure at M’bé, Côte d’Ivoire. 
*Values in the same column not sharing a letter superscript differ significantly (P<0.05, GLMM)
Treatment Total released % recaptured (95% 
C.I.) 
% Immediate mortality 
(95% C.I.) 
% 24h mortality (95% 
C.I.) 
% with fluorescent 
dust (95% C.I.) 
Untreated insert 395 90.38 [87.5  ̶ 93.3] 1.12a [0.03   ̶ 2.21] 2.8a [1.1   ̶ 4.5] ̶  
10% beta-cyfluthrin treated 
insert 
389 84.31 [80.7  ̶ 87.9] 55b [49.6   ̶ 60.4] 64b [58.8   ̶ 69.2] ̶  





Fig. 4.1 a) Photo of the components of the eave tube assay; b) Picture of the experimental hut 







Fig. 4.2 Weekly mortality rates of pyrethroid resistant An. gambiae s.l. M’bé strain after exposure to insecticide treated insert using 3min 



































Fig. 4.3 Residual activity over twelve months of 10% beta-cyfluthrin (selected from initial 
screening) on insert against pyrethroid resistant An. gambie s.l. from M’bé 
 
Fig. 4.4 Actual exposure time and induced mortality of individual pyrethroid resistant 
















































Spatio-temporal trend in insecticide resistance 
in Anopheles gambiae following wide-scale 
deployment of a “Lethal house Lure” in 










The materials presented in this chapter will be submitted for publication in Emerging Infection 
Diseases as: 
 
Welbeck A. Oumbouke, Antoine M.G. Barreaux, Patricia Pignatelli, Eleanore D. Sternberg, 
Innocent Z. Tia, Alphonsine A. Koffi, Ludovic P. Ahoua Alou, Jackie Cook, Matthew B. 
Thomas, David Weetman and Raphael N’Guessan. Spatio-temporal trend in insecticide 
resistance in Anopheles gambiae following wide-scale deployment of a “Lethal house Lure” in 







Spatio-temporal trend in insecticide resistance in Anopheles gambiae following wide-scale 




The In2Care EaveTubes is a novel house-based intervention which uses the electrostatic 
coating technology as insecticide delivery system. Although this insecticide application 
method has resistance breaking potential, it is necessary to evaluate whether community-level 
deployment of pyrethroid treated EaveTubes would increase selection pressure on malaria 
mosquitoes. In the context of a cluster randomised controlled trial (CRT) of screening plus 
EaveTubes (SET) in the presence of long lasting insecticidal net (LLIN), we assessed the 
spatio-temporal change in resistance to pyrethroids and additionally to other insecticide classes 
(carbamates, organophosphates and organochlorines) in Anopheles gambiae from a subset of 
trial villages. Pyrethroid resistance intensity increased significantly in study arms over the 
timeframe of the study and this was mostly associated with transcriptional change in the 
carboxylesterase COEAE1F. However, the difference between arms was not significant, which 
was consistent with the trend found with a range of metabolic resistance genes detected in the 
area. Analysis of the knockdown resistance mutations (1014F, 1014S and 1575Y) suggest no 
role of these genes in the observed change in pyrethroid resistance phenotype. There was no 
significant change in resistance pattern with insecticides from the other major adulticide classes 
tested except with pirimiphos methyl, against which resistance prevalence increased in some 
villages despite no temporal change in Ace-1 allelic frequency. The increase in pyrethroid 
resistance level associated with the deployment of pyrethroid treated EaveTubes suggests that 
a non-pyrethroid version of the technology should be considered.        
 
 







Recent gains in reducing malaria burden have mostly been driven by the widespread roll-out 
of insecticide-based control measures, which  have been associated with prevention of about 
500 million clinical cases of malaria  since 2000 [1]. While vector control remains a key 
component of the global malaria control strategy, the efficacy of existing control methods relies 
on continued vector susceptibility to insecticides. Unfortunately, insecticide resistance in 
African malaria vector populations of malaria is widespread with resistance to at least one of 
the four major classes of neurotoxic adulticides reported in 73 countries in 2018 [2]. The 
emergence and geographical distribution of insecticide resistance may have contributed to the 
recent stagnation of progress in malaria control with increased cases of malaria reported in 55 
countries between 2015 and 2017 [3].  
The rise in insecticide resistance in malaria vectors is ascribed with the extensive use of 
insecticide in agriculture for crop protection [4] and the wide-scale use of insecticide based 
vector control strategies, most notably long-lasting insecticidal net (LLINs) [5]. Target-site 
insensitivity and increased expression of metabolic genes are the two most studied types of 
insecticide resistance mechanisms. The former results in reduced affinity between the 
insecticide and its binding site. This occurs in the para voltage-gated sodium channel (vgsc), 
through a substitution from leucine to either phenylalanine (L1014F) or serine (L1014S), and 
confers knock down resistance (kdr) to pyrethroids, the insecticides deployed on all existing 
nets, and dichlorodiphenyltrichloroethane (DDT) [6,7]. Another variant of the kdr resistance 
mechanism occurring in vgsc is known as N1575Y [8] which, in conjunction with L1014F, 
enhances resistance to pyrethroids and DDT. Aside from these three well-described kdr 
resistance mutations, additional mutations in the sodium channel have recently been reported 
in Anopheles gambiae and Anopheles coluzzii mosquitoes [9]. Most of these previously 
unknown mutations were shown to occur on a 1014F haplotype background, and may increase 
resistance to pyrethroids. The occurrence of target site modifications has also been reported in 
acetylcholinesterase, which inhibits the neuro transmitter acetylcholine, and was shown to 
cause resistance to organophosphates and carbamates [10,11]. Metabolic resistance involves 
increased activity of three families of enzymes: carboxylesterases (COEs), Glutathione-S-
transferases (GSTs) and cytochrome P450s [12]. Genes from the P450s family have 
increasingly been linked to the detoxification of pyrethroids and carbamates [13–16]. Apart 




mechanisms of resistance may be contributing to the strong phenotype of resistance being 
reported in malaria vectors, especially across West Africa [17,18]. Reduced penetration of 
insecticide associated with the thickening of insects’ cuticles have been linked with resistance 
in vector populations [19]. Recently, a new type of insecticide resistance mechanisms involving 
an over-expression of a family of chemosensory proteins, referred to as sensory appendage 
proteins (SAPs), was shown to mediate pyrethroid resistance in Anopheles gambiae mosquitoes 
[20]. All of these resistance mechanisms that confer greater survival benefit to mosquitoes in 
the presence of insecticides represent a substantial challenge to malaria control efforts. 
Although vector resistance is widespread in much of sub-Saharan Africa, the situation in West 
African countries, including Côte d’Ivoire, is particularly worrisome with resistance to all but 
the newest licenced adulticides reported in the key vector species, An. gambiae and An. coluzzii   
[21]. Reported resistance mechanisms for southern Côte d’Ivoire include target site mutations 
(kdr and Ace-1), and overexpression of P450s genes, notably Cyp6M2 and Cyp6P3 [13]. More 
recently, a comprehensive investigation into the resistance profile of An. gambiae s.s. 
mosquitoes in central Côte d’Ivoire, conducted prior to a randomized controlled trial (CRT) of 
the In2Care EaveTubes strategy [22], reported resistance mechanisms broadly similar to that 
in An. coluzzii from Tiassalé, in southern Côte d’Ivoire [23]. However, additional important 
detoxification enzymes, most notably the pyrethroid and pyriproxyfen-metabolizing P450 
enzyme, Cyp9K1[24], were found to be strongly over-expressed.  
The EaveTubes trial is investigating whether house screening (S) plus EaveTubes (ET) in 
combination with LLINs provide greater protection against malaria transmission than LLINs 
alone in a pyrethroid resistance area in central Côte d’Ivoire. The In2Care EaveTubes is a novel 
house-based intervention which involves screening of houses to prevent mosquito house entry 
and killing of host-seeking mosquitoes as they make contact with an insecticide treated 
electrostatic netting placed in PVC tube inserted in eave gap. From several available 
insecticides tested, the pyrethroid beta-cyfluthrin, provided the best residual killing activity in 
the eave tubes against local mosquitoes and was selected for the  trial [25]. Though effective 
against resistant mosquitoes, a clear concern is that additional use of a second pyrethroid in 
eave tubes with that used on LLINs could select for further resistance. The study reported here 
aimed to (i) investigate the temporal and spatial dynamic of insecticide resistance in Anopheles 
mosquitoes in trial arms (SET+LLIN and LLIN alone) over the course of the CRT and (ii) 




PermaNet 2.0 (deltamethrin) and EaveTubes (beta-cyfluthrin), translates into an increase in 




The study was conducted concurrent with the CRT in the Gbèkè region in central Côte d’Ivoire. 
The trial involves 40 villages located within 50 km radius of the city of Bouaké, with 20 villages 
assigned to each study arm. The area is characterized by a humid tropical climate with an 
average annual temperature of 18.9 °C and average relative humidity of 66.6%. Rice cultivation 
is the main agricultural practice, along with some vegetable farming. Malaria transmission 
occurs year-round and peaks during the wet season, between May and October [26,27]. 
The CRT spanned 2 years, between May 2017 and May 2019. To assess change in resistance 
prevalence, intensity and gene frequency in Anopheles mosquitoes from the study area, 
insecticide resistance monitoring was performed at four different time points: before the trial 




Mosquito collection and rearing 
Longitudinal resistance monitoring surveys were performed in eight villages (four per study 
arm) once in 2016, 2017, 2018, and 2019. Village selection for resistance monitoring was 
mainly driven by the presence of productive mosquito-breeding habitats.  Mosquito larvae were 
collected from each village using the dipping method. This was performed in the same time 
period each year (September to November) except for the 2019 monitoring survey where 
collection was done between June and August. Anopheles larvae and pupae were collected from 
a variety of habitats spanning small puddles to rice fields. To avoid collection of larvae hatched 
from eggs laid by one or a few female mosquitoes, which might not give an accurate profile of 
resistance, mosquito larvae were sampled, if possible, from multiple breeding sites. Collection 
from various breeding habitats from the same village were then pooled and transported to the 




ground Tetramin fish food and reared to adulthood under controlled conditions. Emerging adult 
mosquitoes were kept in netted cages and maintained on 10% honey solution until 
susceptibility testing. All adult female mosquitoes were morphologically identified as An. 
gambiae s.l. using taxonomic keys. 
 
WHO susceptibility tests 
Insecticide resistance prevalence in the Anopheles gambiae s.l. mosquitoes from the trial area 
was assessed annually between 2016 and 2019 using standard WHO susceptibility assays. 
Mosquitoes were exposed to papers supplied by the Vector Control Research Centre of 
Universiti Sains Malaysia, impregnated with diagnostic concentrations of deltamethrin 
(0.05%), the insecticide in the LLIN (PermaNet 2.0), and cyfluthrin (0,15%), the insecticide 
deployed in the EaveTubes [25]. To track change in resistance to the four major classes of 
adulticides used in public health, the list of insecticides tested per year was expanded whenever 
possible to include bendiocarb (0.1%, tested once every year), DDT (4%, tested in 2016, 2017 
and 2019), and pirimiphos methyl (0.25%, tested in 2018 and 2019). Two to three-day old adult 
female mosquitoes, emerged from larvae collected from study villages were used in WHO 
susceptibility assays. Four replicates of 20-25 adult female mosquitoes were exposed for 1h to 
insecticide-treated papers, alongside 20-25 exposed to untreated paper (control). Mosquito 
mortality was recorded 24h post-exposure. Mosquitoes that survived exposure to either 
pyrethroid were monitored for an additional 24h, after which the survivors were preserved in 
RNA later for subsequent molecular testing. 
Resistance intensity assays 
The level of resistance to deltamethrin was also monitored annually, using adapted Center for 
Disease Control and Prevention (CDC) resistance intensity bioassay. The cap and the inside of 
each 250 mL Wheaton bottle was coated with a range of deltamethrin concentrations 
(7.81µg/mL to 1000µg/mL), producing a range of mortality rates between 0% and 100% in 
mosquitoes from the study villages. Control bottles were treated with acetone only. The 
susceptible An. gambiae Kisumu strain (SS) served as a reference and was tested against dosage 
range 0.001µg/mL-0.5µg/mL. Two to three days old adult female mosquitoes were exposed 







To determine mosquito species and genotype Anopheles mosquitoes from study villages for 
the presence of target site resistance mechanisms, genomic DNA was extracted from a pair of 
legs taken from field mosquitoes unexposed to insecticides. The legs were boiled in 20µL of 
buffer solution for 30 min at 95°C. Identification to species within the An. gambiae complex 
was performed using SINE-PCR [28].  
Detection of mutations in the voltage gated sodium channel, 1014S, 1014F and 1575Y [8,29], 
and the Ace-1 G119S [30]  mutation in acetylcholinesterase was performed on unexposed 
mosquitoes using TaqMan® PCR assays.  
Whole genome microarray  
A first genome-wide transcription analysis was performed in 2016 prior to the start of the 
EaveTubes trial to identify genes differentially expressed in Anopheles gambiae populations 
from two study villages relative to susceptible laboratory colonies of Anopheles mosquitoes 
[22]. The second microarray analysis in 2019 was performed after completion of the trial to (i) 
identify any changes in gene expression between 2016 and 2019 and (ii) establish whether 
additional resistance-associated genes, which probably were absent or undetectable at baseline, 
have been selected over the duration of the CRT.  
The microarray experimental design followed that used in 2016, with whole genome 
transcription analysis performed on Anopheles mosquitoes from the same villages (one from 
each study arm) using an interwoven loop design (Fig. 5.S1). However, in contrast to 2016 
where An. gambiae s.s. was the most predominant species in the two villages studied, 
Sessenouan (SET+LLIN arm) and N’Guessan Pokoukro (LLIN alone arm), An. coluzzii 
became the most prevalent species in N’Guessan Pokoukro (NP) in 2019. Therefore, field 
mosquitoes included in the microarray analysis were An. gambiae from Sessenouan and An. 
coluzzii from N’Guessan Pokoukro. 
Gene expression profiles of unexposed, female An. coluzzii mosquitoes from N’Guessan 
Pokoukro village and the survivors of deltamethrin exposure from Sessenouan village were 
compared to those of two susceptible lab strains, Anopheles gambiae Kisumu and Anopheles 
gambiae Ngousso. The use of unexposed mosquitoes from the control village and bioassay 




allows comparison of gene expression between years (2016 and 2019). Significant differential 
expression between field mosquitoes from the two villages and the two insecticide susceptible 
lab strains was identified using a filtering approach. This was based on a P < 0.05 (after 
Bonferroni correction), a fold change in expression > 2 or <-2 and directionality i.e. the same 
direction of differential expression (upregulated or down-regulated) in the 4 comparisons 
(N’Guessan Pokoukro vs Kisumu, N’Guessan Pokoukro vs Ngousso, Sessenouan vs Kisumu, 
Sessenouan vs Ngousso). Total RNA was extracted from batches of ten female An. gambiae 
s.l. mosquitoes using a PicoPure RNA isolation kit (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. Total RNA extracted from mosquitoes was treated using DNase 
(RNase free DNase set, Qiagen Hilden Germany). Before further use, the concentration and 
quality of the extracted RNA were evaluated using a NanoDrop spectrophotometer (Thermo 
Fisher Scientific) and a 2100 Bioanalyzer (Agilent Technologies). Four biological replicate 
extractions of total RNA for each mosquito population or colony were amplified and labelled 
using the Low Input Quick Amp Labeling Kit (Agilent Technologies). The Agilent Agam15k 
array was used for dual-color hybridizations (N’Guessan Pokoukro vs Kisumu, N’Guessan 
Pokoukro vs Ngoussou, Sessenouan vs Kisumu, Sessenouan vs Ngoussou) [31]. The labelled 
samples were hybridized using a Gene Expression Hybridization Kit (Agilent Technologies). 
Washing, scanning and feature extraction were performed according to the manufacturer’s 
recommendations. The design of the microarray experiment was optimized through 
comparison of the above strains across four microarray slides.  
 
Quantitative reverse transcriptase PCR for candidate gene expression in field mosquitoes 
The expression of (i) a subset of genes found over-expressed at baseline from microarray 2016 
results and (ii) additional genes detected in the 2019 samples with known insecticide 
metabolism activity was investigated using reverse-transcription quantitative PCR (RT-qPCR). 
The qPCR analysis was performed only on unexposed mosquitoes from eight study villages 
because previous qPCR analyses of baseline candidate genes showed no difference in gene 
expression between bioassay survivors and unexposed mosquitoes [22]. Moreover, the focus 
of the present study was not on insecticide-induced genes, but rather temporal changes in 
expression of genes potentially associated with pyrethroid resistance following use of 
pyrethroid-based control interventions. Prior to qPCR experiments, RNA was extracted from 




synthesized from 11g of RNA using oligo (dT) 20 (50 μM) and SuperScript III (200U) 
(Invitrogen) and purified through a DNA-binding column (Qiagen). Three pairs of primers of 
each target gene were designed using Primer-BLAST tool (NCBI: 
http://www.ncbi.nhi.gov/tools/primers-blat/). The primer pair with the highest efficiency value 
(~100%), determined by running standard qPCR using serial dilution of a single cDNA sample, 
was selected for subsequent qPCR (details of the primers are given in Table 5.S1). For each 
qPCR reaction, four biological replicates of each treatment group and two technical replicates 
were used. QPCR was performed using an Agilent Mx3005P QPCR System and the cycling 
condition was as follows: 95°C for 3 min, 40 cycles of 95°C for 10 s and 60°C for 10 s. 
Expression of the genes was normalized using references genes (Ribosomal S7 and Elongation 
Factor).  
Statistical analysis 
WHO assessments of mortality rates are: less than 90% indicates resistance; higher than 98% 
indicates susceptibility: between 90 and 98% requires further testing to confirm resistance 
status [32]. The variation in bioassay mortality of An. gambiae mosquitoes and gene 
frequencies over time between villages, study arms and years was tested using generalized 
linear mixed effect models (GLMMs) with a binomial distribution and a logit link function 
using the “lme4” package. The models included bioassay mortality as the response variable, 
insecticide tested as the explanatory variable with villages and year treated as random effects. 
Analysis of gene frequency data was performed using also a generalised linear mixed models 
with allelic frequency as fixed effect and study arm, villages and year as random effects. The 
intensity of resistance (Resistance Ratio, or RR50) was estimated by comparing the LD50 of 
the wild population relative to that of the susceptible lab strain. A MAANOVA model was used 
to analyse microarray data using previously described custom R-scripts [31]. Differentially 
expressed genes (over/under expressed) were those with a fold change consistently greater than 
2 or less than -2 across the four comparisons (N’Guessan Pokoukro vs Kisumu, N’Guessan 
Pokoukro vs Ngousso, Sessenouan vs Kisumu, Sessenouan vs Ngousso) and with a significant 
Bonferroni p value in all four comparisons. 
Prior to analysis of the qPCR data, significant outliers were identified in SPSS v23 and 
excluded from the dataset. The ΔΔCt method incorporating PCR efficiency was used to 
compare expression of each target gene between field mosquitoes and the lab strain[33]. 




estimated using a t-test (P < 0.05). A linear mixed model with study arm nested within village 
was used to compare the level of expression of candidate genes between study villages, 
intervention arms and years.  
Results 
Trends in phenotypic resistance in An. gambiae mosquitoes 
The trend in bioassay mosquito mortality in trial villages over the study period is presented in 
Fig. 5.1 and Fig 5.S2. Over the four-year monitoring period, 13,641 female Anopheles gambiae 
s.l. mosquitoes were tested in bioassays with deltamethrin (0.05%), cyfluthrin (0.15%), DDT 
(4%), bendiocarb (0.1%) and pirimiphos methyl (0.25%). Anopheles gambiae populations from 
surveyed villages were resistant to all the insecticides tested (Fig. 5.1). Resistance prevalence 
was highest with DDT (<15% mortality) (Fig. 5.S2) with no significant difference in resistance 
frequencies between years (P > 0.05). The pattern of resistance with deltamethrin mirrors that 
of cyfluthrin, with mortality rates for both insecticides ranging between 12% and 52% (Fig. 5.1 
A & B). Although there was some variation in mortality rates for both pyrethroids in study 
villages over the study period, temporal change in resistance prevalence was generally not 
significant (P > 0.05). Resistance prevalence with deltamethrin showed no significant temporal 
change in both intervention arms (P > 0.05, Fig. 5.2 A). In contrast, mosquito mortality with 
cyfluthrin decreased significantly over time in LLIN and SET+LLINs arms (Fig. 5.2 B). There 
was generally no evidence of a difference in temporal response between arms with either 
pyrethroid (P > 0.05). Resistance to bendiocarb persisted in all study villages between 2016-
2019; however, there was generally no evidence of a significant increase in bendiocarb 
resistance prevalence over time (P > 0.05) (Fig. 5.1C); overall mean mortality rates ranged 
between 26.8-53.2%. While An. gambiae s.l. mosquito populations from surveyed villages 
were resistant to the organophosphate pirimiphos methyl (PM), the frequency of PM resistance 
was lower compared to that with insecticides from other classes tested; mortality rates ranged 
from 48.6-81.42%. (Fig. 5.1D). There was evidence of a significant increase in the prevalence 
of resistance to PM over time in most villages (P < 0.001). 
The intensity of resistance to deltamethrin was high at baseline, in 2016, in all villages reaching 
over 1400 fold (ranging 1441-2405 fold) (Table 5.1, Fig. 5.3). The level of resistance to 
deltamethrin increased significantly over time in CRT villages (P < 0.0001) and both arms (P 




change in resistance intensity in 2019 compared to baseline corresponds to an increase of 36% 
in study villages, 29% in the LLIN arm and 41% in SET+LLIN arm. Although the intensity of 
deltamethrin resistance was generally greater in the SET+LLIN arm than in the LLIN-only 
arm, the difference between arms was not significant in any year (P = 0.47).                                 
(Table 5.3). 
Dynamics of Anopheles mosquito species  
Overall, 3,735 An. gambiae s.l. mosquitoes from WHO susceptibility assays were identified to 
species level. An gambiae and An. coluzzii were found in sympatry in all villages over the study 
period. In 2016, An. gambiae was the dominant vector species in the study area (50-100%) 
with An. coluzzii making up only a small fraction of the mosquito population in most villages 
(< 10%) and study arms (3.2-13%) (Fig. 5.5 & 6). While the proportion of the latter species 
increased in the following years in surveyed villages (4.5-90%) and study arms (30.4-53.2%) 
compared to baseline, An. gambiae was found to be consistently more abundant throughout. 
The proportions of hybrids were very low, never exceeding 2% of the collection across 
monitoring years. In general, both malaria vector sibling species, An. gambiae and An. coluzzii, 
were found in comparable proportions between study arms from 2017 onwards (Fig. 5.6). 
Temporal and spatial variation of target-site resistance genes 
A total of 2,106 mosquitoes were screened for target-site mutations over the four consecutive 
years. The 1014S mutation was only detected in 2019 in one mosquito specimen, heterozygote 
for the mutation, from one village (Saoundi) in the intervention arm (SET+LLIN). The 
frequency of the vgsc 1575Y mutation was found to be consistently low throughout the course 
of the study (15%) (Fig. 5.7 A & C). Although there was a declining trend in allelic frequencies 
of the 1575Y mutation over time, this temporal change was neither significant across villages 
nor in study arms (P > 0.05). There was no evidence of a significant difference in allelic 
frequency of this mutation between arms at any time point (P > 0.05). 
 
The 1014F mutation, on the other hand, was found at much higher frequencies (0.62-1%) and 
appeared to vary between years in study villages and intervention arms (Fig. 5.7 B & D). There 
was a decrease in allele frequency of the 1014F mutation in 2019 as compared to baseline in 
all villages, but the difference was only significant in the Kouakro village where this decreased 
significantly from 0.90 to 0.72% (P = 0.01) (Fig. 5.7B). In both study arms, allele frequencies 




0.01) (Fig. 5.7D). However, breaking down the data by species showed that the 1014F allele 
frequency increased in the most dominant vector species (An. gambiae) reaching almost 
fixation in 2019 (0.98 in LLIN arm, and 1 in SET+LLIN arm) (Table 5.4). Over the course of 
the study period, the 1014F mutation was found to be consistently higher in An. gambiae than 
in An. coluzzii (P < 0.01). Although allele frequencies of this mutation were comparable 
between arms in 2016 (P = 0.7) and in 2017 (P = 0.2), there was a significant difference in 
subsequent years with a higher frequency in the LLIN arm (0.91) compared to the SET+LLIN 
arm (0.87) in 2019 (P = 0.008). However, there was no evidence of a significant difference in 
allele frequency between LLIN (0.98) and SET+LLIN (1) in the major vector species An. 
gambiae in 2019 (P > 0.05). 
The allele frequency of the insensitive acetylcholinesterase mutation, Ace-1, varied in all 
villages over years, ranging between 0.22 to 0.51 (Fig. 5.8). There was an increase in the 
frequency of the Ace-1 mutation between 2016 and 2019 in most villages, but the rise in 
frequency was only significant in N’Guessan Pokoukro village (from 0.26 in 2016 to 0.51 in 
2019, P = 0.04).  
 
Genome-wide transcription analysis 
Microarray experiments were conducted with mosquito samples collected in 2019 to explore 
whether the roll-out of pyrethroid based interventions (SET and LLINs) in the study area have 
selected for additional resistance genes and/or resulted in a significant increase in expression 
of the resistance-linked detoxification genes identified at baseline (2016). These molecular 
assays involved unexposed An. coluzzii mosquitoes from one control village and An. gambiae 
from one intervention village. Differentially expressed genes were those that exhibited a 
consistently higher/lower expression in resistant field mosquito population from both study 
villages versus susceptible lab strains with a significant multiple-testing corrected P-value. 
Based on this filtering approach, a total of 551 significant probes were identified, out of the 
14,914 tested (Table 5.S2). 310 probes were over-transcribed corresponding to 241 genes 
(Table 5.S3). Over-expressed genes with demonstrable or likely link with resistance included 
8 cytochrome P450s, 2 glutathione S-transferases (GSTs), one redox gene, one salivary protein 
(D7r2), and 13 cuticular genes. The composition of over-expressed genes was generally similar 
between 2016 and 2019; however, additional well-characterized P450 genes, not found 
significantly over-expressed in 2016, was identified in 2019 (Cyp6P4 and Cyp6Z3) in addition 




cuticular genes were the most predominant over-expressed genes in 2019 with up to 13 genes 
compared to only one in 2016. Interestingly, four cuticular genes which were not differentially 
expressed in 2016, were within the top 20 overexpressed genes in the 2019 samples, of which 
CPLCG4, CPCFC1 and CPLCG5 exhibited >29-fold change and CPAP3-C with >11-fold 
change, relative to susceptible strains (Table 5.S3). Other highly over-expressed genes included 
the cytochrome P450s Cyp6P3 (18-fold change compared with 14.2 in 2016) and Cyp9K1 (16.3 
fold-change compared with 20.1 in 2016). Additional most highly over-expressed genes 
comprised a salivary protein (D7r2, 37.2 fold-change), GSTS1 (FC = 20.5), Rps9 (FC = 17) 
and h+ transporting atp synthase subunit (FC = 85.9). 
Potential changes in transcriptome expression were determined with An. gambiae mosquitoes 
from the intervention Sessenouan village based on estimated difference in gene fold change 
over time (Table 5.S4). Such investigation was not possible with the control N’Guessan 
Pokoukro village, because of the change in species composition in that village resulting in 
different Anopheles species (An. gambiae in 2016 and An. coluzzii in 2019) being used in 
microarray studies between years, which preclude any comparison. Out of the 310 probes over-
expressed in all the field resistant mosquito populations compared to susceptible lab colonies, 
62 probes corresponding to 46 genes had higher fold change in 2019 than in 2016 in Anopheles 
mosquitoes from the intervention Sessenouan village. The highest absolute fold change 
differences between 2019 and 2016 were with cuticular genes including CPLCG5 (FC = 18.5), 
CPLCG4 (four probes, average FC = 12.1), CPCFC1 (FC = 9.7), CPR 59 (FC = 8.4) and 
CPLCG3 (FC = 7).  
 
Temporal and spatial change in expression of candidate genes  
To investigate changes in expression of resistance-associated genes across selected study 
villages and intervention arms over time, several candidate genes from the 2016 and 2019 
microarray results were selected. This included over-transcribed genes with putative or 
established association with insecticide resistance, which were over-expressed in both years 
(Cyp6P3, Cyp6M2, CyP9K1), in 2016 only (COEAE1F), and in 2019 only (Cyp6P4, Cyp6Z3), 
and genes that exhibited higher fold change in 2019 compared to level in 2016 (CPLCG5 and 
CPF3). Gene expression was significantly higher in selected trial villages in 2019 compared to 
levels at baseline with all screened candidate genes except CPLCG5 and CPR 131 (P < 0.05, 
Fig. 5.9). Between 2016 and 2019, gene expression with Cyp6P3 was consistently highest, 




expression with candidate genes was generally higher in 2019 compared to 2016 in study arms, 
the difference in expression between years was significant for COEAE1F only (P = 0.005). 
Consistent with the resistance intensity data, gene expression levels with the most highly over-
expressed genes were comparable between intervention arms (Fig. 5.10).  
 
Discussion 
Although early work provides evidence that pyrethroid treated EaveTubes can break resistance 
in African malaria mosquitoes, it was unclear whether this intervention, if taken to scale, would 
increase the level of pyrethroid resistance in mosquitoes. To address this, the current study was 
conducted in the context of a randomised controlled trial of the EaveTubes intervention to 
investigate the dynamic of insecticide resistance in Anopheles malaria mosquitoes from a 
subset of CRT villages over the course of the trial.  
 
An. gambiae and An. coluzzii were the only Anopheles mosquitoes identified in the area. 
Although both vector species were found in sympatry throughout the trial, the former appeared 
as the predominant species, and occurred in much higher proportion over the three-year follow-
up period. However, earlier studies investigating the diversity of mosquito species in the study 
area by means of human landing catches (HLC) documented the occurrence of additional 
malaria transmitting mosquitoes including An. funestus and An. nili [27]. Vector composition 
has been shown to vary according to mosquito sampling technique [34] and in the current study, 
mosquitoes used for resistance monitoring were obtained from larval collections rather than 
HLC. It is likely that the difference in mosquito sampling method (HLC versus larval 
collections) might account for the absence of An. funestus and An. nili in the mosquitoes that 
were collected.  
At baseline, the local An. gambiae mosquito population exhibited high prevalence and intensity 
of resistance to pyrethroids, with deltamethrin resistance level as high as 2400 fold (ranging 
1441-2405). This level of resistance increased significantly across study villages and 
intervention arms over the course of the CRT, reaching up to 3000 fold (ranging 1697-3061) 
by the end of the trial. The rise in the level of resistance to pyrethroids suggests that the 
deployment of the pyrethroid-based interventions (SET+LLIN and LLIN alone) had exerted a 
selection pressure on malaria vector mosquitoes. Evidence of an increase in pyrethroid 
resistance following deployment of pyrethroid based interventions, for example pyrethroid 




the temporal change of resistance in response to vector control methods, additional sources of 
selection pressure, namely from agricultural and household use of insecticides [37,38], might 
have contributed to the observed increase in pyrethroid resistance intensity. It is worth 
emphasizing that, while there was clear-cut evidence of a significant increase of resistance 
intensity to deltamethrin, no such pattern was detected in the resistance prevalence data. This 
adds to the existing evidence that diagnostic dose assays, although useful in providing 
information on the spread of resistance, have less potential in detecting major changes in 
resistance intensity [39]. For example, findings from a three-year study in Burkina Faso 
similarly reported no change in pyrethroid resistance prevalence, despite evidence of a 
significant temporal increase in the intensity of pyrethroid resistance [17]. 
 
Results of the study revealed a decreasing trend of vgsc-1014F mutations, which was 
particularly evident in intervention arms. Although unexpected, these findings are consistent 
with a study in Sudan reporting a declining frequency of the vgsc-1014F mutation in An. 
arabiensis following distribution of pyrethroid LLIN [40]. The decrease in allele frequencies 
of kdr mutations, although not unique to this study, are in contrast to the rising level of 
pyrethroid resistance and suggests no contribution of this gene to the change in phenotypic 
resistance.  
Allelic frequency of an emerging resistance gene, for example pyrethroid resistance 
strengthening vgsc-1575Y mutation, is expected to increase further in response to the wide-
scale use of pyrethroid based control tools. However, as shown in this study and elsewhere 
[41], the frequency of the vgsc-1575Y mutation remained relatively low over the study period. 
This is probably due to the fact that this kdr gene co-occurs exclusively with the vgsc-1014F, 
which is almost fixed in most West African countries, thus limiting potential for further 
increase in allele frequency. Indeed, this was evidenced in a recent work showing no significant 
increase of this mutation over a two-year period in a setting where the vgsc-1014F mutation 
had reached fixation in the local populations of An. gambiae [8]. On the other hand, the vgsc-
1014S mutation, formerly limited to East-Africa, is now co-occurring along with vgsc-1014F 
across West Africa. Over the course of the study, this mutation was detected in only one 
mosquito specimen, heterozygote for the mutation, and was found on a vgsc-1014F 
background. While this third variant of the kdr mutation is being reported in an increasing 
number of countries in West Africa [42–44], its allele frequency, as seen in this study, appears 




giving rise to individual mosquitoes bearing the double East (1014S) and West African kdr 
(1014F) mutations [44,45]. This underscores the need for studies exploring the contribution of 
the co-occurrence of these genes to pyrethroid resistance and potential impact on control 
efforts. 
 
Microarray analysis were performed on mosquitoes sampled from study villages before and 
after the CRT to investigate the underlying molecular mechanisms contributing to the 
increasing level of pyrethroid resistance. Resistance to pyrethroid was initially common in the 
area and, was mainly driven by P450 genes: Cyp6P3, Cyp6M2 and Cyp9K1. While these well-
characterised genes were still up-regulated in the 2019 mosquito samples, additional resistance-
associated genes including, most notably P450s (Cyp6P4 and Cyp6Z3), cuticular genes, 
Glutathione-S-transferase (GSTS1) and salivary gland gene (D7r2) were among the most over-
transcribed resistance-associated genes identified at the end of the trial. In a context of 
decreasing pattern of vgsc-kdr mutations, the significant increase in the intensity of pyrethroid 
resistance was probably due to the marked rise of this set of genes, especially those linked to 
pyrethroid resistance, for example P450s and cuticular genes. It should be noted that the top 
emerging resistance-linked enzymes were mostly cuticular proteins belonging to a range of 
protein families (CPLCG, CPCFC, CPR and CPAPn). This suggests that these selected 
cuticular proteins (CPs) may have played a role in the increased phenotypic resistance. 
However, this result should be interpreted with cautious as the microarray data were obtained 
from only two villages and the other villages may have different trends. CPs made up the bulk 
of the mosquito cuticle [46] and, when over-expressed, were shown to be associated with 
cuticle thickening that reduces insecticide penetration and confer resistance to insecticide from 
unrelated classes. The role of cuticular genes in insecticide resistance has, until recently, 
received little attention. However, given the rise of extremely high resistance phenotypes in 
mosquitoes, which are unlikely to be mediated by target-site and metabolic resistance 
mechanisms alone, there is increasing interest in understanding the molecular mechanisms 
underpinning cuticular resistance in Anopheles mosquitoes and its role in pyrethroid resistance 
[46,47]. 
 
The deployment of new PermaNet 2.0 LN in the study area resulted in a significant increase in 
pyrethroid resistance level over the course of the EaveTubes trial, and this was primarily 




COEAE1F. This is consistent with previous studies [41,48] and suggests that, unless control 
methods incorporating insecticides with new mode of action are developed for vector control, 
pyrethroid resistance intensity may evolve further as coverage and net usage rates increase.  
Although a significant temporal increase in pyrethroid resistance intensity was evident in both 
study arms, the level of resistance was comparable between arms over the course of the trial. 
This is in line with the gene expression data showing similar expression level of the most over-
transcribed genes between SET+LLIN and LLIN-only arms at all time points. However, 
because of the dual source of selection pressure from the pyrethroids in the net (deltamethrin) 
and the EaveTubes intervention (beta-cyfluthrin), resistance intensity was expected to be 
significantly higher in the SET+LLIN arm. One possible reason explaining the lack of 
difference in resistance intensity between arms include proximity of control and intervention 
villages with potential for migration of mosquitoes between intervention arms. Indeed, study 
villages were a few kms apart and it is possible that mosquito migration between LLIN and 
SET+LLIN villages made the detection of the difference difficult. This is supported by highly 
variable resistance bioassay and gene expression data, between villages within arms. It is also 
possible that the two-year resistance monitoring period was too short for evidence of stronger 
selection pressure in SET+LLIN arm to be detected in bioassays and resistance genotyping 
analysis. Follow-up resistance monitoring studies in the trial area should be conducted to 
provide a definitive evidence on whether pyrethroid treated EaveTubes combined with 
pyrethroid LLIN exert stronger selection pressure on malaria mosquitoes compared to LLIN 
alone.                                                                                         
The pyrethroid treated EaveTubes intervention was shown to reduce malaria incidence by 38%, 
compared to LLIN alone in this high pyrethroid resistance setting (Sternberg et al, submitted) 
This indicates that despite the significant increase in pyrethroid resistance intensity and 
resistance mechanisms associated with the SET+LLIN intervention, the intervention did 
control malaria to some extent. Nevertheless, the increase in pyrethroid resistance, as shown in 
the present entomological study, is a concern and stresses the need for new product 
development of new active ingredients that show no cross-resistance to existing chemical 
classes that can be deployed in EaveTubes for improved vector control and effective insecticide 
resistance management. 
 
Despite evidence of between-year variation, the resistance pattern remained relatively constant 




prevalence of resistance to PM increased significantly in half of surveyed villages despite no 
on-going PM based IRS in the area. This could indicate selection pressures coming from 
agricultural use of the insecticide. A recent study in Cameroon reported resistance in malaria 
vectors against a new insecticide class for IRS (the neonicotinoid clothianidin), resulting from 
an unregulated use of this chemical for crop protection [49]. This emphasizes that cross-
sectoral collaboration between agriculture and public health is of utmost importance to develop 
resistance management strategies and preserve the efficacy of existing and new insecticides. 
The increase in PM resistance could be due to the rise in the carboxylesterase COEAE1F and 
potentially cuticular proteins. Nevertheless, additional studies are required to uncover the 
resistance mechanisms driving PM resistance in this setting and elsewhere in Africa.  
 
Conclusion 
Deploying pyrethroid treated EaveTubes and LLIN in the same geographical setting was 
associated with a significant increase in pyrethroid resistance level mostly due to over-
expressed P450 genes and potentially cuticular proteins. Although the pyrethroid-based lethal 
house lure was shown to be effective in reducing malaria transmission (Sternberg et al, 
submitted), its impact on pyrethroid resistance compels product development effort to identify 
insecticides that show no cross-resistance with pyrethroids for use in the EaveTubes. As 
previously demonstrated with IRS, deploying EaveTubes with non-pyrethroid insecticides 
against a background of LLIN may slow down the spread of pyrethroid resistance [40,50,51] 
and is the way forward. Given the rise of resistance-associated cuticular genes, there is an 
urgent need for functional genetic validation studies in this area to understand the potential 
contribution of these genes to increasing levels of resistance both to pyrethroids and other 
insecticides (pirimiphos methyl). With kdr mutation reaching fixation level in this part of Côte 
d’Ivoire and in most West African countries, the emergence of highly resistant mosquitoes, as 
demonstrated in this study and elsewhere [41,48], appeared mostly due to metabolic and 
additional resistance mechanism including cuticular genes.                             
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Fig. 5.1 Mean percentage mortalities of Anopheles gambiae s.l. mosquitoes from chosen 
CRT villages following exposure to diagnostic concentration of (A) deltamethrin, (B) 













Fig. 5.2 Mean percentage mortalities of Anopheles gambiae s.l. mosquitoes from study arms 
following exposure to diagnostic concentration of (A) deltamethrin and (B) cyfluthrin in 




Table 5.1: Temporal variation in resistance intensity to deltamethrin in a subset of CRT villages between 2016 and 2019. 
  
 #Susceptible reference strain;  
 LD: lethal doses expressed in μg/mL;  
 RR50: Resistance ratio, calculated by dividing the LD50 of the field mosquito population by that of the susceptible reference strain 





                                      
  2016    2017    2018  2019 
Strains Slope (SE) LD50 (95%CI) RR50    Slope (SE) LD50 (95%CI) RR50  
Change in RR* 
(95%CI)   Slope (SE) LD50 (95%CI) RR50  
Change in RR* 
(95%CI)   Slope (SE) LD50 (95%CI) RR50  
Change in 
RR* (95%CI) 
Kisumu# 1.3 (0.18) 0.01 (0.009 - 0.02) ‒  1.3 (0.18) 0.01 (0.009 - 0.02) ‒ ‒  1.3 (0.18) 0.01 (0.009 - 0.02) ‒ ‒  1.3 (0.18) 0.01 (0.009 - 0.02) ‒ ‒ 
Akan 1.7 (0.18) 27.2 (20.3 - 35.2) 1873  1.6 (0.14) 30.6 (24.7 - 37.3) 2102 1.1 (0.8 - 1.5)  2.1 (0.21) 43.8 (34.9 - 54.8) 2954 1.6 (1.2 - 2.05)  1.7 (0.19) 39.2 (29.7 - 51.0) 2644 1.4 (1.1 - 1.8) 
Kolo 1.5 (0.15) 21.9 (15.8 - 28.5) 1504  1.4 (0.14) 22.5 (16.6 - 29.2) 1549 1.03 (0.7 - 1.4) 1.4 (0.14) 35.3 (26.6 - 45.6) 2375 1.6 (1.2 - 2.1)  1.4 (0.16) 27.4 (19.0 - 37.2) 1884 1.2 (0.9 - 1.7) 
Konzo 1.6 (0.13)  23.5 (19.1 - 28.3) 1617  1.8 (0.13) 26.7 (22.6 - 31.2) 1834 1.1 (0.8 - 1.5)  1.8 (0.19) 46.2 (35.3 - 59.7) 3178 2 (1.5 - 2.6)  1.6 (0.16) 40.8 (31.4 - 52.0) 2803 1.7 (1.3 - 2.3) 
Koua 1.7 (0.17) 22.4 (17.4 - 28.0) 1542  1.6 (0.16) 26.5 (19.9 - 33.9) 1822 1.2 (0.9 - 1.6)  1.8 (0.19) 48.1 (37.4 - 61.1) 3305 2.1 (1.6 - 2.8)  2.0 (0.14) 45.4 (38.4 - 53.5) 3061 2 (1.5 - 2.6) 
NP 2.1 (0.25) 33.7 (25.7 - 43.2) 2314  1.6 (0.13) 34.6 (27.9 - 42.3) 2380 1.03 (0.8 - 1.3) 1.7 (0.18) 39.5 (30.0 - 51.1) 2660 1.2 (0.9 - 1.5)  1.4 (0.14) 37.5 (28.5 - 48.1) 2528 1.1 (0.9 - 1.4) 
Saou 1.7 (0.12) 35.0 (28.9 - 41.9) 2405  1.7 (0.18) 27.0 (20.4 - 34.6) 1855 1  1.9 (0.16) 42.1 (34.5 - 50.9) 2894 1.5 (1.2 - 2.0)  1.8 (0.14) 38.1 (31.6 - 45.7) 2621 1.4 (1.1 -1.8) 
Seou 1.8 (0.14) 21.0 (17.2 - 25.0) 1441  1.5 (0.23) 24.8 (15.5 - 36) 1707 1.2 (0.9 - 1.6)  1.6 (0.19) 38.3 (27.7 - 51.4) 2631 1.8 (1.4 - 2.4)  1.6 (0.12) 25.2 (20.6 - 30.2) 1697 1.2 (0.9 - 1.6) 




 Table 5.2: Temporal variation in resistance intensity to deltamethrin in Anopheles gambiae s.l. from study arms 
 * difference in resistance ratio in mosquito population from the same study arm over two consecutive years. 
 
 









                                    
  2016*    2017    2018  2019 
 Study arms Slope (SE) LD50 (95%CI) RR50    Slope (SE) LD50 (95%CI) RR50  
Change in RR* 
(95%CI)   
Slope 
(SE) LD50 (95%CI) RR50  
Change in 
RR* 




LLIN 1.6 (0.09) 24.7 (21.7 - 28.0) 1701  1.6 (0.09) 27 (23.1 - 31.1) 1854 1.1 (0.9 - 1.3)  1.6 (0.1) 39 (33.2 - 45.5) 2665 1.6 (1.4 - 1.8) 1.5 (0.09) 31.4 (26.5 - 36.7) 2159 1.3 (1.1 - 1.5) 
SET + LLIN 1.6 (0.1) 26 (22.3 - 30.1) 1790   1.5 (0.9) 30.9 (26.1 - 36.0) 2121 1.2 (1.03 - 1.35)   1.9 (0.1) 42.3 (37.2 - 41.9) 2908 1.6 (1.4 - 1.8) 1.8 (0.1) 41.7 (35.9 - 48.2) 2810 1.6 (1.4 - 1.8) 
                                
  2016*    2017  2018  2019 
 Study arm Slope (SE) LD50 (95%CI) RR50    Slope (SE) LD50 (95%CI) RR50    
Slope 
(SE) LD50 (95%CI) RR50    Slope (SE) LD50 (95%CI) RR50  
LLIN 1.6 (0.09) 24.7 (21.7 - 28.0) ‒  1.6 (0.09) 27 (23.1 - 31.1) ‒  1.6 (0.1) 39 (33.2 - 45.5) ‒  1.5 (0.09) 31.4 (26.5 - 36.7) ‒ 




Table 5.4: Variation in allele frequencies of vgsc kdr mutations (1014F and 1575Y) in Anopheles gambiae from study villages between 2016-2019 
                                  
Study arms Species 2016    2017    2018    2019  
N tested F(1014F) F(1575Y)   N tested F(1014F) F(1575Y)   N tested F(1014F) F(1575Y)   N tested F(1014F) F(1575Y) 
LLIN An. gambiae (S) 178 0.97 0.12  178 0.96 0.09  184 0.95 0.11  192 0.98 0.08 
 An. coluzzii (M) 3 0.5 0.00  133 0.68 0.10  108 0.61 0.11  78 0.76 0.08 
 An. gambiae s.l. + M/S 181 0.96 0.12  314 0.84 0.10  293 0.82 0.11  271 0.91 0.08 
                 
SET+LLIN An. gambiae (S) 167 0.97 0.11  126 0.99 0.08  177 1 0.08  181 1 0.06 
 An. coluzzii (M) 19 0.87 0.08  188 0.67 0.07  95 0.68 0.09  90 0.6 0.09 













Fig. 5.4: Temporation variation of estimated marginal means of deltamethrin resistance ratio in 












































































Fig. 5.5 Variation in species composition in chosen study villages between 2016-2019. The green area 
in the pie charts represent the proportion of An. gambiae, the pink area represents the proportion of 














Fig. 5.7 Variation in allele frequencies of vgsc kdr (1014F and 1575Y) mutations in Anopheles 
gambiae from study villages (A-B) and intervention arms (C-D) between 2016-2019. Between 











Fig. 5.9 Box-whisker plots show temporal change in mean fold difference in expression of candidate genes (relative to susceptible colony samples) across villages. The boxes represent the 








Fig. 5.10 Box-whisker plots show temporal change in mean fold difference in expression of candidate genes (relative to susceptible colony samples) across study arms. The boxes represent 





Fig. 5.S1: Interwoven microarray loop design comparing field mosquito samples from two CRT 
villages (one control cluster: np=N’Guessan Pokoukro and one intervention cluster: se=Sessenouan) 
and two lab colonies (kis= An. gambiae Kisumu and ng= An. gambiae N’goussou). Each circle 
represents mRNA extracted from a pool of 10 female An. gambiae s.s. Individuals microarrays are 





Fig. 5.S2 Mean percentage mortalities of Anopheles gambiae s.l. mosquitoes from chosen CRT villages 
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Evaluation of an alpha-cypermethrin + PBO mixture long-lasting insecticidal net 
VEERALIN® LN against pyrethroid resistant Anopheles gambiae: an experimental hut trial 




Background: Long-lasting insecticidal nets (LLINs) are the primary method of malaria 
prevention. However, the widespread resistance to pyrethroids among major malaria vector 
species represents a significant threat to the continued efficacy of pyrethroid LLIN. Piperonyl 
butoxide (PBO) is a synergist that inhibits the activity of metabolic enzymes of the cytochrome 
P450 family known to detoxify insecticides including pyrethroids. Synergist LLIN incorporating 
PBO and a pyrethroid may provide improved control compared to pyrethroid-only LLIN.  
Methods: The efficacy of VEERALIN® LN (VKA polymers Pvt Ltd, India), an alpha-
cypermethrin PBO synergist net was evaluated in experimental huts in M’bé, central Côte d’Ivoire 
against wild pyrethroid resistant Anopheles gambiae. Comparison was made with a standard alpha-
cypermethrin-treated net (MAGNet® LN, VKA polymers Pvt Ltd, India). Nets were tested 
unwashed and after 20 standardized washes. 
Results: VEERALIN® LN demonstrated improved efficacy compared to MAGNet® LN against 
wild free-flying pyrethroid-resistant An. gambiae. Before washing, VEERALIN®LN produced 
mortality of An. gambiae (51%) significantly higher than the standard pyrethroid-only net (29%) 
(P < 0.0001). Although there was a significant reduction in mortality with both LLINs after 20 
washes, VEERALIN® LN remained superior in efficacy to MAGNet® LN (38 vs 17%) (P < 
0.0001). Blood-feeding was significantly inhibited with both types of insecticide-treated nets 
relative to the untreated control net (P < 0.0001). Unwashed VEERALIN® LN induced 
significantly higher blood-feeding inhibition of An. gambiae (62.6%) compared to MAGNet® LN 
(35.4%) (P < 0.001). The difference persisted after washing, as there was no indication that either 
LLIN lost protection against biting or blood-feeding. The level of personal protection derived from 
the use of VEERALIN® LN was high (87%) compared to MAGNet® LN (66–69%) whether 
unwashed or washed. The AI content of VEERALIN® LN after 20 washes decreased from 6.75 
to 6.03 g/kg for alpha-cypermethrin and from 2.95 to 2.64 g/kg for PBO, corresponding to an 
overall retention of 89% for each compound. 
Conclusions: The addition of the synergist PBO to a pyrethroid net greatly improved protection 
and control of pyrethroid-resistant An. gambiae. The pyrethroid-PBO VEERALIN® LN has the 
potential to reduce transmission in areas compromised by pyrethroid resistance.  
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Long-lasting insecticidal nets (LLINs) are considered best practice for malaria prevention in the 
majority of African countries. The estimated proportion of people sleeping under nets in sub-
Saharan Africa rose to 53% in 2015 from a low of less than 2% in 2000. This increase in net use 
has resulted in about half a billion clinical malaria cases averted over the same time period [1]. 
This substantial reduction in malaria cases justifies ongoing efforts by National Malaria Control 
Programmes (NMCPs) to increase ownership and use of LLIN.  
 
Despite the significant headway made, malaria remains a major public health problem in many 
countries. Recent estimates from the WHO World Malaria Report indicate that progress has stalled 
between 2015 and 2017, with some countries even reporting an increase in the number of cases 
[2]. One potential factor contributing to this is the rise in resistance to pyrethroid insecticides in 
malaria vectors across Africa. Although some malaria and health facility surveys in Benin have 
not provided evidence that resistance is adversely affecting malaria transmission or burden [3, 4], 
household and hut trials [5, 6] indicate that pyrethroid resistance can significantly reduce the 
efficacy of standard LLIN for vector control and personal protection. While findings from these 
malaria and health facility surveys in Benin suggested no association between pyrethroid 
resistance and malaria transmission, these are observational studies and therefore provide no 
conclusive evidence on the impact of resistance. Moreover, malaria prevalence remains high in 
many areas of Benin despite the widespread use of LLIN. This emphasises the need for additional 
control measures to improve control and reduce malaria transmission.  
 
Although LLIN may provide some protection against insecticide-resistant Anopheles mosquitoes, 
this may depend on the frequency and strength of the resistance [7–9]. To meet the resistance 
challenge and restore malaria vector control, new active ingredients are being developed and 
tested. A new class of net combines two compounds: the pyrethroid and the synergist piperonyl 
butoxide (PBO) for improved control of pyrethroid-resistant Anopheles mosquitoes. PBO is an 
insecticide synergist which inhibits the action of resistance-associated metabolic enzymes of the 
cytochrome P450 family [10]. The inhibition of P450 enzymes by the PBO results in the pyrethroid 
on the net being available to induce excito-repellency and mortality. The role of these enzymes in 
the detoxification of insecticides including pyrethroids and to cause resistance is well documented 
[11–14]. The addition of PBO to pyrethroid net as a strategy to overcome resistance especially in 
areas where this is driven by overexpression of P450 enzymes known to metabolise pyrethroids 
has been demonstrated in a range of experimental hut trials across Africa [15–19]. Simulation 
modelling suggests that a switch in net policy toward pyrethroid-PBO net would result in up to 0.5 
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clinical malaria cases averted per 1000 people per year [20]. Pyrethroid-PBO net was given World 
Health Organization (WHO) policy recommendation as a new class in 2017 based on 
epidemiological data from a cluster randomized trial in Muleba, Tanzania [21], which showed that 
Olyset® Plus LN (Sumitomo Chemicals Co. Ltd, Tokyo, Japan) reduced malaria-infection 
prevalence by 33% over 21 months of use compared to the standard LLIN, Olyset® Net, under a 
scenario of high pyrethroid resistance and net use. A recent Cochrane review predicted that PBO-
pyrethroid LLIN is expected to be more effective in areas of moderate to high resistance mediated 
by metabolic resistance than in settings of low or no insecticide resistance [22]. 
 
The recommendation of new product class applies to all pyrethroid-PBO nets prequalified by the 
WHO [23]. All of these products differ from Olyset® Plus in terms of their design/specifications, 
which in turn is likely to affect their field performance. Key differences between these products 
include the spatial location of the PBO (all net panels or just the top panel), PBO loading dose, 
type and concentration of pyrethroid and wash-fastness and bioavailability of PBO or partner 
pyrethroid. VEERALIN® LN (VKA polymers Ltd, Tamil Nadu, India) is a new PBO-
alphacypermethrin synergist LLIN that contains PBO on all net panels and recently acquired WHO 
interim recommendation. The Vector Control Product Evaluation Centre (VCPEC) based within 
Institut Pierre Richet (IPR) in Bouaké, central Côte d’Ivoire was therefore commissioned by the 
WHO to undertake a phase-2 experimental hut study of VEERALIN® LN in an area of high 




Study area and experimental huts 
The hut trial was conducted at the M’bé field station in central Côte d’Ivoire, 40 km south of 
Bouaké city. The site is a large rice irrigated valley producing mostly An. coluzzii year-round. The 
mosquito population from the site has developed resistance to multiple insecticide classes. 
Resistance mechanisms include target site insensitivity (1014F and Ace-1) [24] and increased 
activities of insecticide-metabolizing enzymes (esterases, oxidases and GSTs) [25] including 
highly overexpressed CYP6P3 (Oumbouke & N’Guessan, in preparation). A recent investigation 
into the level of resistance to pyrethroids in Anopheles-mosquitoes from the study area reported 
over 1700-fold resistance to deltamethrin [26]. 
The West African style experimental huts were used for the field trial. [27]. They were made of 
concrete bricks, with roofs of corrugated iron, ceilings lined with plastic sheeting and the interior 
walls plastered with cement. Each hut was built on a concrete base surrounded by a water-filled 
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moat to prevent entry of mosquito predators. Mosquitoes enter the hut through four 1-cm wide 
window slits, located on three sides of the hut. Mosquitoes exiting the hut are caught in a veranda 
trap located on the fourth side. 
 
WHO susceptibility assays 
To determine the prevalence of resistance to pyrethroids, WHO cylinder assays were conducted 
using papers treated with diagnostic concentration of 0.05% alpha-cypermethrin, the same 
pyrethroid used in MAGNet® and VEERALIN® LLINs. WHO susceptibility tests were 
performed using 2–3 day-old adult female mosquitoes, collected as larvae from the M’bé field 
station. Four replicates of 25 female mosquitoes were tested in cylinder assays and mortality was 
scored 24 h after exposure. Exposure of the susceptible An. gambiae strain to alpha-cypermethrin 
treated paper in cylinder tube was conducted to check the quality of the insecticide-treated paper. 
Mosquitoes exposed to untreated paper served as control.  
 
LLINs and washing procedure 
MAGNet® LN is a long-lasting net containing 5.8 g/kg alpha-cypermethrin incorporated in 
monofilament, high-density polyethylene (HDPE), 150-denier manufactured by VKA polymers. 
MAGNet® LN received full WHOPES recommendation in 2011 [28]. 
 
VEERALIN® LN is a long-lasting net manufactured by VKA polymers Pvt Ltd, India. Alpha-
cypermethrin is incorporated into 130-denier monofilament polyethylene fibres with a target dose 
of 6.0 g AI/kg (216 mg AI/m2) alpha-cypermethrin and 2.2 g/kg (79.2 mg/m2) PBO.  
 
The nets were washed following the WHOPES-phase II washing protocol [29]. The time for 
regeneration of the active ingredients between washes was 1 day for MAGNet® LN and 5 days 
for VEERALIN® LN and therefore washing was done every 5 days using 2 g/litre soap solution 
(‘savon de Marseille’). One complete washing cycle of each net ran for 10 min as follows: each 
net was first agitated for 3 min then left to soak for 4 min and again agitated for 3 min. Net agitation 
was performed by stirring each net with a wooden pole at 20× rpm. After washing, nets were rinsed 
twice in clean water (10 l per rinsing, i.e. 20 l per net). Nets were dried horizontally in the shade, 







Net treatments and experimental hut trial procedure 
The following treatment arms were trialed in experimental huts: (i) VEERALIN® LN unwashed; 
(ii) VEERALIN® LN washed 20 times; (iii) MAGNet® LN unwashed; (iv) MAGNet® LN 
washed 20 times; and (v) untreated polyester net (100 denier).  
 
These five treatment arms were randomly allocated to 5 experimental huts. To account for potential 
bias due to differential hut attractiveness, nets were rotated among huts every week according to a 
balanced Latin square scheme. Three nets were used per treatment arm and each net was tested 
within hut on 2 consecutive nights during the week. Before the hut trial, holes (16-cm2 in diameter) 
were made in the nets (2 on each side and 1 on each end) to simulate moderately damaged net 
during field use. The huts were thoroughly cleaned and aired for a day at the end of each rotation.  
 
The hut trial spanned 5 weeks (from June to July 2014) corresponding to 30 nights of collection 
per hut. Five local human volunteers gave informed consent and slept in the huts from 20:00 h to 
05:00 h each night. To reduce bias resulting from the inherent difference in individual 
attractiveness to host-seeking mosquitoes, sleepers were rotated between huts on successive 
nights. Each morning, mosquitoes were collected from huts using mouth-operated aspirators from 
inside the room, nets and veranda traps and physiological status (live, dead, unfed, blood-fed, 
semi-gravid, gravid) recorded. Mosquitoes were transported to the laboratory at the Institut Pierre 
Richet (IPR), Bouaké, Côte d’Ivoire, and identified to the species level. Live female mosquitoes 
were provided with 10% honey solution and mortality recorded 24 h later.  
 
Outcome measures 
The following outcomes were used to assess the efficacy of the treatments as per WHO guidelines 
[30]: (i) deterrence: the percent reduction in the number of mosquitoes in treatment hut relative to 
control hut with untreated net; (ii) exit rate; (iii) blood-feeding inhibition rate: the percentage 
reduction in blood-feeding in a hut with treated net compared to a hut with untreated net; (iv) 
percentage mortality of adult females; (v) overall insecticidal effect = 100 (Kt–Ku)/Tu, where Kt 
is the number of mosquitoes killed in the treated hut, Ku is the number dying in the untreated 
control hut and Tu is the total number collected from the control hut [5]; (vi) personal protection; 
percentage reduction in mosquito biting in hut with treated net compared to hut with untreated net 







Determination of alpha-cypermethrin content in unwashed and washed MAGNet® and 
VEERALIN® LLINs was performed before and after washing and post-trial in accordance with 
WHO guidelines [29]. PBO content was also assessed in VEERALIN® LN. A piece of netting 
measuring 30  30 cm was cut from each of the five locations of each net. Extraction of alpha-
cypermethrin and PBO was performed using the CIPAC method [31]. These compounds were 
extracted by refluxing with xylene for 30 min in the presence of dioctyl-phthalate as an internal 
standard and citric acid. Concentrations of alpha-cypermethrin and PBO were subsequently 
measured by Gas Chromatography with Flame Ionization Detection (GC-FID). 
 
Cone bioassays  
The efficacy of VEERALIN® and MAGNet® LLINs was assessed by WHO cone bioassay using 
susceptible An. gambiae before and after washing and after field trial. One hundred 2–5 day-old 
female mosquitoes were subjected to 3 min exposure in replicates of 5 mosquitoes per cone at 25 
± 2 °C and a relative humidity of 75 ± 10% [30]. Mortality was scored 24 h after exposure.  
 
Statistical analysis 
Data were entered into an Excel database and subsequently imported into the R statistical software 
version 2.15.0. for analysis. Proportional outcomes from the bioassays (mortality) and the hut trial 
(exophily, blood-feeding and mortality) were analysed using generalised linear mixed models 
(GLMMs) with a binomial distribution and a logit link function was fitted to the data using the 
lme4 package [32]. Net type and hut were included as fixed effects, and sleepers and day of 
mosquito collection were treated as random effects. Numeric outcomes (number entering each hut, 
feeding and dying) were analysed using generalised linear models with a Poisson distribution. 
Pairwise comparisons were performed using the multcomp package in R [33]. 
 
Results 
WHO susceptibility assays 
Mortality of the susceptible An. gambiae exposed to 0.05% alpha-cypermethrin in WHO 
susceptibility tests was 100%. Mortality of An. gambiae from M’bé exposed to the diagnostic dose 
of alpha-cypermethrin was 68% (n = 108), indicating frequency of resistance to pyrethroids of 






Experimental hut trial 
In the 5-week trial, 1054 An. gambiae-mosquitoes were collected from the control hut, 
representing a mean number of 29 females per night. Both MAGNet® and VEERALIN® LLINs 
reduced hut entry of An. gambiae; unwashed MAGNet® LN reduced entry by 52% and unwashed 
VEERALIN® LN by 65%. There was little reduction of deterrency after washing the two LLINs 
20 times (Table 6.1).  
 
Relative to the untreated control, the proportions of mosquitoes exiting into the verandas was 
significantly greater with each type of insecticide treated net by 47–65% (GLMMs, P < 0.0001) 
(Table 6.1, Table 6.S1 & Table 6.S2). Before washing VEERALIN® and MAGNet® LLINs 
induced similar level of exiting (55%) but after washing exiting was significantly greater for 
VEERALIN® LN (64.7%) than for MAGNet® LN (46.8%) (GLMMs, P < 0.0001). 
 
Blood-feeding was significantly inhibited by insecticide-treated net treatment compared to the 
untreated control net (GLMMs, P < 0.0001). Unwashed VEERALIN® LN induced significantly 
greater blood-feeding inhibition (62.7%) than MAGNet® LN (35.5%) (GLMMs, P < 0.0001) 
(Table 6.1, Fig. 6.1). The difference persisted after washing, being no loss of protection with either 
LN.  
 
All insecticide-treated nets induced greater mortality than the untreated net (GLMMs, P < 0.0001) 
(Fig. 6.2) (Table 6.S1 & Table 6.S2). The unwashed VEERALIN® LN produced mortality of 
51%, although this was significantly greater than that induced by MAGNet® LN unwashed (29%) 
(GLMMs, P < 0.0001). After washing, mortality with the PBO-LLIN and pyrethroid-only LLIN 
decreased significantly to 38.2% for VEERALIN® LN and to 17.3% for MAGNet® LN (GLMMs, 
P < 0.0001); the decrease relative to the unwashed net was 24.8% for VEERALIN® LN and 40% 
for MAGNet® LN.  
 
The level of personal protection derived from the use of VEERALIN® and MAGNet® LLINs 
(unwashed and washed) against An. gambiae-biting ranged between 86.6–87.1% with 
VEERALIN® LN and 66.2–69% for MAGNet® LN before and after washing. The Overall Killing 
Effect was low (< 16%) across all treatments (Table 6.1). Before washing, VEERALIN® LN 
induced significantly greater overall killing effect (15.5%) compared to MAGNet® LN (11.8%), 
but the difference was not significant (GLM, P = 0.41). Although there was a reduction in killing 
effect with VEERALIN® (11.5%) and MAGNet® (6.4%) LLINs after washing, the decrease in 





Mortality rates of the susceptible An. gambiae were 100% with all treated nets assayed in WHO 
cone at the three time points (before, after washing and after field trial).  
 
Chemical analysis 
The mean alpha-cypermethrin content in MAGNet® and VEERALIN® LLINs and the 
concentration of the synergist PBO in VEERALIN® LN are presented in Tables 6.2 and 3. The 
initial concentrations of alpha-cypermethrin in VEERALIN® LN (6.91 and 6.75 g/kg) and 
MAGNet® LN (6.39 and 5.95 g/kg) were close to the target dose of 6 g/kg ± 25% for 
VEERALIN® LN and 5.8 g/kg ± 25% for MAGNet® LN, with a within-net variation of less than 
10%. After washing, the alpha-cypermethrin content was 6.03 g AI/kg for VEERALIN® LN and 
5.65 g AI/kg for MAGNet® LN corresponding to an overall wash retention rate of 89% for 
VEERALIN® LN and 95% for MAGNet® LN. After the 5-week hut trial, there was marginal 
decline in alpha-cypermethrin content (< 15%) with either LLIN washed or unwashed. The initial 
concentration of PBO in the unwashed VEERALIN® LN (2.63 g/kg) was within the acceptable 
range of the target dose of 2.2 g/kg ± 25% but was slightly overdosed in the VEERALIN® LN 
that was destined to be washed 20 times (2.95 g/kg) (Table 6.3). After 20 washes, there was a 
decrease in PBO content from 2.95 to 2.64 g AI/kg, corresponding to an overall wash retention of 
89%. After hut trial, there was a small decrease in PBO content (< 20%, Table 6.3). 
 
The decrease in insecticide content after washing of VEERALIN® and MAGNet® LLINs was 
associated with a significant decrease in hut mortality; however, personal protection was 
maintained and blood-feeding rates did not differ between unwashed and 20 times washed LLINs 




Malaria control and pyrethroid-only nets are under threat from the increasing prevalence and 
intensity of pyrethroid resistance among malaria vectors [34]. To preserve insecticide mosquito 
net technology, the most widely used form of vector-control method, and continue progress toward 
elimination, a class of mosquito net incorporating the synergist piperonyl butoxide (PBO) has been 
developed to neutralise some forms of metabolic resistance to pyrethroids. On the basis of a cluster 
randomised trial of Olyset® Plus LN, which demonstrated epidemiological evidence of the greater 
effectiveness of pyrethroid-PBO nets in areas of resistance, the WHO has conditionally endorsed 
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pyrethroid-PBO nets as a new product class for malaria control in areas where resistance is 
conferred by monooxygenase-based resistance mechanisms. Apart from Olyset® Plus LN, there 
are several brands of PBO LLINs, which are being developed for approval by the WHO 
prequalification team. The purpose of the present study was to evaluate in experimental huts the 
efficacy of the pyrethroid-PBO net, VEERALIN® LN versus the pyrethroid-only net, MAGNet® 
LN, against pyrethroid-resistant populations of An. gambiae mosquitoes at the M’bé field station 
in Côte d’Ivoire. 
 
In experimental huts, MAGNet® LN, an alpha-cypermethrin treated net reduced mosquito 
survival and blood-feeding by approximately 30% for both outcomes. This low effect size 
achieved by MAGNet® LN against pyrethroid-resistant An. gambiae s.l. mosquitoes is consistent 
with findings from previous experimental hut trials with pyrethroid-only LLINs performed at the 
same site [9, 26] and elsewhere [7, 8, 35]. This provides further evidence of the poor performance 
of pyrethroid LLIN in areas where malaria-vectors have developed multiple mechanisms of 
pyrethroid resistance [7, 36].  
 
The addition of PBO to alpha-cypermethrin in the net was associated with a significant 
improvement in control and protection against mosquito bites. VEERALIN® LN killed 
significantly higher proportions (38–51%) of the highly resistant population of An. gambiae 
compared to MAGNet® LN (17–29%). In previous hut trials comparing pyrethroid-PBO net with 
pyrethroid-only nets, e.g. Olyset® Plus versus Olyset® LLINs or PermaNet® 3.0 versus 
PermaNet® 2.0 LLINs, the difference in induced mortality between PBO and standard LLIN could 
not be attributable to PBO conclusively because the original concentration of pyrethroid or the 
bleed rate of pyrethroid in the pyrethroid-PBO net differed from that in the pyrethroid-only LLIN 
[17, 18, 37]. In the present study, the loading dose of alpha-cypermethrin in VEERALIN® and 
MAGNet® LLINs were similar (6 and 5.8 g/kg, respectively) as was the wash retention of alpha-
cypermethrin over 20 washes (89 and 95%, respectively). Therefore, the substantial increase in 
mortality observed with VEERALIN® LN was most likely due to the PBO component, which is 
known to inhibit the activity of key pyrethroid-detoxifying enzymes [10]. However, it should be 
noted that full control of pyrethroid-resistant mosquitoes was not achieved with VEERALIN® LN 
in experimental huts. This could be due to the presence of resistance mechanisms unaffected by 
the synergist PBO. Another plausible explanation could be that the dose of PBO (target dose of 
2.2 g/kg) deployed in VEERALIN® LN and the bleed rate of PBO to the net surface (wash 
retention index = 98.9% per wash) was insufficient to inhibit the range of P450 enzymes associated 
with resistance in the local An. gambiae. For example, in an area of Benin with increased oxidase 
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activity, Olyset® Plus LN containing 5 times higher the loading concentration of PBO (10 g/kg) 
and a much higher bleed rate (wash retention index of 96% per wash) produced significantly higher 
mortality of the local An. gambiae-mosquitoes (67–81%) [18] compared to the effect size with 
VEERALIN® LN in the present study. Of course, the resistance situation in Benin [38] would not 
be directly comparable with the resistance situation in Côte d’Ivoire [24] and care should be taken 
not to overinterpret or compare trial data taken from different locations or times. Nevertheless, 
there is a significant variation in the loading dose and wash retention index of PBO in the current 
brands of pyrethroid-PBO nets pre-qualified by WHO. There is an urgent need for comparative 
trials of the different brands of pyrethroid-PBO LLINs in the same location and time in order to 
rank their efficacy or equivalence. The doses applied to the different brands should be informed 
by calibration studies designed to determine the dose and the optimal bleed rate of PBO required 
to fully inhibit oxidase-based resistance mechanisms in the target vector species. 
 
Apart from the greater killing effect observed with VEERALIN® LN, there was a significant 
reduction in human-vector contact resulting from the high blood-feeding inhibition (60%), 
deterrence (> 64%), exiting of mosquitoes (55–64%) and personal protection (87%). The blood-
feeding inhibition and personal protection against mosquito bites is arguably a more important 
attribute of pyrethroid-PBO LLIN than mortality. While the level of protection induced by 
VEERALIN® LN did not decrease with washing, there was a significant decrease in mortality 
after 20 standardized washes. Nevertheless, VEERALIN® LN remained superior in terms of 
mortality to MAGNet® LN washed to some extent. The significant loss in mortality and 
maintenance of personal protection observed with VEERALIN® LN after washing stresses the 
need for evaluating the durability of PBO net under operational household conditions. Reduction 
in mosquito mortality occurring after washing is a shortcoming common to all existing pyrethroid 
PBO nets. Hut trials with PermaNet® 3.0 LN performed in pyrethroid-resistant areas in Benin [15] 
and Côte d’Ivoire [17] showed a significant decrease in efficacy after washing both in terms of 
mortality and blood-feeding inhibition with the PBO net performing no better than the pyrethroid-
only LLIN. A typical example is the community trial of Olyset® Plus LN in Tanzania: the PBO 
content under rural condition of use decreased by 83% compared to a decrease by only 42% for 
permethrin after 21 months. Despite this decrease in PBO content over this period, a 33% reduction 
in malaria-infection prevalence in children protected with Olyset® Plus LN was still observed 
compared to those living in area covered with Olyset® LN. The superior performance of the PBO 
net Olyset® Plus LN was sustained over 21 months of use in the Tanzanian study and efficacy is 
still being monitored to determine whether this effect is maintained over the assumed net lifespan 




Most hut trials evaluating the efficacy of PBO nets were conducted in areas where An. gambiae 
(s.l.) is the predominant malaria-vector species [15, 17–19]. Hut efficacy data of PBO nets against 
other major malaria vectors including An. funestus and An. arabiensis is mainly confined to East 
Africa. In a recent WHOPES-commissioned hut trial carried out in Ifakara, Tanzania, 
VEERALIN® LN produced low mortality of An. arabiensis and An. funestus, which was not 
significantly different to MAGNet® LN [39]. This contrasts with findings from the present study 
and the difference in performance of VEERALIN® LN in both countries could be attributed to the 
inherent differences in behaviour between mosquito vector species, in the strength/mechanisms of 
resistance or to differences in hut design used [27].  
 
Although the present study demonstrated the potential of VEERALIN® LN to enhance control 
and reduce transmission in areas compromised by pyrethroid resistance, proof of impact on malaria 
metrics would ideally require large scale cluster randomized trials in a West African setting. 
VEERALIN® LN belongs to the same class of net as Olyset® Plus LN. According to the latest 
WHO recommendation on deployment of PBO nets, a candidate PBO net belonging to the same 
class of a net for which epidemiological data are available does not need to be subjected to another 
CRT [40]. Instead, the effectiveness of the candidate PBO net is to be assessed using appropriate 
and relevant entomological endpoints as recently set forth by WHO [41]. Following the 
demonstration by the CRT in Muleba, Tanzania, of the benefit of PBO net over standard pyrethroid 
net on malaria metrics, all currently available PBO nets, have been endorsed by WHO [40]. 
Deployment of PBO net by National Malaria Control Programmes is now advocated for by WHO 
in areas where resistance is mostly driven by monooxygenase-based mechanisms. A second CRT 
currently underway in Uganda is evaluating two types of pyrethroid-PBO net (PermaNet® 3.0 and 
Olyset® Plus LLINs) [42]. This trial may provide evidence on whether the difference in dose and 
location of PBO between these nets under evaluation make any difference to the size of the effect 
on transmission. Given the recommendation to endemic countries to deploy PBO-based LLIN, it 
will be necessary to demonstrate that each type of pyrethroid PBO nets is efficacious against 
metabolic resistant Anopheles mosquitoes. WHO now requires that all second-in-class products 
need to demonstrate equivalence to the first-in-class in experimental hut conditions [40, 41]. 
Studies based on non-inferiority in experimental hut trials that will generate evidence on the 
relative entomological efficacy of all five pyrethroid PBO nets are essential to generate that 







The pyrethroid-PBO VEERALIN® LN was more efficacious than standard pyrethroid-only 
MAGNet® LN in experimental huts both in terms of mosquito mortality and protection against 
mosquito bites and therefore meets WHO interim approval. The study provides evidence on the 
potential of PBO nets to enhance control of pyrethroid-resistant An. gambiae mosquitoes and 
reduce transmission in West Africa.  
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Fig. 6.1 Blood-feeding rates of wild pyrethroid resistant An. gambiae in experimental huts in 
M’bé, Côte d’Ivoire. Error bars represent 95% Cis 
 
 
Fig. 6.2 Mortality rates of wild pyrethroid resistant An. gambiae in experimental huts in 




Table 6.1 Experimental hut trial results of unwashed and 20-times washed pyrethroid-PBO and pyrethroid-only LLIN against pyrethroid 
resistant Anopheles gambiae in M’bé, Côte d’Ivoire 
 
 Note: Values in the same row sharing a letter superscript do not differ significantly (P > 0.05, GLMMs)
  Untreated net MAGNet® LN 0w MAGNet® LN 20w VEERALIN® LN 0w VEERALIN® LN 20w 
Total no. of females caught 1054 506 519 366 377 
Mean no. caught/night 29.2a 14.0b 14.4b 10.2c 10.5c 
% Deterrence  – 52.0 50.7 65.3 64.2 
Total no. of females in veranda 248 279 243 203 244 
% Exiting (95% CI) 23.5 (21.0–26.1)a 55.1 (50.8–59.5)b 46.8 (42.5–51.1)c 55.5 (50.4–60.6)b 64.7 (59.9–69.5)d 
Total no. of blood-fed females 665 206 225 86 89 
% Blood-feeding inhibition  – 35.5 (31.3–39.7) 31.4 (27.4–35.4) 62.7 (57.7–67.6) 62.6 (57.7–67.5) 
% Personal protection  – 69.0a 66.2a 87.1b 86.6b 
Overall insecticidal effect (%) – 11.8a 6.4b 15.5a 11.5a 
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Table 6.2 Content of alpha-cypermethrin in LLINs used in the experimental hut trial 
Treatment Concentration of alpha-cypermethrin (g/kg) 
Before trial After washing After trial 
MAGNet® LN unwashed 6.39 – 6.47 
MAGNet® LN 20 washes 5.95 5.65 5.84 
VEERALIN® LN unwashed 6.91 – 7.40 
VEERALIN® LN 20 washed 6.75 6.03 5.78 
 
 
Table 6.3 Content of piperonyl butoxide (PBO) in VEERALIN® LN used in hut trial 
Treatment Concentration of PBO (g/kg) 
Before trial After washing After trial 
VEERALIN® LN unwashed 2.63 – 3.90 























Exploring alternative insecticide delivery 
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Background: New malaria control strategies, in addition to long lasting insecticidal nets and 
indoor residual spraying, are required to further reduce malaria burden. The In2Care® 
EaveTubes is a house modification designed to block and kill malaria mosquitoes, attempting 
to enter houses, using an electrostatic netting treated with insecticide powder. A previous study 
demonstrated high residual efficacy of insecticide-treated electrostatic netting in semi-field 
setting, but persistence under village condition of use is still untested. The current study 
evaluated the residual bioefficacy of beta-cyfluthrin treated inserts deployed during a cluster 
randomized controlled trial (CRT) of EaveTubes in central Côte d’Ivoire. New generation 
LLINs and IRS insecticides with proven resistance breaking potential were also evaluated 
under semi-field conditions for potential use as alternative methods to deliver insecticides in 
the lethal house lure. 
Methods: Using the previously described “eave tube assay”, the residual efficacy of beta-
cyfluthrin treated inserts deployed in trial villages was evaluated every month, using pyrethroid 
resistant Anopheles gambiae s.l. from central Côte d’Ivoire. Pieces of netting from new 
generation LLINs (PermaNet 3.0 roof, Olyset Plus, and Interceptor G2) were placed inside 
tubes and tested. PVC tubes coated with pirimiphos methyl were also tested as vehicles for 
insecticides in tubes. Performance of these potential alternatives to electrostatic netting, in 
comparison to beta-cyfluthrin treated inserts, was assessed in experimental huts using release-
recapture experiments. Decay of insecticidal activity was monitored at monthly intervals.  
Results: The efficacy of beta-cyfluthrin was relatively short-lived in the field during the CRT, 
with mortality of pyrethroid resistant Anopheles gambiae mosquitoes declining below 80% 
after 4 months. In the release-recapture experiment, mortality rates from the roof of PermaNet 
3.0 (50.4%) and pirimiphos methyl coated PVC tube (66.8%) were in the same range as 
mortality rates from beta-cyfluthrin treated insert (62.8%). However, efficacy was significantly 
lower with both Olyset Plus (25.9%) and Interceptor G2 LNs (21.6%). Persistence of 
insecticides applied on the PVC tube and in the nets was low, with all active ingredients 
showing a significant decrease in activity (< 50% mortality) within 2 months. 
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Conclusion: Beta-cyfluthrin provided effective control of pyrethroid resistant Anopheles 
mosquitoes for only 4 months under field condition. This stresses the need for new formulation 
of insecticides or alternative vehicles of insecticide that give prolonged control of insecticide 
resistant mosquitoes. The level of efficacy with netting from PermaNet 3.0 and PVC tube 
coated with pirimiphos methyl was comparable to the beta-cyfluthrin treatment originally 
selected for use in the CRT. However, the short persistence of these alternative modes of 




















The primary methods of malaria vector control currently in use are long lasting insecticidal 
nets (LLINs) and indoor residual spraying (IRS). These methods prevent disease transmission 
by targeting mosquito behaviours that occurs inside of houses, namely blood feeding and 
resting [1,2]. Even though these strategies have contributed to most of the recent reduction in 
malaria burden across sub-Saharan Africa [3], the disease remains an important public health 
problem, claiming about half a million lives annually [4]. New tools that target mosquitoes 
surviving exposure to insecticide treated surfaces [5] and those biting outside of sleeping hours 
and outdoor [6] are required to build on the recent gains, and meet the control target set forth 
in the World Health Organization (WHO) Global Technical Strategy [7].  
An improved understanding of mosquito ecology and behaviour [8] could inform the design of 
new strategies of control. There is evidence that major African malaria vectors have a strong 
preference for using eave gaps (the space between the roof and the wall) found in many 
traditional African houses as an entry point. This behaviour offers vector control opportunities; 
for example host-seeking mosquitoes could be prevented from entering houses through the 
blocking of eave gap and other openings in house walls [9,10]. Evidence from a number of 
observational and randomized controlled trials suggest that house improvement that prevents 
mosquito entry is associated with reduction of indoor mosquito biting and transmission of 
malaria [11–13]. Although house modification has contributed to malaria elimination in 
developed countries, its potential as a vector control tool remains largely underexploited in 
Africa. However, there is now increasing interest in adding house improvement to the current 
malaria control arsenal [14]. 
While blocking eaves of houses prevent mosquito entry, the strong affinity that mosquitoes 
have for this opening means that it can be targeted for insecticide treatment. In2care EaveTubes 
is a house modification intervention classified generically as a “lethal house lure” 
(https://apps.who.int/iris/bitstream/handle/10665/274451/WHO-CDS-VCAG-2018.03-
eng.pdf) by the WHO Vector Control Advisory Group (VCAG). This control method consists 
of taking sections of plastic pipe and fitting these with a screened insert and installing them 
into a closed eave space. Similarly to open eaves, human odours emanating from houses are 
channelled but through the tubes which takes advantage of the mosquito preference for entering 
through the eaves. The insert placed inside the tube is treated with insecticide powder 
formulation that delivers a lethal dose onto mosquitoes as they attempt to enter house to blood 
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feed. Thus, the lethal house lure, in this case, consists of a physical component comprised of 
netting insert (blocking mosquito entry) and a chemical component (insecticide) used to treat 
the netting. The potential for this approach to control malaria vectors and reduce transmission 
was demonstrated in a number of semi-field and modelling studies [12,13,15–17]. Whether the 
encouraging results from these preliminary small-scale evaluations will impact malaria metrics 
is under investigation in a cluster randomised controlled trial (CRT) in central Côte d’Ivoire 
[18].  
The insert inside the In2Care EaveTubes has a special electrostatic coating which enhances the 
bioavailability of powder formulated insecticides on the netting surface [19]. Evidence from 
previous work show that various active ingredients and formulations with proven resistance 
breaking potential can be deployed on electrostatic netting to good effect when freshly applied 
[19], but only the pyrethroid beta-cyfluthrin was effective over a 9 month period [15]. Although 
the persistence observed with beta-cyfluthrin is encouraging, this high residual activity was 
obtained under controlled conditions, which might be different if evaluated under field 
conditions.  
While electrostatic netting treated with insecticide holds potential for controlling insecticide 
resistant mosquitoes when deployed as a lethal house lure, there is scope for tapping into 
existing technologies including new generation LLINs and IRS insecticides to achieve a similar 
effect when inserted or applied in an eave tube. New LLINs are coming to market, treated with 
a mixture of a pyrethroid and either a synergist (piperonyl butoxide (PBO) [20–23]), an insect 
growth regulator (pyriproxyfen (PPF) [24–26]) or a pyrrole insecticide (chlorfenapyr [27–30]). 
Similarly, there are new IRS products formulated with the organophosphate insecticide 
pirimiphos methyl [31] or the neonicotinoid clothianidin [32]. These new products are effective 
against pyrethroid resistant mosquitoes and could be deployed as a lethal house lure in areas 
with pyrethroid resistant vectors. 
The present study aimed to investigate: (i) the residual activity of pyrethroid treated insert 
under field conditions, and (ii) alternative ways of delivering insecticides in in a lethal house 






Experiments were conducted with Anopheles gambiae sensu lato (s.l.) mosquitoes collected 
around Bouaké, central Côte d’Ivoire. This mosquito population has a high prevalence of 
resistance to the major classes of mosquito adulticides, including pyrethroids [33–35]. 
Mosquitoes were collected as larvae from breeding sites using the dipping method and reared 
to adult in insectary under controlled temperature and humidity conditions (27 ± 2 °C, 60 ± 
20% RH). Larvae were fed on grounded Tetramin baby fish food. Adult mosquitoes emerging 
from pupae were placed in 30cm x 30cm netted cages and maintained on 10% honey solution 
until testing. 
 
Residual activity of beta-cyfluthrin treated EaveTubes insert under field conditions 
This assessment or experiment was done as part of a cluster randomised controlled trial (CRT) 
in central Côte d’Ivoire. Forty villages were selected for the CRT with half assigned to 
EaveTubes plus screening (SET) and LLIN and the other half allocated to LLIN alone [36]. 
The CRT was investigating whether SET provides any added protective benefit against malaria 
transmission on top of LLIN. Beta-cyfluthrin was selected for the CRT based on an earlier 
study that found long-lasting activity (>9 months) of this pyrethroid on eave tube insert under 
controlled, semi-field conditions [15].  
Inserts fitted to houses in the 20 intervention villages were machine-treated by In2care with a 
wettable powder formulation of 10% beta-cyfluthrin (Tempo 10©, Bayer). The dose of 
insecticide applied was in the range 300–500 mg per insert. 
To monitor the efficacy of treated insert under field conditions in real houses, residual activity 
was tested monthly using a subsample of inserts from study villages using the eave tube 
bioassay.  
The procedure of this bioassay was described in detail in Oumbouke et al. [15]. In brief, the 
assay comprises of a 20-cm long plastic tube containing an insert such that it is flush with one 
end of the tube and mosquitoes are introduced into the tube through the opposite end, which is 
fitted with an untreated netting to keep mosquitoes inside the tube. A 1.5L plastic bottle filled 
with hot water and wrapped in stocks worn the previous night was placed behind the insert and 
served as a host cue. Mosquitoes attracted to the heat and odour cues then contact the 
insecticide-laden insert. The eave tube assay is similar to the previously described MCD bottle 
assay [37] in that both mimic the interaction between host-seeking mosquitoes and insecticide-
treated surfaces. To increase host-seeking activity, mosquitoes were starved for 6h prior to 
testing. Approximately 100 mosquitoes in batches of 20-25 were exposed for 1 hour in the eave 
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tube bioassay. Following exposure, mosquitoes were released in netted cages and provided 
with 10% honey solution and mortality scored after 24h.  
Four beta-cyfluthrin treated inserts were sampled from each eave tube village every month for 
this monitoring activity. The number of inserts tested was based on logistical constraints in the 
field. Bioefficacy testing was performed monthly until activity decreased below 80% mortality 
at which point all of the inserts in the villages were replaced with freshly treated inserts.  
Semi-field evaluation of two alternative insecticide delivery approaches in EaveTubes  
Insecticide treatments 
 Insecticide-treated electrostatic netting in tubes was shown to produce a significant reduction 
in overnight mosquito survival in previous semi-field studies [12,15–17]. The experiments 
described here explore alternatives to electrostatic netting for delivering insecticides in this 
system. The following new generation LLIN and IRS insecticides were tested in experimental 
hut surrounded by enclosure at the M’bé field station near Bouaké, central Côte d’Ivoire: 
PermaNet 3.0 roof: PermaNet 3.0 is a long-lasting insecticidal net manufactured by 
Vestergaard S.A. (Switzerland). The top panel, which was tested in the present study, is made 
of monofilament polyethylene (100 denier) fabric and treated with a mixture of the pyrethroid 
deltamethrin at 4g/kg and the synergist piperonyl butoxide (PBO) at 25g/kg. The side panels 
(not tested here) are made of multi-filament polyester (75 denier) fabric with a strengthened 
lower part incorporated with deltamethrin at 2.8g/kg. 
Olyset Plus is a long-lasting insecticidal net manufactured by Sumitomo Chemical (Japan). The 
net is made of 150 denier high-density mono-filament polyethylene yarn incorporating a 
mixture of the pyrethroid permethrin at 20g/kg and PBO at 10g/kg on all net panels. 
Interceptor G2 is a long-lasting net manufactured by BASF (Germany). The net is a dual-active 
LLIN made up of knitted multi-filament polyester fibres incorporating a mixture of the 
pyrethroid alpha-cypermethrin at 2.4g/kg and the pyrrole insecticide chlorfenapyr at 4.8g/kg. 
The organophosphate pirimiphos methyl is a WHO recommended insecticide used extensively 
in IRS campaigns. Capsule suspension formulation of pirimiphos methyl (Actellic CS, Basel, 
Switzerland) was tested in the present study.  





Semi-field performance of the alternative tube treatments was tested in two experimental huts 
at the M’bé field station, near Bouaké, central Côte d’Ivoire. The huts are of the West African 
design [38], 3.25 m long, 1.76 m wide and 2 m high. The interior walls of the huts are made of 
concrete brick, with a corrugated iron roof. A plastic cover was affixed onto the roofing as 
ceiling. Each hut was built on a concrete base with a water-filled moat, to prevent invertebrate 
predators from preying on dead or knocked down mosquitoes. A number of modifications were 
made to the huts for these experiments: (i) six holes were drilled at eave level (1.7 m from the 
ground) on three sides of the hut (two holes on each side), (ii) insecticide treated tubes were 
fitted into the holes, (iii) an enclosure was built around each hut to allow recapture of 
mosquitoes outside of the hut (Fig. 7.1). The semi-field enclosure consists of a wooden frame 
erected on the concrete base, 50 cm from the exterior wall of the hut. The roof was made of 
plastic sheeting which extended beyond the edge of the enclosure as an overhang to prevent 
rain from entering. The bottom half of the frame was made out of wooden panels and the top 
half was screened with polyethylene netting. White plastic sheeting was installed on the floor 
of the enclosure to facilitate the collection of dead mosquitoes. A zipper access door was 
positioned on the front side of the hut to allow entry into and exit from the enclosure. 
Release-recapture experiments 
In the first experiment, six 30 cm x 30 cm netting samples were cut from the LN and inserted 
in tubes in one experimental hut. Six pieces of untreated netting of the same size were placed 
in the second experimental hut, located 50m away. The netting samples were cut from Olyset 
Plus and Interceptor G2 and from the roof panel of PermaNet 3.0 and evaluated on different 
occasions.  
In a second experiment, tubes were dipped in aqueous solution of pirimiphos methyl at 10g/m2. 
The tubes were treated by rolling one tube at a time in insecticide solution for 5 minutes and 
subsequently left to dry for 24h before testing. Tubes treated with pirimiphos methyl were 
screened with untreated netting. A control hut fitted with untreated tube containing untreated 
netting was tested in parallel. In the third experiment, six inserts freshly treated with beta-
cyfluthrin were installed in one experimental hut (the intervention) and six untreated inserts 
were placed in tubes in a second experimental house (the control).  
Two adult volunteers were recruited to sleep in the huts. Volunteers sleepers rotated between 
huts on consecutive nights to account for any potential difference in attractiveness to 
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mosquitoes. The volunteers entered the hut at 20:00h and slept under intact untreated nets. 
Approximately 100 non-bloodfed sugar starved 5-day old female An. gambiae mosquitoes 
were released into each enclosure every release night 15 min after sleepers entered their 
respective huts. Mosquitoes were recaptured the following day at 05:00 inside the enclosure. 
Mosquitoes collected were brought back to the laboratory at Institut Pierre Richet (IPR) in 
Bouake, Côte d’Ivoire. Dead mosquitoes were counted and discarded. Surviving mosquitoes 
were provided with 10% honey solution and any delayed mortality was scored up to 72h later. 
Sample size calculations 
Evidence from previous semi-field studies suggests that insecticidal tube produces about 50% 
reduction in overnight mosquito survival [12,13,15,16]. Based on this, the number of release 
night required to detect a 50% reduction in survival with 80% power and significance level of 
5% was determined for each treatment in the R software using the “pwr” package. Eight 
replicates of release-recapture were performed for each treatment, which according to the 
sample size calculation was above the number required to demonstrate the expected effect size.  
Insecticide susceptibility assays 
Insecticide susceptibility assays were performed to measure susceptibility to the constituent 
actives in the LLINs and pirimiphos methyl in the local An. gambiae mosquito population. 
Diagnostic concentration of the pyrethroids deltamethrin (0.05%), permethrin (0.75%), alpha-
cypermethrin (0.05%) and pirimiphos methyl (0.25%) were tested in WHO cylinders following 
WHO guidelines. A higher concentration of pirimiphos methyl (1%) was also tested in assays. 
Synergist assays were conducted by pre-exposing mosquitoes to PBO, which neutralises the 
activity of the cytochrome P450s involved in pyrethroid metabolism in mosquitoes. Because 
of stability issues with chlorfenapyr on filter paper, adapted Centre of Disease and Control 
(CDC) bottle assays were used to measure resistance to chlorfenapyr. Bottles were coated with 
chlorfenapyr at the diagnostic dose of 50µg/mL [39]. Four replicates of 25 female mosquitoes 
(sugar fed, aged 2-3 days) were exposed for 1h to insecticide treated papers or bottles. Mortality 
was recorded 24h (pyrethroids) and 72h (chlorfenapyr) post-exposure. Mosquitoes in the 






Residual activity of new generation LLINs and pirimiphos methyl treatment  
The residual activity of the best performing alternative delivery methods (PermaNet 3.0 roof 
and pirimiphos methyl coated PVC tube) in the release-recapture experiments was assessed. 
Four 30cm x 30cm pieces from PermaNet 3.0 netting and four PVC tubes treated with 
pirimiphos methyl at the dosages of 1g/m2 and 10g/m2 were tested using the previously 
described eave tube assays [15]. Testing was performed on the netting pieces and the treated 
tubes at monthly intervals. To evaluate AI decay under realistic ambient conditions, the pieces 
of the LN (installed in tubes) and the IRS treated tubes were stored between testing in holes 
drilled at eave level in an experimental hut at the institute. Four replicates of 25 non-blood fed 
6h sugar-starved, 5-day old mosquitoes were tested for each bioassay. Intervention and control 
mosquitoes were monitored for up to 72h before scoring post-exposure mortality. 
When mortality decreased below 50%, the netting samples were washed once and re-tested in 
the eave tube bioassays. Net washing was conducted following WHO guidelines [40]. Briefly, 
the pieces were washed individually for 10 min in a soap solution (savon de Marseille at 2g/L 
of deionised water) using a shaker bath set a 155 movements/min and 30°C. Samples were then 
rinsed twice in clean water for 10min and left to dry for 3-4 hours. Washed netting samples 
were tested only after full regeneration of the active ingredient (1 day) [41].  
Chemical analysis  
Content of deltamethrin and piperonyl butoxide was determined in the roof panel of unwashed 
PermaNet 3.0 netting at month 0, and the washed samples at month 2. Extraction of 
deltamethrin and PBO was performed using the CIPAC method [42]. Both compounds were 
extracted by refluxing with xylene for 30 minutes in presence of dioctyl phthalate as internal 
standard and citric acid. Concentrations deltamethrin and PBO was subsequently measured by 
Gas Chromatography with Flame Ionization Detection (GC-FID). 
Data analysis 
All statistical analysis was performed using the R software version 3.5.3. Residual efficacy 
data across treatments was analysed using generalized linear models (GLMs) with the “arm” 
package. The models included insecticide treatments as independent variable and mosquito 
mortality as the outcome. Interactions between insecticides and residual efficacy testing 
interval were also included in the models. Pairwise comparisons were performed with the final 
model using the “multcomp” package. For the release-recapture experiments, generalized 
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linear mixed models (GLMMs) with a binomial distribution and a logit link function was fitted 
to the data using the “lme4” package. The models included treatment as fixed effect. Enclosure, 
sleepers and release-recapture study nights were treated as random effects. Significance of the 
fixed effect in the model was tested using likelihood ratio test (LRT). Susceptibility bioassay 
data were analysed using a χ 2-square test with Yates continuity correction.  
Ethical approval 
Ethical clearance for the study was obtained from the ethics review committee of the London 
School of Hygiene and Tropical Medicine and the Côte d’Ivoire National Ethics Committee. 
Hut sleepers were all male and > 18 years old. Written informed consent was obtained from all 
volunteer sleepers taking part in the study prior to the release-recapture experiments. 
Results 
Bioefficacy and residual activity of beta-cyfluthrin treated inserts deployed in study 
villages 
Bioefficacy and residual activity of the beta-cyfluthrin treated inserts collected from study 
villages are presented in Fig. 7.2. Five rounds of insert retreatments were done over the two 
years of the cluster randomized controlled trial. Mortality of pyrethroid resistant mosquitoes 
exposed to the beta-cyfluthrin treated inserts from the first two treatment rounds was generally 
< 80% within only three months post-treatment (Fig. 7.2). Beta-cyfluthrin was more durable in 
the subsequent rounds, killing over 82% of An. gambiae by the end of three months (Fig. 7.2). 
While mosquito mortality rates decreased significantly by four months for inserts from the 
second treatment round (<75% mortality, P < 0.05), the decrease in efficacy was marginal in 
subsequent rounds, with inserts producing >80 % mortality of pyrethroid resistant An. gambiae 
mosquitoes.  
WHO susceptibility assays 
The mortality rates of An. gambiae s.l. mosquitoes exposed to the diagnostic concentrations of 
the active ingredients in PermaNet 3.0, Interceptor G2, Olyset Plus, and to pirimiphos methyl 
are presented in Fig. 7.3. Mortality with the pyrethroid insecticides were less than 25%, 
indicating a high prevalence of resistance to this class of insecticide. Pre-exposure to PBO 
resulted in a significant increase in mortality in the pyrethroid resistant An. gambiae 
mosquitoes, from 17 to 38% with permethrin (χ21 = 10.69, P = 0.001) and from 23 to 95% with 
deltamethrin (χ21 = 107.8, P < 0.001). While An. gambiae s.l. mosquitoes exhibited high 
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resistance to the 0.25% pirimiphos methyl diagnostic concentration (54.7% mortality), 
effective susceptibility was restored (100% mortality) was recorded when the dose was 
increased four-fold to 1%. Chlorfenapyr produced 98% mortality confirming susceptibility to 
this non-neurotoxic insecticide. 
Semi-field performance of new generation LLINs and pirimiphos methyl treatment 
deployed as part of a “Lethal House Lure”  
Results from the overnight release-recapture experiments are summarised in Table 7.1. A total 
of 4774 female An. gambiae s.l. mosquitoes were released over the release-recapture study 
period. The proportion of mosquitoes recaptured was consistently high in all experiments (> 
89% mosquito recapture rate). 
Mortality of An. gambiae s.l. mosquitoes released was significantly higher with all insecticidal 
tubes (21.6-66.8%), compared to the untreated control tube (<5%) (P < 0.001).  
Inserts treated with 10% beta-cyfluthrin killed a greater proportion of pyrethroid resistant An. 
gambiae s.l. (62.8%) than did any of the new generation nettings (P < 0.001). PermaNet 3.0 
was the best performing netting, killing about half of the mosquitoes recaptured (50.4%) and 
the difference in kill rate compared to Olyset Plus (25.9%) and Interceptor G2 (21.6%) was 
significant (P < 0.001). Although mortality with Olyset Plus was higher than that with 
Interceptor G2, the difference in efficacy was not significant (P = 0.35). 
Mortality with the 10% pirimiphos methyl treated tube (66.8%) was higher than all of the 
LLINs (21.6-50.4%), P < 0.001) but did not differ significantly from beta-cyfluthrin (62.8%, P 
= 0.57). 
Residual activity  
Based on results from the release-recapture experiments, only PermaNet 3.0 and pirimiphos 
methyl coated tube were assessed further for residual efficacy at different time points (month 
0, month 1, month 2).  (Fig. 7.4 & 5).  
PermaNet 3.0 LN samples in EaveTubes killed a significantly higher proportion of An. gambiae 
s.l. mosquitoes compared to the control untreated net (<5% mortality, Fig. 7.4). Mortality with 
fresh PermaNet 3.0 netting was 98.1%; however, efficacy decreased significantly over time, 
down to 77.8 % by month 1 (P = 0.005) and 45.2% by month 2 (P < 0.001). Washing PermaNet 
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3.0 after month 2 resulted in a significant increase in mortality compared to the unwashed 
PermaNet 3.0 at month 2 (from 45.2 to 76.6, P < 0.01).  
Both doses of pirimiphos methyl (0.25% and 1%) resulted in >98% mortality in pyrethroid 
resistant An. gambiae s.l. at month 0 (P = 0.96, Fig. 7.5). Although the higher dose was still 
effective at month 1 (>80% mortality), there was a significant decrease in efficacy by 75% (P 
< 0.01) with the lower dose. By month 2, efficacy with the 1% pirimiphos methyl declined by 
about 50% compared to month 0, but the reduction in activity was much greater with the 0.25% 
pirimiphos methyl (up to 86%). This indicates a dose-dependent persistence with the higher 
dose of pirimiphos methyl retaining significantly greater residual efficacy over the two month 
testing period. 
Chemical analysis 
The mean deltamethrin and PBO content in the pieces of PermaNet 3.0 netting are presented 
in Table 7.2. The initial concentrations of deltamethrin (4.09 g/kg) in PermaNet 3.0 was close 
to the target dose of 4g/kg±25%. Likewise, the dose of the synergist PBO (24.1g/kg) in 
unwashed PermaNet 3.0 was close to the target concentration of 25g/kg±25%. The mean 
deltamethrin content in the month 2 PermaNet 3.0 netting following one wash was 3.5 g/kg, 
which was still within the target concentration range (3-5g/kg) although the PBO content was 
halved (from 24.1 to 11.42 g/kg) (Table 7.2).  
 
Discussion  
With the international effort to identify new approaches for controlling malaria, there is 
increasing interest in house modification that could lead to reduced risk of malaria 
transmission. The In2Care EaveTubes is an example of such an intervention, designed to block 
mosquito entry points and kill mosquitoes as they attempt to enter the house, by insertion of 
insecticide-treated electrostatic netting in their path to the interior of the house via the eave 
gap. The present study builds on previous work on the resistance breaking potential of netting 
electrostatically treated with insecticide powders under laboratory and semi-field conditions. 
The aim of the current study was to 1) evaluate the residual efficacy of beta-cyfluthrin treated 
inserts placed in inhabited village houses, and to 2) further explore alternative technologies for 
delivering insecticides in tube using a combination of laboratory and semi-field experiments. 
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The bioefficacy and residual activity of beta-cyfluthrin on inserts deployed in trial villages 
showed mosquito mortality below 80% four months after treatment during the first two rounds 
despite higher impact (>80%) in subsequent rounds. Although freshly treated inserts were bio-
effective against pyrethroid resistant mosquitoes, the residual activity recorded in the present 
study was much shorter than in a previous study which showed >80% mortality for over 9 
months [15]. This disparity could be: due to differences in insecticide application method; 
inserts deployed in the trial villages were treated using an ‘insecticide application machine’ 
[18] developed by In2Care, while in the previous study, inserts were treated by hand [15]. It is 
possible that the amount of insecticide deposited by machine treatment was lower than that 
deposited by hand treatment. It could also be possible that the inserts in villages collected dust, 
which could result in reduced bioavailability of insecticide, rather than a decline in insecticide 
content. An effective lifespan of four months for beta-cyfluthrin treated inserts under field 
conditions means that multiple re-treatment rounds would be required to cover the long 
transmission season in holoendemic settings. Thus there is a need for long-lasting formulations 
to facilitate large-scale use of the lethal house lure strategy. 
 While female mosquitoes of endophilic malaria vectors are shown to rest on insecticide-treated 
house wall long enough to pick up a lethal dose of insecticide even when slow-acting 
chemistries are deployed [43,44], evidence from filming studies show that mosquitoes 
attempting to enter people’s dwellings via eave gap in search for a blood meal spend on average 
<5 min on insecticide-treated insert [45]. This suggests that, in order to be effective, the 
insecticide in the tube should have the attributes of fast-killing and high toxicity with capacity 
to control insecticide resistant mosquitoes with an exposure time of just a few minutes. The 
current insecticide delivery system used in the EaveTubes strategy ─the electrostatic coating─ 
meets these criteria and was shown to break resistance even under scenario of transient contact 
time through enhanced bioavailability and high transfer of insecticide [19]. Although the 
electrostatic coating has demonstrative potential, the development of new insecticides and new 
formulations provides opportunities for alternative insecticide delivery methods in the lethal 
house lure. The semi-field performance of nettings from new generation LLINs and tubes 
coated with pirimiphos methyl was evaluated in experimental huts and compared to 10% beta-
cyfluthrin treated insert. The kill rate with beta-cyfluthrin (63%) was in the same range as the 
mortality rates produced by the top of a PermaNet 3.0 or tubes treated with pirimiphos methyl 
(50-66.8%). The mortality observed was broadly consistent with results from previous studies 
of insecticide treated EaveTubes conducted at the same study site and in East Africa 
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[12,13,15,16]. It is worth noting that the ~50% mortality induced by these treatments 
corresponds to the actual proportion of female mosquitoes contacting the tube over a release-
recapture study night (~44%) [15].  
The level of efficacy achieved with the top side of PermaNet 3.0 netting and tube treated with 
pirimiphos methyl (> 50 % mortality) in release-recapture experiments is predicted to have 
significant impact on malaria transmission according to a mathematical modelling study [46]. 
This suggests that alternative mode of delivery of insecticides including pieces of netting from 
synergist LLIN and eave tube dipped in insecticide solution (pirimiphos methyl) could be used 
in “Lethal House Lure” approach for malaria control.  
Although all of the new generation LLINs tested were efficacious against pyrethroid resistant 
female mosquitoes in the semi-field trial, the magnitude of the impact was significantly lower 
with Olyset Plus (permethrin and PBO) and Interceptor G2 (alpha-cypermethrin and 
chlorfenapyr) than with PermaNet 3.0 (deltamethrin and PBO). The difference between the 
roof of PermaNet 3.0 and Olyset Plus LLINs is likely due to the difference in the levels of 
toxicity of the pyrethroids in the net. PermaNet 3.0 is impregnated with type II pyrethroid 
deltamethrin, whereas Olyset Plus is treated with type I pyrethroid permethrin. There is 
evidence that type II pyrethroids, which contains an alpha cyano group, are more toxic than 
type I pyrethroids [47], and this is supported by the results of the WHO susceptibility assays 
where deltamethrin killed significantly higher proportion (95%) of pyrethroid resistant 
mosquitoes pre-exposed to PBO compared to permethrin (38%). In addition to the difference 
in the type of pyrethroid used in these nets, the dose of PBO in the roof of PermaNet 3.0 
(25g/kg) is almost three times higher than that in Olyset Plus LN (10g/kg).  
The poor performance of the dual-active Interceptor G2 was unexpected given prior evidence 
from experimental hut studies with human occupied IG2 LN nets demonstrating high efficacy 
against wild free-flying pyrethroid resistant mosquitoes [30,48]. Susceptibility to chlorfenapyr 
was confirmed in CDC bottle assay, however the efficacy of this non-neurotoxic insecticide 
depends on a number of factors including exposure duration and the mosquito’s circadian 
activity [49]. Chlorfenapyr is a pro-insecticide and is converted by P450 enzymes into its potent 
form at night, when mosquitoes are active. Because the release-recapture studies were 
conducted overnight, it is unlikely that the low mortality observed was a result of chlorfenapyr 
not being metabolised to its toxic form. On the other hand, given that the interaction between 
host-seeking mosquitoes and tubes is relatively transient in EaveTubes [45,50], it is possible 
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that the exposure duration on the mixture net was not sufficiently long for the mosquitoes to 
pick up a lethal dose of chlorfenapyr which could account for the low mortality induced by 
Interceptor G2.  
Persistence of the alternatives in the tubes was low, and no products show effective control of 
pyrethroid resistant mosquitoes beyond 2 months. Pirimiphos methyl was short-lived, even 
when 10 times higher the concentration of Actellic 300 CS was used. The low persistence of 
Actellic CS reported in the present study contrast with results from previous experimental huts 
and randomized controlled trials demonstrating much longer residual activity of pirimiphos 
methyl (>75% mortality for ~one year) on wall substrates commonly found in rural African 
houses [31,51]. The low persistence was potentially due to the difference in substrate type 
(cement wall versus plastic tube). It could also be that environmental factors such as humidity, 
temperature and UV exposure might have contributed to the rapid decline in activity [52].  
Persistence of active ingredients in the new generation LN, PermaNet 3.0 (roof), was also short 
with mortality rates decreasing below 50% within 2 months. Since the nettings were directly 
exposed to environmental conditions, it is likely that the same factors mentioned above might 
have combined to degrade the insecticide in the nets. Washing PermaNet 3.0 roof resulted in a 
partial recovery in efficacy, which was consistent with the chemical analysis results. Indeed, 
about half the initial concentration of PBO remained in the 2 month old PermaNet 3.0 netting 
after one wash, which appeared sufficient to neutralize metabolic enzymes and restore net 
efficacy to some extent. Nevertheless, the rapid decline in PBO content within 2 months could 
impact persistence in the eaves.  
The nets tested in the present study are treated with low concentration of insecticides to reduce 
toxicity to net-users. However, since nets are deployed in tube placed at eave height, and 
therefore out of reach of house residents, higher than currently recommended dose of 
insecticides in net and chemistry not allowed on net due to safety concern could be considered 
to improve efficacy and persistence. Likewise, based on the dose-dependent efficacy and 
persistence pattern with pirimiphos methyl and the position of tubes at eave level, tubes could 
be treated with higher concentrations of insecticide to provide prolonged control of insecticide 
resistant mosquitoes while minimising exposure to house occupants. 
Conclusion 
Beta-cyfluthrin was short-lived on electrostatic netting under field condition when places in 
tubes at the eaves of houses, providing effective control of pyrethroid resistant Anopheles 
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gambiae mosquitoes for only four months. To improve the feasibility of the lethal house lure 
for malaria control, insecticide treatment options were evaluated for improved persistence. 
Coating PVC tubes with an insecticide solution (pirimiphos methyl) and screening tubes with 
netting from new generation LLINs, mainly the top panel of PermaNet 3.0, reduced overnight 
mosquito survival to levels consistent with beta-cyfluthrin treatment. This provides proof of 
principle that existing technologies could be used as alternative mode of insecticide delivery to 
broaden options for deploying insecticide in EaveTubes. However, the short persistence of the 
alternative options investigated calls for further product development for EaveTubes. 
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Fig. 7.2 Average mortality of pyrethroid resistant An. gambiae mosquitoes exposed to 
beta-cyfluthrin treated inserts retrieved from trial villages. Bars represent average 
mortality for the 20 EaveTubes villages. Round indicates insert re-treatment cycle 
performed during the EaveTubes trial; Round1: Mar 17-May 17, Round2: Jul 17-Aug 
17; Round3: Dec 17-Jan18; Round4: Apr18-May18, Round5: Oct 18-Nov 18 . Error 
bars indicate 95% confidence intervals.  
Fig. 7.3 Mortality (%) of wild An. gambiae s.l. from Bouaké, Côte d’Ivoire exposed to 
insecticides in WHO susceptibility bioassays. Error bars indicate 95% confidence 
intervals. *Susceptibility assays with the pyrrole insecticide chlorfenapyr were performed 
































Tubes treated with pirimiphos 
methyl at 10g/m2 
Total released 759 811 754 809 796 807 
% recaptured (95% C.I.) 93.5 (91.7 - 95.2) 91.5 (89.6 - 93.4) 89.5 (87.2 - 91.8) 92.6 (90.8 - 94.4) 94.8 (93.3 - 96.3) 94 (92.4 - 95.6) 




Fig. 7.4 Residual activity in ET bioassays of netting samples from PermaNet 3.0 (roof) LN tested 
against pyrethroid resistant Anopheles gambiae mosquitoes from Bouake with 1h exposure and 
24h recovery. Error bars indicate the 95% confidence intervals. “After washing” corresponds to 
Month2 net samples washed 1X. 
 
 
Fig. 7.5 Residual activity in ET bioassays over 2 months of PVC tube coated with 
pirimiphos methyl at 1g/m2 and 10g/m2 tested against pyrethroid resistant Anopheles 
gambiae mosquitoes from Bouaké with 1h exposure and 24h recovery. Error bars indicate 
the 95% confidence intervals. 
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Table 7.2: Content of deltamethrin and piperonyl butoxide (PBO) in the roof panel of 























































Treatment Concentration of deltamethrin (g/kg) Concentration of PBO (g/kg) 
Unwashed PermaNet 3.0 LN (roof) 4.09 24.1 
   
































Chapter 8: Discussion 
1. Overview of the key findings 
The global push to expand coverage of core vector control tools, namely long lasting 
insecticidal nets and indoor residual spraying, has led to a halving of malaria burden across sub-
Saharan Africa between 2000 and 2015 [1]. Although this success has resulted in a renewed 
interest to eliminate the disease, the recent stagnation in progress observed between 2015 and 
2017 [2] suggests that additional strategies, unaffected by challenges such as insecticide 
resistance, are urgently needed to supplement existing interventions. The prospect of house 
improvement as a malaria control strategy has been discussed in detail in chapter 1 of this thesis. 
This form of vector control, which involves the blocking of mosquito entry routes, is known to 
have contributed to malaria elimination in developed countries, but remains largely 
underexploited in Africa. Based on the historical role of this intervention in malaria control and 
the expanding body of evidence that deliberate modification of houses can reduce malaria 
transmission, there is interest in exploring the disease control potential of this strategy in 
developing countries. The work described in this thesis has focused on a novel type of house 
modification referred to as screening plus In2care EaveTubes [3]. This house-based 
intervention has recently been described by WHO as a “lethal lure house” approach and 
combines house improvement and targeted delivery of insecticide in the eave space to reduce 
human-vector contact and kill insecticide resistant mosquitoes as they attempt to enter people’s 
houses to search for blood meal. As with a bed net, the intervention has a physical component 
that blocks mosquitoes’ entry routes and an insecticidal component (insecticide treated 
EaveTubes). The prospect for this novel control approach to reduce transmission of malaria was 
demonstrated in a range of modelling [4] and semi-field studies [5,6]. Yet, little is known about 
its functioning and potential contribution to malaria control in areas with high pyrethroid 
resistance. Consequently, the present PhD project was designed, as part of a large randomised 
controlled trial of screening plus EaveTubes (SET), to contribute to our understanding of how 
EaveTubes control malaria in pyrethroid resistant area and explore ways to optimise the 
intervention. This was addressed through three specific objectives.  
The first part of this thesis investigated the resistance profile of the local Anopheles mosquito 
population prior to the SET trial (chapter 2) and evaluated the impact on the efficacy of 
pyrethroid-only LLINs against these vectors in experimental hut (chapters 3 & 6). Results from 
these studies reported multiple insecticide resistance in the local An. gambiae mosquitoes with 
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target-site mutations and over-expressed metabolic genes including P450s and 
carboxylesterases as the main underlying mechanisms. The intensity of pyrethroid resistance in 
the area was extremely high, reaching over 2500-fold change in most sentinel sites and, to our 
knowledge, exceeded the levels so far reported in the literature. As a consequence, control of 
the malaria vector with pyrethroid-only LLINs within experimental huts was severely 
compromised (<30% mortality) despite appreciable level of individual protection against 
mosquito bites (31-55% blood feeding inhibition).  
The second part of this work investigated the residual efficacy of a wide range of insecticides 
on the electrostatic netting, which is the insecticide delivery method of the EaveTubes 
intervention (chapter 4). Whether the community-wide deployment of insecticide treated 
EaveTubes exert any selection pressure on mosquitoes was also explored (chapter 5). A range 
of powder-formulated insecticides belonging to various insecticide classes was tested on 
EaveTubes insert and the one with the highest residual efficacy was selected for subsequent 
testing under semi field conditions (chapter 4) and in the SET trial in study villages (chapter 5 
& 7), against the local insecticide resistant mosquitoes. All candidate insecticides were effective 
against highly pyrethroid resistant Anopheles gambiae when freshly applied but only the 
pyrethroid beta-cyfluthrin was longer lasting. The duration of effective action with this 
pyrethroid was > 9 months under semi-field conditions, but did not exceed 4 months under 
village conditions. In experimental huts, EaveTubes treated with beta-cyfluthrin killed all 
mosquitoes that contacted the tube, with evidence that mosquitoes spent on average a minimum 
of 2 min on insecticide treated insert (chapter 4). On the other hand, the community-wide use 
of beta-cyfluthrin treated EaveTubes was associated with a significant increase in the intensity 
of resistance to pyrethroids (chapter 5). This was supported by a significant temporal increase 
in expression of metabolic genes identified prior to the trial (COEAE1F), and the selection of 
new resistance genes, including   cuticular genes. 
Based on the limited persistence of beta-cyfluthrin under village conditions, the third part of 
this study investigated alternative technologies for delivering insecticides in EaveTubes 
including LLIN material treated with a pyrethroid and a synergist, dual-active LLIN material 
and long-lasting IRS insecticide formulation. The synergist LLIN (top panel of PermaNet 3.0) 
and, and the pirimiphos methyl IRS insecticide showed high-level of efficacy against highly 
resistant Anopheles mosquitoes, with the later delivery sytems providing similar level of control 
as beta-cyfluthrin treated insert in EaveTubes (chapter 7). Although these technologies 
demonstrated potential as alternative methods for deploying insecticides in EaveTubes, none of 
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them was found to maintain insecticidal activity beyond two months. This underscores the need 
for additional studies to further optimize this novel vector control concept. 
These results summarise the key findings of the thesis and have been discussed in detail in 
previous chapters. The present chapter, therefore, discusses the findings in relation to current 
knowledge on vector control and highlights potential future directions. 
 
2. Potential contribution of pyrethroid-only LLIN to malaria control in a context of 
increasing level of pyrethroid resistance 
Pyrethroid LLINs have been the major contributor to the recent decline in malaria burden, with 
about 68 % of the gains attributed to the wide-scale use of nets [1]. This progress in control has 
led to intensified efforts by National Malaria Control Programmes to increase net ownership 
and usage. Standard LLINs reduce malaria transmission by providing: (i) personal protection 
to net users via a combination of the physical barrier of the net and the irritant effect of 
pyrethroid, and (ii) community protection through the mass killing of mosquitoes. Given that 
the efficacy of these nets is reliant on the continued susceptibility of vector mosquitoes, the 
widespread emergence of pyrethroid resistance in major African malaria vectors poses a 
significant threat to the future efficacy of this control strategy. Indeed, as shown in chapters 3 
& 6 of this thesis and in previous meta-analysis [7] and hut studies [8–10], the entomological 
efficacy of pyrethroid-only LLIN is being compromised in areas with high pyrethroid 
resistance, and this calls for additional control strategies to meet global control targets. The 
poor performance of these nets in the study area was anticipated, since a range of pyrethroid 
resistance associated mechanisms including knock down resistance mutations (1014F and 
1575Y) and over-production of efficient pyrethroid metabolizing enzymes, mainly P450s (e.g. 
CYP6P3, CYP9K1 and CYP6M2) and the carboxylesterase COEAE1F was detected in the 
local Anopheles mosquito population (chapter 2). 
Although reduced efficacy of pyrethroid LLINs was evident in the mortality recorded in 
experimental hut trials, this disregards the potential impact of pyrethroids on vector longevity 
and blood feeding propensity, which are key determinants of vectorial capacity. Further, age is 
a key factor influencing the susceptibility of mosquitoes to insecticides. The fraction of these 
pyrethroid resistant mosquitoes old enough to transmit malaria in these areas may still be 
suppressed as resistance-linked enzymes were shown to degrade with age [11,12]  
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 A recent investigation of the long-term consequences of pyrethroid exposure on surviving 
pyrethroid resistant mosquitoes reported a delayed mortality effect [13], which was associated 
with a shortening of the mosquito lifespan. Interestingly, pyrethroid insecticides, which induce 
outright killing effects against susceptible mosquito populations, are now acting more like late-
life acting products in the face of increasing resistance. This delayed effect following LLIN 
exposure was predicted to substantially reduce the malaria transmission potential of pyrethroid 
resistant mosquitoes [13], since 9-16 days [14–16] are required for malaria parasites to develop 
and mosquitoes to become infectious. In addition to the delayed effect of pyrethroid exposure 
on mosquito longevity, sub-lethal doses of pyrethroids were shown to impair the development 
of the Plasmodium falciparum parasite within pyrethroid resistant mosquitoes [17]. Together, 
evidence from these studies suggest that the limited level of control induced by pyrethroid 
LLINs in this thesis may still impact malaria transmission. The sub-lethal effect of pyrethroids 
on resistant mosquitoes may, at least partly, explain the disconnect between the continued 
effectiveness of LLIN and pyrethroid resistance. For example, in a recent randomised controlled 
trial in the Gambia, the use of pyrethroid LLINs was associated with a significant reduction in 
malaria prevalence in children sleeping under nets despite high pyrethroid resistance in the local 
Anopheles mosquitoes [18]. This suggests that conventional pyrethroid-only LLIN could still 
provide malaria control benefit and, therefore, supports on-going effort to increase access to 
bed net in malaria endemics areas. However, while the delayed mortality effect of pyrethroid 
may partly mitigate the impact of resistance and thus justify the continued use of standard LLIN 
for malaria control, there is evidence that this effect can be lost when pyrethroid resistance 
increases in intensity. For instance, although in a study by Viana et al [13], there was evidence 
of a sub-lethal effect from LLIN exposure, this effect appeared substantially reduced or absent 
against a population of mosquito with high pyrethroid resistance intensity. Moreover, a recent 
study reported no delayed effect in a lab colony carrying the pyrethroid resistance associated 
vgsc-1014F mutation [19]. These findings are concerning, given the low immediate mortality 
following exposure to pyrethroids LLINs reported in this thesis. The likely absence of impact 
on mosquito longevity following exposure could translate into a loss of community protection 
in this area with high level of pyrethroid resistance. Furthermore, given that insecticide 
concentration declines when nets age, this could exacerbate increasing pyrethroid resistance 
and further reduce LLIN efficacy under field condition.  
The intensity of resistance in this area was extremely high, reaching over 2000 fold prior to the 
roll-out of new pyrethroid LLIN in the study area. How such high intensity of resistance 
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(measured using adapted CDC bottle assays) relates to the field performance of pyrethroid 
based intervention is unclear. Exposing mosquitoes to a range of higher than diagnostic dose 
(E.g. 1X, 5X and 10X) of insecticide is another common way of measuring the strength of 
resistance, and WHO states that “when resistance is confirmed at the 5× and especially at the 
10× concentrations, operational failure is likely” [20]. Although these methods are routinely 
used to measure resistance intensity, reaching a consensus on how to quantitatively measure 
the strength of resistance has recently been stressed [21]. Because the long-term impact of 
pyrethroid diminishes with resistance intensity, studies to estimate the level of pyrethroid 
resistance that is functionally relevant to malaria transmission are crucial. Such data may help 
identify areas where LLINs might no longer be protective, and guide decision-making on 
whether to switch from pyrethroid LLINs to more effective vector control tools. 
Even though LLIN efficacy may be compromised when confronted with resistance, reduction 
of human-vector contact, due to the physical barrier of the net and the irritant property of 
pyrethroids, could still contribute to disease control in the face of increasing resistance. 
Protection against mosquito bites was substantial in these studies (up to 50% blood feeding 
inhibition) and was significantly and consistently higher than that with untreated net. This is in 
line with findings from a meta-analysis of hut data suggesting that pyrethroid LLINs offer 
greater personal protection than untreated nets, irrespective of resistance [22]. In addition to the 
significant inhibition of blood feeding in experimental huts, studies investigating the sublethal 
effect of LLIN exposure reported a reduction in subsequent host-seeking propensity in 
pyrethroid resistant mosquitoes [19]. This significant level of protection from pyrethroid net in 
the presence of resistance provides good rationale for incorporating pyrethroids in the new 
generation of LLINs being introduced to mitigate pyrethroid resistance and improve malaria 
control.  
The substantial contribution of standard LLIN to the recent achievement in malaria control 
means that this vector control tool will remain a core component of the global malaria control 
strategy. Unfortunately, evidence suggest that the scale-up of standard pyrethroid LLIN is 
exerting a selection pressure on malaria vectors. This has been confirmed in the current thesis 
with pyrethroid resistance increasing significantly over time following deployment of new 
PermaNet 2.0 net in the study area (chapter 7). This rise in the level of pyrethroid resistance 
was consistent with a significant increase of metabolic enzymes over time (COEAE1F) and the 
emergence of cuticular proteins known to confer high-level pyrethroid resistance. Increasing 
pyrethroid resistance subsequent to the scale up of standard LLIN has been reported in a range 
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of studies. For example, a study by Yahouedo et al [23], exploring the dynamic of pyrethroid 
resistance following the widespread distribution of pyrethroid LLIN in south-eastern Benin, 
reported a significant increase in the prevalence of pyrethroid resistance, driven by an increased 
transcription of metabolic detoxification genes [23]. Similar findings were reported from DRC, 
with increased prevalence and intensity of pyrethroid resistance coinciding with the scale-up of 
pyrethroid LLIN [24]. Further, the use of pyrethroid treated net was shown to be the driving 
factor for a genetic sweep, which occurred in a region of the genome that control cytochrome 
P450 mediated pyrethroid resistance in Anopheles funestus [25], one of the major malaria 
vectors in Africa. 
The intensification of pyrethroid resistance, which partly results from the continued use of 
pyrethroid treated nets, could have significant control implications as this may further 
compromise existing and new interventions incorporating pyrethroids. In fact, although 
protection against bites appeared substantial against pyrethroid resistant mosquitoes in 
experimental huts, it is noteworthy that this level of protection (30-50% blood feeding 
inhibition) reported in this thesis is much lower compared to levels reported before the advent 
of pyrethroid resistance (>90 % reduction in blood feeding) [8]. This suggests that the potential 
of standard pyrethroid nets to reduce human-vector contact (personal protection), which is 
mostly ascribed to the irritant effect of pyrethroids, may be further undermined as pyrethroid 
resistance increase in intensity. This is a major concern as all the new generation LLINs 
designed to restore net efficacy are incorporated with pyrethroids [26–28]. Monitoring of the 
declining irritant effect of pyrethroids in these new generation LLINs is therefore of utmost 
importance. Pyrethroid insecticides are still used on nets despite increasing report of pyrethroid 
resistance across sub-Saharan Africa because no substitute insecticide with pyrethroid attributes 
is currently available. While new classes of insecticides have recently been approved for use in 
bednets to kill (chlorfenapyr) [26] or sterilize (pyriproxifen) [29] pyrethroid resistant Anopheles 
mosquitoes, these products do not prevent mosquito blood feeding, and therefore cannot be 
used as stand-alone insecticide on nets. There is a significant prospect that if pyrethroid 
resistance continue to increase in prevalence and, more importantly in intensity, the limited 
killing effect and moderate protection from standard nets would be lost. This emphasizes the 
need for insecticides with novel mode of action and innovative vector control strategies to 
improve control of insecticide resistant mosquitoes and reduce malaria burden in Africa south 
of the Sahara. 
3. Deploying insecticides in “eave space” for malaria control: opportunities and challenges 
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There is increasing recognition that additional control measures would be needed to meet the 
malaria control target outlined in the Global technical strategy for malaria 2016-2030 
(GTS)[30]. The potential contribution of house-based interventions to malaria control and 
elimination has been emphasized in the Roll Back Malaria (RBM) global framework for Action 
and Investment to Defeat Malaria 2016-2030 (AIM) [31]. Standard house improvement does 
not generally rely on the use of insecticides to reduce malaria transmission [32]. Nonetheless, 
a number of house modification strategies including In2care EaveTubes [3], insecticide treated 
eave baffles [33] and insecticide treated eave and window screening [34] have an insecticidal 
component which, according to modelling simulation [4], could contribute to a community-
wide effect under high coverage scenario. The insecticide delivery system of the EaveTubes 
intervention investigated in the present study is the electrostatic netting. As discussed in chapter 
1, this new insecticide application method holds insecticide particle via polarity and was shown 
to improve the efficacy of some of the WHO-licenced adulticides against insecticide resistant 
African malaria vectors through enhanced bioavailability [35]. Even though an early lab study 
has shown that insecticide could be applied on electrostatic netting to control susceptible and 
resistant Anopheles mosquitoes, only a couple of insecticides have been tested (deltamethrin 
and bendiocarb) with no evidence that a broader range of chemicals could be deployed to good 
effect [35]. This was addressed in chapter 4 of this thesis, with results showing that most freshly 
applied insecticides from a wide range of insecticide classes including pyrethroid, carbamate, 
organophosphate, neonicotinoid, entomopathogenic fungus and boric acid were effective (45-
100% mortality) against a population of An. gambiae mosquitoes with extremely high 
pyrethroid resistance (>1700 fold resistance to deltamethrin) [36]. This high level of control 
was confirmed in experimental huts with hut mosquito mortality (50-60%) broadly consistent 
with previous semi-field studies conducted in Kenya [5] and Tanzania [6]. Data from lab and 
hut studies showed that about 50% of the mosquitoes released, which corresponds to the 
percentage mortality, came into contact with the electrostatic netting over a release-recapture 
study night with further evidence that mosquitoes spent a minimum of 2min on the netting. 
Although these results provide some new insight into the behavioural interaction between 
mosquitoes and electrostatic netting within EaveTubes, additional studies using video-
recording approach are needed to investigate how interaction varies across different classes of 
insecticides and mosquito species. Such study may offer new insights for improving the 
EaveTubes intervention. While not all host-seeking mosquitoes make contact with the 
insecticide treated netting during a study night, presumably due to a reduced flow of human 
odour passing through the screened tube [5], a recent study showed that the proportion of female 
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mosquitoes encountering the netting increases significantly over subsequent study nights [37]. 
However, these studies were conducted under semi field condition and disregarded the potential 
impact of human behaviour. In fact, it is likely that the proportion of mosquitoes that come in 
contact with the netting might be lower than reported here, especially in village conditions 
where people spend time outdoors for various activities and represent readily accessible sources 
of a blood meal.  
 The finding that various classes of insecticides with different modes of action can be 
successfully deployed in EaveTubes is positive from a resistance management perspective, as 
it provides prospects for using multiple insecticides in rotation, mosaic or mixture. The 
rotational use of insecticides in EaveTubes can be implemented at national, sub-national, village 
or even household level with different classes of insecticides deployed such that mosquitoes are 
exposed to various insecticides with contrasting mode of action. This may delay or prevent 
emergence of resistance in the targeted mosquito population. The implementation of such a 
WHO recommended resistance management strategy is currently challenging with indoor 
residual spraying, given that only a limited number of insecticides are currently available for 
spray campaign- although considerable efforts are being made, mainly through the NgenIRS 
project and the Zero by 40 initiative, to bring new IRS insecticide formulations to market. 
Nevertheless, while insecticides with novel modes of action may become available in a near 
future for vector control, it is likely that these new or re-purposed chemicals will be cost-
prohibitive especially for IRS. These insecticides might be best suited for the EaveTubes 
strategy or related interventions, as a comparatively smaller amount of insecticide is required 
per house protected. Another crucial opportunity with deploying insecticide in eave space is 
that the location of the treatment, which is generally out of reach from house occupants, allows 
the use of insecticides that are considered unsafe in existing mainstay vector control tools 
(LLINs and IRS). Although most of the active ingredients currently approved for use in vector 
control has been tested on the electrostatic netting in this thesis, future studies testing other 
promising WHO PQ listed vector control products, for example chlorfenapyr (pyrrole), 
clothianidin (neonicotinoid) and the insect growth regulator piriproxyfen, are needed.  
The electrostatic technology provides significant prospect for diversifying the range of 
insecticides available for vector control. However, its application has been limited to the 
EaveTubes strategy, which is suitable only for a particular type of houses (brick-walled houses). 
As discussed above, eave baffles are a related mode of insecticide delivery in houses, which 
could be deployed in poorer-quality dwellings for malaria control. Previous studies have shown 
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that a broad range of insecticide could be applied on eave baffle to reduce human-vector contact 
and thus transmission [33,38]. Deploying a spatial repellent in eave ribbon wrapped around 
open eaves was also shown to expand the protection zone to include the immediate vicinity of 
the house and prevent transmission occurring in the peri-domestic area [39]. Data from another 
recent study suggests that this approach can be used to protect migratory farmers living in 
temporary (makeshift) houses [40]. The use of spatial repellents in eave spaces also provide a 
push-pull based control opportunity as mosquitoes repelled from houses could be subsequently 
caught up in a mosquito trap positioned outdoor [41]. These different modes of delivering 
insecticide in mosquito house entry area including electrostatic netting, eave baffles and eave 
ribbons provide a significant opportunity for extending the lethal house lure strategy to the wide 
range of house types found in malaria endemic settings. In addition to the above benefits 
associated with deploying insecticide in eave spaces, such an approach also holds potential to 
reduce outdoor transmission, though this is beyond the scope of this thesis. Recent evidence 
does indicate that outdoor biting mosquitoes will enter people’s houses at some point during 
their lifetime [42] before they become infectious and, therefore, could be targeted at house entry 
point (eave of houses) with insecticide deployed either on electrostatic netting or alternative 
insecticide delivery systems. Given the increasing importance of outdoor malaria transmission 
and the significant challenge this poses for malaria control and elimination, the potential of 
house-based intervention to reduce transmission occurring outdoor should be further explored. 
While mosquitoes might rest on indoor interventions (E.g. insecticide treated house wall) for a 
longer period of time, evidence from previous studies reveal that mosquito contact time around 
house entry point is comparatively shorter [43,44]. This is one of the main challenges associated 
with controlling mosquitoes in eave spaces and has implications for target product profile 
choices. The transient nature of mosquito contact with EaveTubes implies that insecticides with 
fast-acting effect may be preferred over deterrent or slow-acting products. As discussed above, 
the electrostatic coating technology was shown to kill resistant mosquitoes even when contact 
time is as short as a few seconds [35]. For example, in chapter 4 of this thesis, 5 seconds 
exposure of a highly pyrethroid resistant mosquitoes to pyrethroid treated electrostatic netting 
produced >50% mortality in lab assays. These results support the use of such modes of 
insecticide delivery system in eave spaces. 
Although the location of EaveTubes provides opportunities for using insecticides considered 
unsuitable for use in traditional interventions (due to the close proximity with humans), 
products deployed in this area are directly exposed to environmental factors (temperature, 
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humidity and UV-light exposure) known to break down insecticides [45]. While these factors 
were shown to degrade insecticide in indoor interventions (LLINs and IRS) [45], the effect is 
likely much greater with EaveTubes due to the more direct exposure. This could explain the 
unexpectedly short residual activity with some of the insecticides (for example the 
organophosphate pirimiphos methyl) tested in EaveTubes, despite previous studies reporting 
higher residual activity with the same products applied as an IRS [46,47]. It is also worth noting 
that the electrostatic netting in the EaveTubes differs from traditional substrate and this might 
also account for the shorter duration of insecticidal activity on the electrostatic netting. 
Exposure to UV-light is likely the most significant factor involved in insecticide degradation. 
Therefore, development of insecticide formulations with UV protection additives that protect 
the active ingredient from the impact of sunlight could prolong the duration of effective action 
of chemicals deployed in eave of houses. 
Of all the insecticides tested under semi-field condition, only the pyrethroid beta-cyfluthrin was 
found to be long-lasting (> 80% mortality for more than 9 months) with mosquito mortality 
with the other products decreasing below 80% within one month. Persistence with beta-
cyfluthrin was lower still (< 4 months) under village conditions. These results have been 
discussed in detail in chapter 4 and 6. As reported with durable wall lining [48], dust 
accumulation either from cooking or other sources results in the insecticide on the electrostatic 
netting being covered with dirt which lead to a reduction in the amount of insecticide 
bioavailable to the mosquitoes. This suggests that the rapid decline in residual activity observed 
in this study with most insecticides may not necessarily equate to an actual decrease in 
insecticide content. Analysis of the data on monthly persistence bioassay and the chemical 
content of the electrostatic netting at each testing time point (not measured in this study) might 
have provided more insight into this.  
The short persistence of insecticide on electrostatic netting under village conditions is a 
significant challenge which needs addressing before the EaveTubes intervention is considered 
for wider use in public health. Alternative insecticide delivery options were investigated in this 
thesis and included netting from new generation LLINs and an IRS insecticide formulation 
(Chapter 7). Results from these studies showed that substituting the electrostatic netting with a 
netting treated with pyrethroid and PBO mixture or dipping the tube in an aqueous solution of 
pirimiphos methyl produced level of control of pyrethroid resistant mosquitoes in experimental 
hut broadly similar to pyrethroid treated electrostatic netting. Although these alternative means 
of delivering insecticide in EaveTubes were short-lived, it should be noted that only standard 
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doses of insecticides that are recommended in IRS or LLINs have been tested. As discussed 
above, the location of the EaveTubes provides scope for using higher than recommended 
concentration of insecticides with prospect for boosting efficacy and residual activity. 
 
4. Insecticide resistance management potential of insecticide treated EaveTubes 
The resistance breaking impact of the electrostatic technology was confirmed in the present 
thesis (chapter 4), using a population of Anopheles mosquitoes that exhibits an extremely high 
intensity of pyrethroid resistance. Although there is an unequivocal evidence that such 
insecticide application method can improve the efficacy of existing WHO approved insecticides 
against resistant malaria vectors, little is known about its potential from a resistance 
management perspective. In chapter 5 of this thesis, resistance to a range of insecticides from 
major chemical classes including pyrethroid was monitored in a subset of CRT villages, to 
investigate any potential changes in pyrethroid resistance in response to the deployment of 
pyrethroid treated EaveTubes and standard pyrethroid LLIN in the study area. Results from this 
study showed a significant increase in the intensity of pyrethroid resistance in both study arms 
(SET + LLIN and LLIN only arm) over time, but this was significantly higher in the EaveTubes 
arm (SET+LLIN). The increase in the level of pyrethroid resistance was consistent with a 
significant increase in detoxification genes associated with pyrethroid resistance (P450s and 
potentially cuticular genes). It is possible that the pressure from the EaveTubes component 
might be playing a more important role in the increase in pyrethroid resistance reported. In fact, 
in the EaveTubes arm, mosquitoes are in theory less exposed to pyrethroid LLINs because 
houses are made mosquito proof. Therefore, the selection pressure will mostly come from the 
pyrethroid in the EaveTube. The selection of a pyrethroid (beta-cyfluthrin) for the CRT was 
based on its good residual activity under semi-field condition, commercial availability, safety 
and existing country regulatory approval. Interestingly, the community-wide use of pyrethroid 
EaveTubes was associated with a 38% reduction in malaria incidence (Sternberg et al, 
submitted), which provides proof of the malaria reduction potential of this novel vector control 
concept. However, the reported impact of this intervention on the selection of pyrethroid 
resistance suggests that pyrethroid version of this strategy may be unsuitable from a resistance 
management standpoint. Indeed, combination of interventions incorporating the same class of 
insecticides are not recommended, as this increases insecticide selection pressure [49]. Non-
pyrethroid version of the EaveTubes strategy should therefore be considered for vector control.  
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5. Insecticide resistance in central Côte d’Ivoire and implication for future vector control  
The spread of insecticide resistance in African malaria vectors is one of the most important 
challenges facing National Malaria Control Programmes (NMCPs) and may be a contributing 
factor to the recent increase in malaria burden in a number of countries. Anopheles gambiae 
mosquitoes from this part of Côte d’Ivoire have developed multiple insecticide resistance, 
which is mostly underpinned by target site mutation and metabolic genes of the P450 family. 
Standard pyrethroid LLIN is the only vector control strategy currently used in the country. As 
demonstrated in this thesis, community-wide use of pyrethroid based control strategies is 
associated with the escalation of pyrethroid resistance in Anopheles gambiae mosquitoes. This 
implies that pyrethroid resistance may further increase in prevalence and intensity in malaria 
endemic countries as efforts to increase standard bednet ownership and usage intensify.  
Apart from the EaveTubes and screening strategy, which was found to be effective in this area, 
the significant role of metabolic resistance in the reported pyrethroid resistance suggests that 
synergist LLINs may provide improved control of the local pyrethroid resistant malaria vectors. 
Interestingly, the synergist LLIN VEERALIN tested in experimental hut in chapter 6 was found 
to be more effective in controlling this population of Anopheles mosquitoes compared to 
standard LLIN in terms of mosquito mortality and protection against mosquito biting. The 
chlorfenapyr plus alpha-cypermethrin mixture net (Interceptor G2 LLIN) could also be an 
alternative control option, as a previous hut study demonstrated a significant potential of this 
dual-active net to control malaria transmission in this area (> 80 % mortality, > 40% blood 
feeding inhibition) [10]. Whether this new class of net provides any additional protection 
against malaria transmission compared to a standard pyrethroid-only LLIN is currently under 
investigation in randomized controlled trials in Benin and Tanzania. In addition, 
implementation pilot studies are underway in selected African countries to assess the cost-
effectiveness of this net under operational condition. Although the concept of deploying a 
pyrethroid plus an insect growth regulator (pyriproxyfen) on bednet showed promise as a vector 
control strategy against pyrethroid resistant mosquitoes in previous studies [27,50,51], the 
presence of P450s enzymes, which were shown to metabolise piriproxyfen, suggests that this 
new generation net may not improve control in this area. This is illustrated by the limited impact 
of Olyset Duo against malaria in Burkina Faso (incidence rate ratio 0·88 [95% CI 0·77-0·99; 
p=0·04) [52]. 
Indoor residual spraying with the organophosphate insecticide pirimiphos methyl is being 
deployed in a range of countries to improve control of pyrethroid resistant Anopheles 
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mosquitoes [53,54]. However, the report of organophosphate resistance in the study area 
suggests that insecticides with novel modes of action are needed. The neonicotinoid 
clothianidin which acts as an agonist on nicotinic acetyl choline receptors, is a new insecticide 
developed to combat pyrethroid resistance. A recent hut study in Benin has demonstrated the 
potential of this slow-acting insecticide to control pyrethroid resistant mosquitoes [55] and 
could be an effective control strategy in this setting with resistance to multiple insecticides. It 
is, however, worth noting that instances of suspected resistance to clothianidin have been 
previously reported in various African countries [56]. This underscores the need to investigate 
the status of resistance to this insecticide in the local Anopheles mosquitoes before this chemical 
could be considered for use in this area.  
Although most of the alternative control strategies described above have demonstrable vector 
control potential and could be used in the study area to improve malaria control, they only target 
the feeding and resting behaviour of female mosquitoes. However, there is a range of promising 
control interventions that target different stages of the mosquito life cycle and holds significant 
potential against highly resistant malaria parasite vectors [57,58]. These additional measures 
could be deployed either alone or in combination with other effective interventions in an 
integrated fashion to improve control of insecticide resistant mosquitoes. For example, the 
natural feeding behaviour of both male and female mosquitoes offers control opportunities as 
sugar source could be targeted with insecticide to control resistant malaria mosquitoes. Such 
approach is referred to as Attractive Targeted Sugar Bait (ATSB) and has been successfully 
tested alone and in combination with current standard of care (LLIN) against highly pyrethroid 
resistant mosquitoes in semi-field [59,60]. A recent large-scale field trial evaluating the efficacy 
of ATSB in combination with standard LLINs in Mali demonstrated a significant reduction in 
mosquito density and entomological inoculation rate [61]. In addition to sugar feeding, adult 
mosquitoes were shown to aggregate into swarms for mating at specific sites where they could 
be targeted with an insecticide spray. In a recent study in Burkina Faso, targeting mosquito 
swarm with an aerosol insecticide was associated with a significant reduction in the size of the 
mosquito population and a change in male mosquito age structure towards younger male 
mosquitoes that are unable to mate [62]. Other interventions including larval source 
management (LSM), which involves the management of mosquito breeding sites to prevent the 
immatures stages of mosquito from reaching adulthood and has proven effective in a range of 
settings [63,64]. While challenges associated with the existence of multiple and inaccessible 
mosquito larval habitats have limited the potential of this intervention, there is now interest in 
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using drone technology [65], for example to map out mosquito breeding sites for a more 
efficient targeting of immature stages of mosquitoes. A randomised controlled trial evaluating 
LSM in combination with house improvement and standard net is currently underway in 
Malawi [66]. This CRT should provide evidence on whether an integrated vector management 
approach using these interventions provides any added protective benefit compared to current 
standard of care. Gene drive is one of the new contemporary control methods which is receiving 
increased attention and may be a game changer for malaria control. This novel control strategy 
involves the spread of genetic traits in the wild mosquito population to reduce mosquito vector 
competence (E.g. gene that impedes parasite development within mosquito) [67] and/or 
vectorial capacity (e.g. genetic traits which reduce mosquito survival or fertility) [68] which are 
both key determinants of malaria transmission. Although not exhaustive, this list of potential 
alternative control strategies, in addition to the EaveTubes intervention investigated in this 
thesis, might be effective against the multiple insecticide resistant mosquitoes from the study 
area and in settings with similar resistance profile. Nevertheless, fully powered randomised 
controlled trials are required to demonstrate the epidemiological impact of most of these 
promising control interventions in setting with differing level of resistance and transmission 
intensity before consideration for use in public health. Given that these trials are costly and 
lengthy to conduct, studies are currently underway to investigate whether key entomological 
indicators from experimental hut studies could be identified and used as a proxy to predict 
potential epidemiological impact of new control interventions  
6. Limitations and Future perspective  
The current thesis was designed to better understand the functioning of the EaveTubes 
intervention and how this strategy control malaria in an area with high pyrethroid resistance. 
While the resistance breaking potential of this novel control strategy was demonstrated against 
a highly resistant population of Anopheles gambiae, none of the new generation IRS 
insecticides including the recently PQ listed IRS insecticide clothianidin was evaluated for 
residual efficacy on electrostatic netting. The low residual activity of the insecticides screened 
in this thesis for bioefficacy and residual activity calls for further product development studies 
to identify longer lasting insecticide for use in EaveTubes. New insecticide formulation mixed 
with UV-resistant additives should be considered to prevent insecticide breakdown and thus 
prolong the duration of effective action of insecticide in EaveTubes. Further investigation of 
alternative insecticide delivery options including netting from new generation nets is equally 
important to broaden the scope for deploying insecticides in EaveTubes for malaria control. 
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Standard netting incorporating doses higher than those tested in the current thesis should also 
be evaluated. Additionally, filming studies to better understand mosquito behaviour around the 
eave of houses could inform further optimization of the intervention. Although the electrostatic 
technonology was efficacious against the local highly resistant An. gambiae mosquitoes, the 
impact of this new insecticide delivery system was not tested against An. funestus, the second 
major malaria vector species in the study area. This limitation was due to the fact that 
mosquitoes used in resistance monitoring studies were sampled from breeding sites typical for 
Anopheles gambiae, which were readily accessible in the study area unlike for An. funestus. 
Future studies should rely on F1 generation of mosquitoes obtained from blood fed, indoor 
resting females mosquitoes. This sampling method, in contrast to larval collection, capture all 
major malaria vectors mediating tramsmission in the area. Another limitation to the study is 
that information on the use of insecticides for crop protection in the area was not collected. This 
data would be useful to understand the potential contribution of additional sources of insecticide 
selection pressure to the reported increase in pyrethroid resistance in the area. 
The positive and significant correlation between pyrethroid resistance intensity and gene 
expression provide evidence that reliable DNA-based resistance markers could provide a means 
for tracking the spread of insecticide resistance. The development of these markers are urgently 
needed for a more efficient monitoring and management of insecticide resistance in African 
malaria vectors. The deployment of the pyrethroid treated EaveTubes and standard LLIN in the 
study area have given rise to additional genes, especially several linked to cuticle formation. 
Understanding of the potential impact of cuticular resistance, which can cause cross resistance 
across insecticide classes is crucial. Functional genetic validation studies, for example RNAi-
induced knockdown of these genes, should be performed to investigate their potential role in 
the reported temporal change in phenotypic resistance. 
7. Conclusion 
Although pyrethroid LLINs have contributed to most of the gains achieved over recent years, 
the recent stalling of progress means that new control interventions are urgently needed. Indeed, 
data from this study confirmed that pyrethroid resistance is undermining the entomological 
efficacy of standard LLIN in a setting where high allelic frequency of target site mutation and 
over-expression of pyrethroid metabolizing enzymes are reported in Anopheles gambiae 
mosquitoes. Targeting these mosquitoes using the electrostatic technology was shown to restore 
the efficacy of existing insecticides that are less effective when deployed through traditional 
delivery system (LLIN and IRS). Moreover, this work provides evidence that mosquitoes that 
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come into contact with the electrostatic netting are killed in about 2 min, which makes the 
electrostatic netting a suitable insecticide delivery system for the EaveTubes strategy or similar 
house-based intervention given the transient nature of mosquito behaviour around eave space.  
While further studies are required to further optimize the EaveTubes intervention, its potential 
to reduce vectorial capacity of highly pyrethroid resistant Anopheles gambiae mosquitoes and 
thus malaria transmission has been demonstrated in this thesis. Notably, the CRT showed 38% 
reduction in malaria incidence associated with the use of the intervention compared to existing 
control method in an area with high transmission intensity and pyrethroid resistance. The 
expanding housing market in Africa provides an opportunity to incorporate protective features 
in house design to reduce malaria transmission. However, as with any intervention that targets 
the built environment, the lack of existing distribution pathways means that cross sectoral 
collaboration between public health and the housing sector will be crucial for deploying house 
based interventions in Africa for malaria control. 
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Annex 1: List of current WHO prequalified long lasting insecticidal net, as of September 2020 
Net brand name Manufactuerer name and address Active ingredient 
Olyset Net Sumitomo Chemical Co., Ltd, Japan Permethrin 
Olyset Plus Sumitomo Chemical Co., Ltd, Japan Permethrin, Piperonyl butoxide 
Interceptor BASF SE, Germany Alpha-cypermethrin 
Interceptor G2 BASF SE, Germany Alpha-cypermethrin, chlorfenapyr 
Royal Sentry Disease Control Technologies, LLC, USA Alpha-cypermethrin 
Royal Sentry 2.0 Disease Control Technologies, LLC, USA Alpha-cypermethrin 
Royal Guard Disease Control Technologies, LLC, USA Alpha-cypermethrin, pyriproxyfen 
PermaNet 2.0 Vestergaard SA, Switzerland Deltamethrin 
PermaNet 3.0 Vestergaard SA, Switzerland Deltamethrin, Pieronyl butoxide 
Duranet LLIN Shobikaa Impex Private Limited, India Alpha-cypermethrin 
Duranet Plus Shobikaa Impex Private Limited Alpha-cypermethrin, Piperonyl Butoxide 
MiraNet A to Z Textile Mills Ltd, Tanzania Alpha 
MAGNet V.K.A. Polymers Pvt Ltd, India Alpha-cypermethrin 
VEERALIN LLIN V.K.A. Polymers Pvt Ltd, India Alpha-cypermethrin, Piperonyl Butoxide 
Yahe LN Fujian Yamei Industry & Trade Co Ltd, China Deltamethrin 
SafeNet  Mainpol GmbH, Germany Alpha-cypermethrin 
Yorkool LN Tianjin Yorkool International Trading Co., Ltd, China Deltamethrin 
Panda Net 2.0 LLIN LIFE IDEAS Biological Technology Co., Ltd, China Deltamethrin 
Tsara Boost NRS Moon netting FZE, Dubai Deltamethrin, Piperonyl butoxide 
Tsara Plus NRS Moon netting FZE, Dubai Deltamethrin, Piperonyl butoxide 
Tsara Soft NRS Moon netting FZE, Dubai Deltamethrin 
Tsara NRS Moon Netting FZE, Dubai Deltamethrin 
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Annex 2: List of current WHO prequalified insecticides for indoor residual spraying, as of September 2020 
Net brand name Manufactuerer name and address Active ingredient 
SumiShield 50WG Sumitomo Chemical Co., Ltd, Japan Clothianidin 
Fendona 10 SC BASF SE, Germany Alpha-cypermethrin 
Fendona 6 SC BASF SE, Germany Alpha-cypermethrin 
Fendona 5 WP BASF SE, Germany Alpha-cypermethrin 
RUBI 50 WP Tagros Chemicals India Pvt. Ltd Alpha-cypermethrin 
RUBI 100 WP Tagros Chemicals India Pvt. Ltd Alpha-cypermethrin 
RUBI 50 SC Tagros Chemicals India Pvt. Ltd Alpha-cypermethrin 
RUBI 100 SC Tagros Chemicals India Pvt. Ltd Alpha-cypermethrin 
RUBI 250 WG-SB Tagros Chemicals India Pvt. Ltd Alpha-cypermethrin 
PALI 250 WG Tagros Chemicals India Pvt. Ltd Deltamethrin 
Revival 100 WP Tagros Chemicals India Pvt. Ltd Lambda-cyhalothrin 
Revival 100 CS Tagros Chemicals India Pvt. Ltd Lambda-cyhalothrin 
Pendulum 6 SC Gharda Chemicals Limited Alpha-cypermethrin 
ICON WP Syngenta Crop Protection AG, Switzerland Lambda-cyhalothrin 
K-Othrine WG250 Bayer S.A.S., France Deltamethrin 
K-Othrine Polyzone  Bayer S.A.S., France Deltamethrin 
Ficam Bayer S.A.S., France Bendiocab 
Bayer S.A.S. Bayer S.A.S., France Clothianidin, Deltamethrin 
Actellic 300CS Syngenta Crop Protection AG, Switzerland Pirimiphos-methyl 
Actellic EC Syngenta Crop Protection AG, Switzerland Pirimiphos-methyl 
ICON 10 CS - IRS Syngenta Crop Protection AG, Switzerland Lambda-cyhalothrin 
Bistar 10 WP  FMC Corporation, Philadelphia, USA Bifenthrin 
Vectron20WP Mitsui Chemicals Agro, Inc., Japan Etofenprox 
FastM Saerfu (Henan) Agrochemical Co., Ltd., China Bendiocarb 
 
